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Parkinson’s disease (PD) is the second most common neurodegenerative disease in indus-
trialized countries. However, the molecular mechanisms leading to neuronal death in PD still 
remain unclear. About 5-10% of PD patients suffer from familial forms of the disease and so 
far, 16 chromosomal regions have been associated with familial PD. As disease progression 
and outcome of familial and sporadic forms of the disease are very similar, studying the cel-
lular function of genes associated with familial PD might hopefully yield in a better under-
standing of the molecular pathways that are involved in the disease pathogenesis. Two major 
pathways have been proposed to be causing neuronal cell death in PD: dysfunction of the 
cellular protein degradation machineries and accumulation of misfolded proteins as well as 
mitochondrial dysfunction. The aim of the present study was to investigate the cellular func-
tion and toxicity of two PD-associated genes, α-synuclein (αS)/PARK1 and 
ATP13A2/PARK9, in the nematode C. elegans. 
 
Protein aggregations in the brain of PD patients, the so-called “Lewy bodies”, are one of the 
main pathological hallmarks in PD. The main component of Lewy bodies is the protein αS. 
Mutations, as well as increased expression levels of αS, have been shown to cause familial 
PD. In both cases increased aggregation rates of αS have been demonstrated. Therefore, 
until now it was believed that fibrillar αS aggregates cause neurodegeneration in PD. It re-
mained unclear however, whether insoluble fibrillar aggregates of αS or rather smaller oligo-
meric precursors are causing toxicity. To address this question we decided to compare the 
aggregation properties and toxicity of different variants of αS including synthetic variants that 
do not form fibrillar aggregates but stop aggregation at the stage of small soluble oligomers. 
This analysis revealed that the oligomer-promoting variants exhibit higher toxicity than wild 
type (wt) αS or the PD mutants. This suggests that not the fibrils but rather the soluble oligo-
mers are the toxic species of αS. However, it remained unresolved which molecular mecha-
nisms are involved in mediating αS toxicity. To shed light on this aspect, the effects of αS on 
mitochondrial morphology were investigated. It was previously reported that αS can localize 
to mitochondria and that overexpression can cause mitochondrial pathology. Electron mi-
croscopy (EM) and spinning disk confocal microscopy analysis demonstrated that mitochon-
drial morphology is severely affected in both C. elegans muscle cells and neurons express-
ing αS. While expression of wt human αS in muscle cells induces both mitochondrial frag-
mentation and the occurrence of long and thin mitochondrial tubules, expression of the oli-
gomer-promoting variant of αS, for which increased toxicity was demonstrated, predominant-
ly leads to long, thin and interconnected mitochondria. Based on these observations we pro-
pose a model in which the effects of αS expression on mitochondrial morphology are de-
pendent on the relative abundance of different species of αS (monomeric vs. different oligo-
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meric forms and fibrils) and their relative amounts. The finding that mitochondrial fragmenta-
tion is also occurring in aged worms without expression of αS suggests that expression of αS 
accelerates the physiological aging process. 
 
The second part of my PhD thesis is concerned with the cellular function and toxicity of an-
other PD-related gene, the lysosomal P-type ATPase catp-6, which is the C. elegans ortho-
log of human ATP13A2 (PARK9). Phenotypic analysis of deletion mutants of this gene re-
vealed severely impaired egg laying which causes a strong reduction in brood size. The mu-
tants also exhibit a markedly delayed postembryonic development. Thus, asynchronous de-
velopment of different tissues might be causing the defects in the egg laying apparatus as 
coordinated differentiation is crucial for establishing the connection of the different tissues 
involved in egg laying. Furthermore, a locomotion defect, which is already apparent at larval 
stages and can be rescued by restoring CATP-6 function specifically in muscle cells, was 
detected in catp-6 mutants. This raised the question what causes these defects on a cellular 
level. As a functional interaction of CATP-6 and αS was reported previously and given that 
αS causes drastic reorganization of the mitochondrial network, it was decided to investigate 
mitochondrial morphology and function in deletion mutants of catp-6. Loss of function of 
CATP-6 leads to severe changes in mitochondrial morphology with formation of networks of 
long and very thin mitochondrial tubules and clustering of mitochondria around the nucleus. 
The observations that the mitochondrial fission protein DRP-1 forms large clusters in catp-6 
mutants and that RNAi against drp-1 did not change mitochondrial morphology in catp-6 mu-
tants suggest that loss of function of DRP-1 might be the cause for reorganization of the mi-
tochondrial network in catp-6 mutants. Besides morphological defects, also functional im-
pairments of the mitochondria were observed upon loss of function of CATP-6, with deletion 
mutants exhibiting a reduced membrane potential, changes in the composition of complex IV 
as well as increased oxygen consumption. A possible explanation for the latter might be an 
up-regulation of mitochondrial mass. catp-6 mutants moreover exhibited increased sensitivity 
to oxidative stress and a reduced lifespan. In agreement with this, the mitochondrial stress 
response was found to be strongly up-regulated in catp-6 mutants. Future investigations are 
needed to determine whether these effects could be due to excess reactive oxygen species 
(ROS) production by the mutants caused by defects in the respiratory chain. In line with mi-
tochondrial function being compromised in the mutants, we see an increased activation of 
the cellular energy sensor AMPK, which, in reaction to a rise in the cellular AMP/ATP ratio, 
acts to inhibit anabolic process and stimulate catabolic processes in the cell in order to main-
tain the cellular energy balance. In future studies it will be important to determine the exact 
molecular and cellular mechanisms how loss of function of the lysosomal P-type ATPase 
CATP-6 can cause such drastic effects on mitochondrial morphology.  






2.1. Parkinson’s Disease 
 
Parkinson’s disease (PD) is the second most common neurodegenerative disease in hu-
mans. The cardinal symptoms of PD are tremor, rigor and bradykinesia (Parkinson, 
2002)[reviewed in (Fahn, 2003)]. These symptoms are caused by a massive degeneration of 
dopaminergic (DA) neurons in the substantia nigra (SN). The SN is part of the basal ganglia 
– a deep brain region that is involved in movement control – especially in the planning and 
initiation of movements (Brodal, 2004). Factors contributing to the particular vulnerability of 
DA neurons of the SN to cell death in PD will be discussed in section 2.2.1 of this introduc-
tion. At later stages of the disease, the pathology spreads to other brain regions and even at 
early stages, other parts of the brain can be affected. For example, patients often suffer from 
disturbances in olfaction before their movement becomes affected, which is also supported 
by histological examinations revealing histological alterations in the olfactory bulb at early 
stages of the disease (Braak et al., 2004). The major risk factor for developing PD is age. 
While the disease prevalence in Europe is about 1% for persons at the age of 65-70, this 
value rises to 3-4% if a population between 80 and 90 years of age is considered (de Rijk et 
al., 1997). On the histological level, PD is characterized by the occurrence of proteinaceous 
inclusion bodies in the surviving dopaminergic neurons (Lewy, 1912) [reviewed in (Forno, 
1996; Shults, 2006)]. These inclusions are called Lewy bodies (LBs) and are mainly com-
posed of aggregated proteins. The picture of a LB is shown in Fig. 2.1.  
 
 
The most abundant protein in LBs is α-synuclein (αS) (Baba et al., 1998; Spillantini et al., 
1998; Spillantini et al., 1997; Takeda et al., 1998), a protein that has been linked to genetic 
cases of PD (Kruger et al., 1998; Polymeropoulos et al., 1997; Zarranz et al., 2004). As LBs 
are a very characteristic feature in post-mortem brains of PD patients, they were for a long 
time considered to be causative for neurodegeneration. However, it is important to keep in 
Fig. 2.1: Lewy bodies are the histological hallmarks of PD. 
α-synuclein staining reveals the presence of a large Lewy body (LB) 
and smaller cytoplasmic inclusions (CI) in SN neurons of PD pa-
tients. Reprinted by permission from Macmillan Publishers Ltd: 
[Nature Reviews Molecular Cell Biology] Ross and Poirier, copyright 
(2005). (Ross and Poirier, 2005). 
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mind that the analysis of material from patients that have died with manifested PD can only 
deliver insight into late stages of the disease because symptomatic manifestation starts only 
after a considerable portion of SN nigra neurons have already died. Only those neurons that 
have survived over the course of the disease can be subjected to histological analysis. 
Therefore, it is even possible that inclusion of misfolded proteins into large bodies has a pro-
tective role when compared to smaller aggregates distributed throughout the cell. Currently, 
the treatment of PD is symptomatic and aims in restoring DA levels in the striatum, the region 
to which DA neurons of the SN are projecting. This is achieved by treatment with L-DOPA, a 
precursor of DA that can pass the blood-brain-barrier and is metabolized to DA in the brain. 
Alternatively, COMT- (catechol-O-methyl transferase) and MAO-B- (monoamine oxidase B) 
inhibitors, which inhibit the degradation of DA, or DA agonists can be used for treatment of 
PD. However, all of these options are aiming to compensate the reduced DA levels but do 
not prevent further degeneration of neurons. A protective treatment that increases survival of 
the neurons would be desirable. In order to develop such treatments, it is necessary to first 
identify the molecular mechanisms that are involved in initial steps of the disease. Another 
task will then be to find biomarkers that allow an earlier diagnosis so that treatment could be 
started before the occurrence of massive neurodegeneration. 
 
 
2.1.1. Particular vulnerability of DA neurons in the SN 
 
The DA neurons in the SN of the midbrain seem to be particularly susceptible to neuro-
degeneration in PD. Although there are some other brain regions that also show signs of 
pathology like the locus coerulius (LC), the dorsal motor nucleus of the vagus or the basal 
nucleus of Meynert in the brain stem, DA neurons in the SN seem to be most severely af-
fected. Three characteristic features of these neurons have been proposed as a reason for 
their particular sensitivity to PD pathogenesis. 
 
First, DA neurons produce neuromelanin, a pigment that is responsible for the dark appear-
ance of the SN. Neuromelanin is generated by the auto-oxidation of catecholamines, i.e. do-
pamine. Two nuclei in the human brainstem are exhibiting high levels of this pigment – the 
SN and the LC. Notably both are affected in PD. Although under physiological conditions 
neuromelanin might have a protective effect by chelating redox-active metal ions; it might 
become toxic under conditions of increased iron concentration as observed in PD patients 
(Dexter et al., 1991). It was proposed that in case of an overload with iron, neuromelanin 
promotes the generation of reactive oxygen species (ROS) (Double et al., 2002; Enochs et 
al., 1994; Youdim et al., 1994) More recently, neuromelanin was shown to inhibit the pro-
teasomal system (Maruyama et al., 2006; Shamoto-Nagai et al., 2004) and, as dysfunction of 
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the ubiquitin-protea¬some system (UPS) seems to be one of the main pathogenic mecha-
nisms of PD, this inhibition might contribute to the increased vulnerability of the SN neurons. 
Furthermore, it was shown that neuromelanin induces oxidative stress in mitochondria and 
causes mitochondrial dysfunction (Shamoto-Nagai et al., 2004) and is thus also affecting the 
second major pathway of PD pathogenesis. 
 
The second aspect for the increased susceptibility of SN DA neurons is their neurotransmit-
ter DA or, more precisely, DA metabolites. DA metabolism leads to the formation of H2O2 and 
dopamine-quinone and these metabolic products are causing oxidative stress [reviewed in 
(Lotharius and Brundin, 2002)], thus rendering these neurons more vulnerable to PD patho-
genesis, also going along with mitochondrial dysfunction and increased occurrence of ROS. 
Given the already high load of ROS in DA neurons due to the DA metabolism, toxic thresh-
olds are reached faster in these cells. Furthermore, it was reported that DA can form cova-
lent adducts with αS which in turn leads to the stabilization of proto-fibrillar variants of αS 
(Conway et al., 2001; Norris et al., 2005) that have been hypothesized to be the toxic species 
of αS (Volles and Lansbury, 2003). 
 
The third characteristic feature of the DA neurons in the SN, which might explain their partic-
ular vulnerability, is that they exhibit a continuous pace-making activity that is driven by 
L-type Ca2+-channels (Chan et al., 2007). The Ca2+-ions that thereby enter the cell have to be 
transported out again, and this transport is ATP-dependent. Thus, an increased ATP produc-
tion by the mitochondria in these neurons is required which in turn also leads to increased 
oxidative stress (Guzman et al., 2010). The basal ganglia neurons of the SN tend to oscillate 
and synchronize their activity (Brown, 2006). During these synchronous bursts of high activity 
SN neurons consume high amounts of oxygen for ATP production and therefore particularly 
rely on functional mitochondria. Thus, basal levels of ROS and the energetic requirements 
are increased in this cell type which leads to an increased sensitivity to oxidative stress and 
mitochondrial dysfunction emerging during PD pathogenesis. 
 
 
2.1.2. Genetics of PD 
 
Both environmental and genetic factors seem to play a role in the disease pathogenesis and 
aging is the major risk factor for developing PD. Only about 5-10% of PD cases suffer from 
familial forms of the disease (Corti et al., 2011; Toulouse and Sullivan, 2008), which in com-
parison to sporadic cases are often characterized by an earlier onset and sometimes also 
present with atypical signs such as dementia and dystonia. However, sporadic and genetic 
forms of PD share many symptomatic and histological features and it is thus assumed that 
the molecular mechanisms underlying disease pathogenesis are similar in the two forms. 
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Therefore, investigation of the cellular function and toxicity of the genes that are linked to 
familial PD will also help to get a better understanding of the molecular pathways involved in 
disease pathogenesis of sporadic PD. To date, at least 11 genes have been associated to 
PD (Corti et al., 2011) and the most relevant of these will be discussed below. An overview of 
the PD-related genes is shown in Table 2.1. So far, two major pathophysiological pathways 
of PD have been described – disturbance in the UPS and increased protein aggregation on 
the one hand [reviewed in (Olanow and McNaught, 2006)] and disturbance of mitochondrial 
function and oxidative stress on the other hand [reviewed in (Bueler, 2009; Burbulla et al., 
2010; Vives-Bauza et al., 2010a)]. An overview of the pathways involved in PD pathogenesis 
and the effects of different PD-associated genes on these pathways is depicted in Fig. 2.3 at 
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Table 2.1: Overview of PD-associated genes. 




The gene encoding α-synuclein (αS), SNCA, was the first gene linked to autosomal domi-
nantly inherited PD [reviewed in (Corti et al., 2003)]. Furthermore, αS was shown to be the 
predominant component of Lewy bodies (Baba et al., 1998; Spillantini et al., 1998; Spillantini 
et al., 1997; Takeda et al., 1998) and changes in the promoter region of the SNCA gene 
seem to be associated with sporadic forms of the disease (Mueller et al., 2005; Pals et al., 
2004). It was shown, that increased expression levels of αS, as observed in the case of mul-
tiplication of the locus, are sufficient to cause PD (Chartier-Harlin et al., 2004; Farrer et al., 
2004; Ibanez et al., 2004; Singleton et al., 2003). Therefore, overexpression of αS has been 
used to generate animal models of the disease (Auluck et al., 2002; Lakso et al., 2003; 
Masliah et al., 2000).  
 
α-synuclein encodes for a small 140 aa protein which belongs to the group of natively un-
folded proteins (Weinreb et al., 1996). αS can bind lipids (Kubo et al., 2005; Sharon et al., 
2001) and adopts a more structured α-helical conformation when associated to membranes 
(Eliezer et al., 2001). Furthermore, an interaction of αS with the presynaptic co-chaperone 
CSPα, which protects against high neuronal activity, was demonstrated [reviewed.in 
(Chandra and Südhof, 2008)] The protein is very prone to aggregation which involves for-
mation β-sheet structures and which initially was thought to be the cause for toxicity. αS is a 
member of the synuclein protein family which also comprises β- and γ-synuclein but only αS 
is associated to PD. Initially, αS was found as a component of amyloid plaques in Alz-
heimer’s disease and was therefore called NCAP (non-amyloid beta-component of plaques) 
[reviewed in (Corti et al., 2011)]. The neuronal protein αS is present at presynaptic terminals 
and several studies have implicated a role in regulating synaptic functions including vesicle 
release and DA metabolism (Murphy et al., 2000; Perez et al., 2002) [reviewed in (Stefanis, 
2012)]. It was reported that expression of αS disturbs cellular membrane trafficking by block-
ing vesicle transport between endoplasmic reticulum (ER) and Golgi (Cooper et al., 2006) 
and Golgi fragmentation was reported to be caused by pre-fibrillar αS aggregates (Gosavi et 
al., 2002). Due to the sequence homology to 14-3-3 chaperone proteins, αS was proposed to 
function as a chaperone and this could be experimentally confirmed (Ostrerova et al., 1999; 
Souza et al., 2000). Investigation of the degradation of αS revealed that it can be degraded 
via the two cellular degradation pathways, the UPS and autophagy (Ebrahimi-Fakhari et al., 
2011; Webb et al., 2003). Furthermore, it was reported that αS itself can inhibit both cellular 
degradation pathways, the UPS as well as autophagic degradation via lysosomes (Cuervo et 
al., 2004; Martinez-Vicente et al., 2008; Snyder et al., 2003; Winslow et al., 2010) thereby 
contributing to its own accumulation and toxicity. 
 




Mutations in ATP13A2/PARK9 have been associated with Kufor-Rakeb syndrome (KRS), a 
parkinsonian syndrome that is characterized by more generalized brain atrophy than in typi-
cal PD and that causes additional symptoms aside the motor deficits that are seen in PD 
patients (Ramirez et al., 2006). Most of the mutations identified in KRS patients were found 
to lead to truncated variants of the protein and it was reported that these variants are re-
tained in the ER instead of being transported to lysosomes, the physiological site of 
ATP13A2 action (Ramirez et al., 2006). Therefore, it can be assumed that the KRS muta-
tions in ATP13A2 cause a strong loss of function of ATP13A2. Later on, heterozygous frame 
shift mutations and homo- as well as heterozygous missense mutations of ATP13A2 were 
also identified in PD patients (Di Fonzo et al., 2007; Djarmati et al., 2009; Fong et al., 2011; 
Lin et al., 2008). 
 
ATP13A2 belongs to the superfamily of P-type ATPases which are involved in the transport 
of inorganic ions but also other substrates across membranes. P-type ATPases are charac-
terized by the formation of a phosphorylated intermediate during the course of their reaction 
cycle (Axelsen and Palmgren, 1998; Kuhlbrandt, 2004). The domain structure of P-type 
ATPases comprises 10 transmembrane domains, an actuator domain, a phosphorylation 
domain and a nucleotide binding domain. In Fig. 2.2 the structure of P-type ATPases and a 
schematic drawing of the reaction cycle are depicted. The family of P-type ATPases is divid-
ed into five subfamilies according to their substrate specificities (Axelsen and Palmgren, 
1998; Kuhlbrandt, 2004; Schultheis et al., 2004) and ATP13A2 belongs to the class of 
P5-type ATPases for which the substrate specificity remains to be determined (Axelsen and 
Palmgren, 1998; Kuhlbrandt, 2004; Moller et al., 2008). It was proposed that ATP13A2 is 
involved in transporting divalent cations like Cd2+ and Mn2+ based on the observation that in 
yeast, deletion of the ATP13A2 ortholog Ypk9 causes increased sensitivity to these cations 
(Gitler et al., 2009; Schmidt et al., 2009). At the time when this study was started, it was 
known that wild type ATP13A2 is localized to lysosomes and that truncated mutants accumu-
late in the ER, but the cellular function of the protein as well as the molecular mechanism 
causing toxicity in the mutants were uncharacterized. In 2009, Gitler et al. reported a func-
tional link between ATP13A2 and αS with co-expression of ATP13A2 ameliorating αS-
induced toxicity in several models (Gitler et al., 2009).  
 






PINK1 (PTEN-induced putative kinase 1) is a Serine/Threonine kinase that has been linked 
to early-onset autosomal recessive PD. A mitochondrial targeting sequence is located at the 
N-terminus of the protein and mitochondrial localization was shown in several studies (Clark 
et al., 2006; Silvestri et al., 2005) Mutations in PINK1 have been found in familial cases of 
PD (Valente et al., 2004a) but also in patients suffering from sporadic PD and it was pro-
posed that heterozygous mutations in PINK1 might be a risk factor for PD (Abou-Sleiman et 
al., 2006; Djarmati et al., 2006; Valente et al., 2004b). Most of the mutations that have been 
identified reside in the kinase domain of PINK1 and for some of them a reduced kinase ac-
tivity was reported (Beilina et al., 2005; Sim et al., 2006). This observation, together with the 
autosomal recessive pattern of inheritance, suggests that PD mutations are causing a loss of 
Fig. 2.2: Structure and reaction cycle of P-type ATPases. 
(A) P-type ATPases are anchored in the membrane via ten transmembrane (TM) domains. The residues in-
volved in ion binding are located inside the TM domains. Nucleotide binding domain (N; green), Phosphoryla-
tion domain (P; red) and actuator domain (A; yellow) are facing the cytosol. (B) The reaction cycle starts with 
the ATPase in E1 conformation and with ion 1 (X
+
) entering the ion binding site from the cytosolic side. The 
energy released by coordination of ion 1 induces a conformational change in the protein. Mg
2+
-ATP binds to 
the N-domain and induces a change in conformation resulting in the N-domain contacting the P-domain 
(E1-P state). The γ-phosphate of ATP is subsequently transferred to a conserved Aspartate residue in the P-
domain and this phosphorylation leads to transition of the enzyme to E2-P state in which the A-domain comes 
in close proximity to the P--domain which causes dissociation of ADP. A conformational change in the 
P-domain results in release of ion 1 to the extracellular/luminal side. Subsequently, ion 2 (Y
+
) enters the ion 
binding site and the phosphorylated Aspartate is hydrolyzed. Pi and Mg
2+ 
are released and the enzyme
 
is 
adopting E2 conformation. Opening of the ion binding site and release of ion 2 brings the ATPase back into the 
E1 state and the cycle can be started again. Reprinted with permission from Macmillan Publishers Ltd: [Nature 
Reviews Molecular Cell Biology] Kuhlbrandt, copyright (2004). (Kuhlbrandt, 2004). 
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function of PINK1 (Sim et al., 2006). Knockout (KO) of the Drosophila ortholog of PINK1 was 
described to induce mitochondrial abnormalities, muscle degeneration and reduced fertility 
(Clark et al., 2006; Park et al., 2006; Yang et al., 2006). Interestingly, KO of Parkin in Dro-
sophila caused similar phenotypes (Greene et al., 2003) and it was shown that the pheno-
types induced by PINK1 KO could be rescued by overexpression of parkin but not vice versa 
(Clark et al., 2006; Park et al., 2006; Yang et al., 2006) suggesting that the two proteins func-
tion in the same pathway with parkin being downstream of PINK1. Later on, it was shown 
that the PINK1/Parkin pathway is involved in targeting damaged mitochondria for degrada-
tion via mitophagy, which will be discussed in section 2.2.3 of this introduction.  
 
Parkin 
Parkin is an E3 ubiquitin ligase and has been linked to autosomal recessive, early-onset PD 
(Kitada et al., 1998; Matsumine et al., 1997). Several mutations in Parkin have been identi-
fied in PD patients including deletions, multiplications and missense mutations (Kitada et al., 
1998)[reviewed in (Mata et al., 2004)]. It was shown that Parkin plays a role in protein degra-
dation via the proteasome and PD-associated mutations in Parkin cause loss of ubiquitin 
ligase activity and thus accumulation of its substrates (Shimura et al., 2000; Zhang et al., 
2000). Similar to PINK1 KO, loss of Parkin in flies leads to mitochondrial defects as well as 
muscle degeneration, sperm defects and a reduced life span (Greene et al., 2003). As al-
ready described in the PINK1 section, PINK1 and Parkin are involved in the same pathway 
(mitophagy, see section 2.2.3) and PINK1 is upstream of Parkin (Clark et al., 2006; Park et 
al., 2006; Yang et al., 2006). Besides the functional interaction with PINK1, Parkin was also 
attributed a protective effect against αS-induced toxicity (Haywood and Staveley, 2006; 
Petrucelli et al., 2002; Yang et al., 2003).  
 
DJ-1 
Mutations in DJ-1 have been identified in patients suffering from autosomal recessive, early-
onset PD (Bonifati et al., 2003b) and it was shown that PD-associated mutations in DJ-1 in-
terfere with dimerization, thereby impairing its function (Moore et al., 2005; Olzmann et al., 
2004). DJ-1 acts as antioxidant and redox-sensitive chaperone that is modified in conditions 
of oxidative stress (Bonifati et al., 2003a; Canet-Aviles et al., 2004; Mitsumoto and 
Nakagawa, 2001; Shendelman et al., 2004). A protective function of DJ-1 against oxidative 
stress was observed in Drosophila (Meulener et al., 2006) whereas loss of function of DJ-1 
renders cells more vulnerable to oxidative stress but also ER stress, inhibition of the pro-
teasome or induction of apoptosis (Andres-Mateos et al., 2007; Yokota et al., 2003).  
 




LRRK2 (Leucine-Rich Repeat Kinase 2) is associated with autosomal dominantly inherited 
PD of late onset (Di Fonzo et al., 2005; Funayama et al., 2002; Zimprich et al., 2004). LRRK2 
belongs to the family of ROCO proteins that are characterized by the presence of a ROC 
(Ras of complex protein) and a COR domain (C-terminal of ROC) (Marin et al., 2008). The 
ROC domain is a GTPase that, together with the COR domain, plays a role in intra-molecular 
regulation of the LRRK2 kinase activity and LRRK2 was shown to form dimers (Deng et al., 
2008; Greggio et al., 2008; Guo et al., 2007). Besides the ROC/COR and kinase domains, 
LRRK2 also contains several protein-protein interaction domains like LRR (Leucine rich re-
peat), WD40 and ankyrin repeat domains (Kumar and Cookson, 2011; Mata et al., 2006). 
Mutations in the LRRK2 gene not only account for rare familial form of PD but have also 
been identified in sporadic cases (Gilks et al., 2005; Lesage et al., 2007). Most of the LRRK2 
mutations are located in the GTPase and kinase domain and for several of them an in-
creased kinase activity was demonstrated (Gloeckner et al., 2006; West et al., 2005; West et 
al., 2007). Moreover, inhibition of kinase activity was shown to be protective against LRRK2-
mediated toxicity (Smith et al., 2006; West et al., 2007) indicating that a gain-of-function is 
responsible for disease pathogenesis. LRRK2 localizes to membranes and associates with 
lipid rafts (Biskup et al., 2006; Hatano et al., 2007). Mitochondrial localization of the protein 
was reported in human cell lines and mouse brains (Biskup et al., 2006; West et al., 2005) 
and a recent study has revealed impaired mitochondrial function and dynamics in fibroblasts 
of PD patients carrying mutations in LRRK2. Mitochondria in these cells were more elongat-
ed and interconnected than in cells from healthy controls and reduced membrane potential 
and ATP levels were reported (Mortiboys et al., 2010). Moreover, LRRK2 has been found to 
regulate neurite outgrowth (MacLeod et al., 2006) and deletion of the C. elegans ortholog 
lrk-1 resulted in mistargeting of SV proteins to dendrites (Sakaguchi-Nakashima et al., 2007). 
 
UCH-L1 
A missense mutation in UCH-L1 (Ubiquitin carboxyl-terminal hydrolase L1) was identified in 
only one PD family (Leroy et al., 1998) and a polymorphism at another residue was found to 
decrease the risk for developing sporadic PD at least in some studies (Carmine Belin et al., 
2007; Elbaz et al., 2003; Facheris et al., 2005). UCH-L1 is part of the UPS and is involved in 
cleavage of small adducts of ubiquitin thereby generating free monomeric ubiquitin (Larsen 
et al., 1998). The disease-causing mutation was found to exhibit a decreased hydrolytic ac-
tivity while the protective polymorphism caused an increase in the catalytic activity, suggest-
ing that loss of enzyme activity is involved in disease pathogenesis (Leroy et al., 1998; 
Nishikawa et al., 2003). Interestingly, UCH-L1 was also reported to be a component of Lewy 
bodies further substantiating its link to PD. 






Fig. 2.3: Pathways involved in PD pathogenesis and PD-associated genes affecting these pathways. 
The two major pathways causing cell death in PD are mitochondrial dysfunction (lower half of the schematic 
drawing) as well as accumulation of misfolded proteins and inhibition of the cellular degradation pathways (upper 
half of the diagram). PD-related genes that have been linked to these mechanisms are depicted in blue boxes 
and arrows indicate how they interfere with the above mentioned pathways. Red arrows represent inhibitory ef-
fects or disturbance the organelle’s function; blue arrows are representing stimulating effects. DJ-1 mutations 
interfere with re-folding of misfolded proteins and also inhibit degradation of misfolded proteins thereby causing 
accumulation of misfolded proteins. Furthermore, DJ-1 is involved in the detoxification of ROS and mutations 
interfere with this process causing increased protein damage and misfolding. αS mutations cause aggregation of 
the protein and also inhibit the protein degradation machinery. Mutations in Parkin and UCH-L1 also have an 
inhibitory effect on protein degradation and mutations in ATP13A2 were shown to stimulate αS aggregation but 
are also thought to interfere with lysosomal function and autophagic clearance. LRRK2 was shown to be localized 
to the Golgi and mutations are reducing neurite outgrowth and also cause mitochondrial dysfunction. Mitochon-
drial dysfunction and comprised clearance of damaged mitochondria are caused by mutations in Parkin and 
PINK1. Mitochondrial dysfunction also leads to increased ROS production which results in oxidative damage to 
proteins and higher loads of misfolded proteins. Adapted by permission from Macmillan Publishers Ltd: [Nature 
Medicine] Vila and Przedborski, copyright (2004). (Vila and Przedborski, 2004). 





Mitochondria are cellular organelles that differ from other cellular compartments in that they 
are enclosed by a double membrane. Furthermore, mitochondria have their own genome and 
possess a protein synthesis machinery, which is similar to that of prokaryotes. Only a small 
fraction of mitochondrial proteins is synthesized inside the mitochondrion, while the rest is 
encoded by nuclear genes, translated in the cytosol and then imported into the mitochondria. 
These special properties of the mitochondria are due to their origin – according to the endo-
symbiont theory they originate from prokaryotes that were engulfed by an ancestral eukaryot-
ic cell [reviewed in (Gray and Doolittle, 1982)]. The structure of mitochondria can be divided 
in four components: outer mitochondrial membrane (OMM), intermembrane space (IMS), 
inner mitochondrial membrane (IMM) and mitochondrial matrix. The surface of the IMM is 
enlarged by invaginations, the so-called cristae, and contains the complexes of the respirato-
ry chain which is illustrated in Fig 2.4. Mitochondrial biogenesis does not occurs “de novo” 
but is achieved by incorporation of new components into already existing mitochondria while 
damaged material is removed via the cellular degradation systems. 
 
 
2.2.1. Mitochondrial function 
 
Mitochondria are often described as “cellular power plants” because of their function in 
providing energy in form of ATP to the cell. However, the functions of mitochondria are by far 
more diverse – they are involved in a number of anabolic and catabolic processes as well as 
in cellular signaling pathways and in controlling apoptotic cell death. Catabolic processes 
taking place in the mitochondrial compartment are the citric acid cycle, β-oxidation of fatty 
acids and oxidative phosphorylation at the respiratory chain. A schematic drawing of the res-
piratory chain is depicted in Fig. 2.4. Among the mitochondrial anabolic processes are the 
synthesis of iron-sulfur clusters, heme and lipids. Another important property of mitochondria 
is their capacity of calcium buffering which helps to regulate the intracellular Ca2+ homeosta-
sis. As mitochondria are essential for a plethora of cellular processes, regulation and mainte-
nance of mitochondrial function is very important for the cell.  
 
 







2.2.2. Mitochondrial dynamics 
 
Although typical textbook pictures of mitochondria depict this organelle in a rod-like shape, 
mitochondrial morphology is by far more diverse, ranging from small vesicular structures to 
networks of elongated and highly interconnected tubules, and can be adapted to the cellular 
energy demands [reviewed in (Sauvanet et al., 2010)]. Mitochondrial morphology is also 
highly dependent on the cell type. Mitochondria are not static but highly dynamic and con-
stantly undergoing fusion and division and the balance between fusion and fission events 
determines mitochondrial shape in a cell [reviewed in (Cerveny et al., 2007)]. A number of 
studies in the past decade have shed light on the molecular machineries that are controlling 
mitochondrial dynamics and a growing number of reviews are concerned with this topic. The 
key players involved in regulation of mitochondrial fission and fusion will be introduced below 
Fig. 2.4: Mitochondrial electron transfer chain. 
The mitochondrial electron transfer chain, also known as respiratory chain, resides in the inner mitochondrial 
membrane and comprises several complexes involved in ATP production via oxidative phosphorylation. The 
major principle of oxidative phosphorylation is transfer of electrons from a substrate to molecular oxygen resulting 
in the generation of water. Depending on the substrate, electrons enter the respiratory chain either at complex I 
(NADH-dehydrogenase) or at complex II (Succinate dehydrogenase) and are then passed to complex III (Ubiq-
uinol cytochrome c oxidoreductase). In the case of electrons that have entered the chain via complex I, they are 
first transferred to Coenzyme Q and from there are transferred to complex III. Next, electrons are passed on to 
complex IV (Cytochrome c oxidase) via an intermediary substrate cytochrome c. At complex IV, the electrons are 
finally transferred to molecular oxygen which results in the generation of water. The energy that is freed during 
electron transfer through the respiratory chain is used to build up a proton gradient across the IMM. Protons are 
pumped in the IMS at complexes I, III and IV and the proton gradient is subsequently used by the ATP synthase 
to generate ATP from ADP + Pi. Electrons can leak out of the respiratory chain before the final transfer to molecu-
lar oxygen at complex IV. This primarily happens at complex I and complex III and results in superoxide produc-
tion, a ROS species. ©Finkel, 2011. Originally published in The Journal of Cell Biology. doi: 
10.1083/jcb.201102095. (Finkel, 2011). 
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and the reader is referred to review articles on mitochondrial dynamics (Chan, 2006; Hoppins 




Mitochondrial fusion can be subdivided into two events, namely fusion of the OMM and sub-
sequent fusion of the IMM. The two processes seem to be coupled under normal conditions 
but can also occur independently from each other [reviewed in (Griffin et al., 2006)].  
 
 
As depicted in Fig. 2.5, outer membrane fusion in mammals is mediated by the mitofusins 
Mfn1 and Mfn2, which belong to a group of large dynamin-related GTPases and which are 
localized to the OMM (Chen et al., 2003a) [reviewed in (Hoppins et al., 2007)]. Mitofusins on 
opposing mitochondrial membranes are forming a complex in trans, which results in tethering 
of the membranes and GTPase activity induces fusion of the membranes [reviewed in (Griffin 
et al., 2006; Meeusen and Nunnari, 2005)]. In C. elegans, OMM fusion is mediated by just 
one mitofusin ortholog, which is called fzo-1 (Hales and Fuller, 1997). 
 
In mammals, fusion of the IMM, as depicted in Fig. 2.6, is mediated by OPA1 (optic atro-
phy 1) which, like the mitofusins, belongs to the family of dynamin-related GTPases [re-
viewed in (Chan, 2006)]. OPA1 activity requires the presence of Mfn1 (Cipolat et al., 2004) 
and again, complexes between OPA1 molecules in trans result in tethering of the mem-
branes and subsequent membrane fusion [reviewed in (Hoppins et al., 2007)]. OPA1 can be 
cleaved by several mitochondrial proteases resulting in long and short isoforms of the protein 
and this posttranslational processing seems to be an important mechanism for the regulation 
of OPA1 activity [reviewed in (Cerveny et al., 2007; Hoppins et al., 2007)]. The C. elegans 
ortholog of OPA1 is eat-3 (Kanazawa et al., 2008). 
Fig. 2.5: Fusion of the mitochondrial outer membranes is mediated by mitofusins in mammals.   
(A) Mitochondrial outer membrane fusion is mediated by mitofusins located at the outer membranes of opposing 
mitochondria. Fusion results in mixing of the outer membrane components while the matrices remain separated. 
(B) Mitofusins are tethering the membranes thus bringing them in close proximity to each other. (C) GTPase 
activity of the mitofusins results in a conformational change that leads to fusion of the mitochondrial membranes. 
Adapted by permission from Macmillan Publishers Ltd: [Nature Reviews Neuroscience] Knott et al., copyright 
(2008). (Knott et al., 2008). 
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The cytosolic dynamin-related GTPase Drp1 (Dynamin-related protein 1) is recruited to mito-
chondria to mediate mitochondrial fission. At the mitochondria, Drp1 oligomerizes and forms 
ring-like structures around the mitochondrion. GTPase activity subsequently leads to con-
striction of the membranes in a process that resembles dynamin-mediated constriction of 
vesicles during clathrin-mediated endocytosis [reviewed in (Lackner and Nunnari, 2009)]. A 




In yeast, mitochondrial targeting of the Drp1 ortholog Dnm1 is mediated by the protein Fis1 
(Mitochondrial fission 1) which is anchored in the OMM and recruits Dnm1 via the adaptor 
proteins Caf4 (CCR4 associated factor 4) and Mdv1 (Mitochondrial division protein 1) [re-
viewed in (Lackner and Nunnari, 2009)]. An ortholog of Fis1 has also been identified in 
mammals however it remains controversial whether it also functions in recruiting Drp1 to the 
sites of fission as no adaptor proteins have been identified so far and Fis1 seems to localize 
diffusely to mitochondrial membranes in contrast to punctate pattern of recruited Drp1 [re-
viewed in (Otera and Mihara, 2011)].  
 
Fig. 2.6: OPA1 mediates inner membrane fusion in mammals. 
After successful fusion of the OMM, the GTPase OPA1 mediates 
fusion of the IMM in a process that is dependent on GTPase activi-
ty of OPA1. Adapted by permission from Macmillan Publishers Ltd: 
[Nature Reviews Neuroscience] Knott et al., copyright (2008). 
(Knott et al., 2008). 
Fig. 2.7: Mitochondrial fission is mediated by Drp1.   
Mitochondrial fission is initiated by translocation of Drp1 
to the mitochondrial membrane where it assembles into 
ring-like structures and subsequently mediates con-
striction of the membranes by GTPase activity.  
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Fission activity of Drp1 has been shown to be regulated by several posttranslational modifi-
cations including phosphorylation, S-nitrosylation, ubiquitination and sumoylation [reviewed 
in (Otera and Mihara, 2011; Santel and Frank, 2008)]. As illustrated in Fig. 2.8, the phos-
phorylation status of Ser637 of Drp1 has been demonstrated to play an important role in reg-
ulating mitochondrial fission activity. This residue is located in the GED domain (GTPase 
effector domain) and phosphorylation impairs intra-molecular interaction of the GED domain 
with the GTPase domain which causes decreased GTPase activity [reviewed in (Otera and 
Mihara, 2011)]. While Drp1 that is phosphorylated at this residue is retained in the cytosol 
and cannot mediate fission, dephosphorylation results in translocation of Drp1 to the mito-
chondria thereby stimulating mitochondrial fission activity [reviewed in (Otera and Mihara, 
2011)]. It was demonstrated that phosphorylation of Drp1 at Ser637 is mediated by cAMP-
activated protein kinase A (PKA) and that a phosphomimetic variant of Drp1 (Ser637Asp) 
inhibits mitochondrial fission in cell culture (Chang and Blackstone, 2007; Cribbs and Strack, 
2007). Dephosphorylation of Drp1 Ser637 is mediated by calcineurin (Cereghetti et al., 2008; 
Cribbs and Strack, 2007) and expression of Drp1 Ser637Ala, which cannot be phosphory-







Besides fusion and division, mitochondrial transport is also contributing to the dynamic na-
ture of this organelle by controlling distribution of mitochondria. Mitochondrial transport is 
especially important in neurons where presence of mitochondria in the neurites is required to 
ensure ATP supply and Ca2+-homeostasis for proper synaptic function. Mitochondrial 
transport predominantly occurs along microtubules but in mammalian neurons it also de-
pends on actin [reviewed in (Dimmer and Scorrano, 2006)]. While intact mitochondria are 
primarily transported in the anterograde direction by kinesin, dynein motors mediate retro-
Fig. 2.8: Phosphorylation status of Drp1 regu-
lates mitochondrial fission activity.   
Phosphorylation of Drp1 prevents mitochondrial 
translocation and thus inhibits mitochondrial 
division. Phosphorylation of Ser637 is mediated 
by PKA in response to a rise in cAMP levels 
while Ca
2+
-mediated activation of calcineurin 
promotes dephosphorylation of Drp1 thereby 
stimulating mitochondrial translocation and fis-
sion activity.  
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grade transport of damaged mitochondria back to the cell body where they are degraded or 
complemented by fusion with intact mitochondria [reviewed in (Otera and Mihara, 2011)]. 
The proteins Miro and Milton are involved in mitochondrial transport and a Ca2+-binding motif 
of Miro plays an important role in adapting mitochondrial motility to local Ca2+-concentrations 
[reviewed in (Dimmer and Scorrano, 2006; Otera and Mihara, 2011)]. Balanced fission and 
fusion of mitochondria is crucial for mitochondrial transport and lack of either fission or fusion 
strongly impairs mitochondrial transport [reviewed in (Chen and Chan, 2006)]. 
 
Function of mitochondrial fission and fusion 
 
Mitochondrial fusion enables the exchange of components between mitochondria which al-
lows for complementation of defective components in one of the mitochondria and thereby 
helps to keep mitochondria in a functional state [reviewed in (Otera and Mihara, 2011)]. Ac-
cordingly, inhibition of fusion results in impaired respiratory chain activity [reviewed in (Otera 
and Mihara, 2011)]. Besides enabling complementation, mitochondrial fusion has also a pro-
tective function against apoptosis which involves increased mitochondrial fragmentation [re-
viewed in (Chen and Chan, 2006)].  
 
In contrast, mitochondrial fission plays a role in mediating proper distribution of the mitochon-
dria but also serves to ensure degradation of damaged mitochondrial components by sepa-
rating damaged from intact material so that subsequent mitophagy of the defective part can 
take place [reviewed in (Otera and Mihara, 2011)]. Mitochondrial division is also required for 
equal sequestration of mitochondria into the daughter cells during cell division [reviewed in 
(Otera and Mihara, 2011)] and deletion of the C. elegans ortholog drp-1 causes embryonic 
lethality which can be at least in part attributed to defects in mitochondrial segregation [re-
viewed in (Lackner and Nunnari, 2009)]. Finally Drp1-mediated fission is an early step of 
apoptosis and blocking mitochondrial fission by expression of DN Drp1 is protective against 
apoptotic cell death [reviewed in (Youle and Karbowski, 2005)]. 
 
Loss of the mitochondrial fusion genes has been associated to neurodegeneration. In hu-
mans, mutations in mitofusins have been identified as cause for Charcot-Marie-Tooth dis-
ease type 2A, a neurodegenerative disease of the peripheral nerves (Zuchner et al., 2004) 
and loss of OPA1 is associated with dominant optic atrophy a disease which is characterized 
by degeneration of the retinal ganglion cells (Alexander et al., 2000; Delettre et al., 2000). It 
was also reported that a mutation in the fission protein Drp1 causes microcephaly, abnormal 
brain development and optic atrophy resulting in lethality (Waterham et al., 2007). This 
demonstrates that well-balanced mitochondrial dynamics are essential for ensuring mito-
chondrial function and several pathologic conditions like PD, Alzheimer’s disease and Hun-
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tington’s disease have been associated with disturbances of the fission/fusion systems [re-
viewed in (Cho et al., 2010)]. 
 
 
2.2.3. Mitochondrial quality control – stress response pathways and mitophagy 
 
 
Mitochondrial stress response 
 
The mitochondrial stress response is a compartment-specific pathway to react to an overload 
of unfolded proteins. It belongs to a number of other cellular stress responses like the cyto-
solic heat shock response and the unfolded protein response in the ER (UPRER) [reviewed in 
(Broadley and Hartl, 2008)] and they all are induced by a disequilibrium in protein folding 
which results in high loads of un- and misfolded proteins. A number of studies have investi-
gated the mitochondrial unfolded protein response (UPRmt) in C. elegans and have shed light 
on the processes involved in this pathway and an illustration of the pathway is shown in 
Fig. 2.9. Yoneda et al. demonstrated that disturbance of protein handling inside mitochondria 
by knockdown of genes encoding mitochondrial chaperones or proteases leads to increased 
expression of the mitochondrial chaperones HSP-6 (C. elegans ortholog of human mitochon-
drial Hsp70) and HSP-60 (C. elegans ortholog of human Hsp60) (Yoneda et al., 2004). Sub-
sequently, ubl-5, a ubiquitin-like protein was identified in an RNAi screen for genes involved 
in the induction of the UPRmt. Knockdown of ubl-5 prevented induction of the mitochondrial 
stress response and it was furthermore demonstrated that in wild type worms, UBL-5 is 
translocated to the nucleus upon induction of the mitochondrial stress response (Benedetti et 
al., 2006). Haynes et al. identified another cytosolic protein, the transcription factor DVE-1 
which plays an important role in the UPRmt. Upon induction of the mitochondrial stress re-
sponse, DVE-1 forms a complex with UBL-5 and is translocated to the nucleus where DVE-1 
stimulates expression of the mitochondrial chaperones HSP-6 and HSP-60 (Haynes et al., 
2007). Haynes et al. furthermore demonstrated that silencing of the mitochondrial protease 
CLPP-1 interferes with induction of the mitochondrial stress response upstream of DVE-1 
nuclear translocation. They proposed a model in which peptides generated by cleavage of 
mitochondrial proteins by CLPP-1 are mediating the signaling to the cytosol that is needed 
for activation of the stress response (Haynes et al., 2007). In 2010, another study by Haynes 
et al. revealed that a mitochondrially localized peptide transporter, HAF-1, as well as the 
transcription factor bZIP also play a role in activation of the UPRmt suggesting that peptides 
generated by CLPP-1-mediated cleavage are transported to the cytosol where they induce 
signaling to activate the mitochondrial stress response (Haynes et al., 2010). The target 
genes of the bZIP transcription factor ZC376.7 are not known by now. 
 









Another quality control system for mitochondria is the selective degradation of mitochondria 
via mitophagy. Mitophagy is a special form of autophagy and relies on the same core ma-
chinery as macroautophagy [reviewed in (Kanki and Klionsky, 2010)]. Mitophagy, similar to 
autophagy can be induced under conditions of starvation but was also found to serve in 
clearance of damaged mitochondria under normal conditions [reviewed in (Tanaka, 2010)]. 
Intriguingly, two PD-related proteins, PINK1 and Parkin play an essential role in the specific 
targeting of damaged mitochondria for elimination via mitophagy [reviewed in (Springer and 
Kahle, 2011)]. A prerequisite for clearance of damaged mitochondrial material is its separa-
tion from intact components. It was shown that this can be achieved by mitochondrial fission 
Fig. 2.9: Mitochondrial unfolded protein response (UPR
mt
) in C. elegans.   
The UPR
mt
 is induced by an overload of misfolded proteins in the mitochondria. Misfolded proteins are either 
removed by degradation by SPG-7, a mitochondrial protease, or are cleaved into small peptides by another mito-
chondrial protease, CLPP-1. The small peptides subsequently are released into the cytosol via the ABC trans-
porter HAF-1 and trigger formation of a complex of the transcription factor DEV-1 and UBL-5, a ubiquitin-like 
protein. This complex as well as another transcription factor, ZC376.7 translocate to the nucleus where DVE-1 
stimulates expression of the mitochondrial chaperones HSP-6 and HSP-60. The chaperones are imported into 
the mitochondria and help to re-establish proper protein folding. The targets of the bZIP transcription factor 
ZC376.7 are not yet known. 
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generating uneven daughter-organelles, one containing intact material while the other is 
comprised of damaged material and is characterized by a reduced membrane potential (Twig 
et al., 2008a). Fusion of these mitochondria with intact organelles is prevented due to lack of 
OPA1 activity at the damaged mitochondrion (Twig et al., 2008a).  
 
Damaged mitochondria are then selectively targeted for mitophagy (as illustrated in 
Fig. 2.10), a process that is mediated by PINK1-dependent recruitment of Parkin to the mito-
chondrion [reviewed in (Springer and Kahle, 2011)]. While in healthy mitochondria, PINK1 is 
proteolytically processed and rapidly degraded, it accumulates on depolarized mitochondria 
because the cleavage is dependent on an intact mitochondrial membrane potential [reviewed 
in (Imai and Lu, 2011)]. Full length PINK1 subsequently recruits Parkin to the damaged or-
ganelle resulting in ubiquitination of OMM proteins like mitofusins and VDAC1 (Voltage-
dependent anion-selective channel protein 1). Ubiquitination of mitofusins stimulates their 
degradation thereby preventing fusion of the damaged mitochondrion with other organelles 
(Gegg and Schapira, 2011). Ubiquitination of proteins at the OMM leads to recruitment of 
several adaptor proteins which in turn bind LC3 on pre-autophagosomal membranes and 
thereby stimulate induction of mitophagy [reviewed in (Vives-Bauza and Przedborski, 2011)]. 
The fact that two PD-related proteins are key players in clearance of damaged mitochondria 




Fig. 2.10: Removal of damaged mitochondria via mitophagy.   
(A) A reduction in the mitochondrial membrane potential results in stabilization of full-length PINK1 at the mito-
chondria which in turn recruits Parkin to the mitochondrial surface. (B) Parkin subsequently ubiquitinates OMM 
proteins like mitofusins, the mitochondrial fusion proteins, and VDAC1 resulting in recruitment of the adaptor 
proteins HDAC6 and p62. (C) The adaptors then bind to LC3 on pre-autophagosomal membranes thereby initiat-
ing mitophagy. Reprinted from Trends in Molecular Medicine, 17/3, Vives-Bauza and Przedborski, Mitophagy: the 
latest problem for Parkinson's disease, Pages 158–165, Copyright (2011), with permission from Elsevier. (Vives-
Bauza and Przedborski, 2011). 
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2.3. Parkinson’s Disease and Mitochondria 
 
 
A growing body of evidence supports the view that mitochondria play a key role in the patho-
genesis of PD. In 1989, Schapira et al. reported that the activity of complex I of the respirato-
ry chain is reduced in the SN of PD patients thereby providing the first hint that compromised 
mitochondrial function could be involved in the disease pathogenesis (Schapira et al., 1989). 
A number of subsequent studies demonstrated that the complex I deficiency in PD patients 
was not restricted to the SN but could also be seen in other tissues (Haas et al., 1995; Krige 
et al., 1992; Parker et al., 1989; Yoshino et al., 1992) suggesting that the pathological 
changes are more systemic and that it is rather the particular vulnerability of the SN to these 
defects which is causing the specific degeneration of neurons in this region (compare sec-
tion 2.1.1 of this introduction). In line with reduced complex I activity being involved in the 
pathogenesis of PD, intoxication with MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) 
was found to cause a parkinsonian syndrome. MPTP is metabolized to its active metabolite 
MPP+ in astrocytes which is subsequently taken up by DA neurons via the DA transporter. In 
the neurons, it causes mitochondrial complex I inhibition resulting in reduced ATP production 
[reviewed in (Tipton and Singer, 1993)]. Epidemiological studies have further substantiated 
the finding that complex I inhibition contributes to the development of PD, as an increased 
risk for PD was reported following exposure to the pesticides rotenone and paraquat, which 
are known to be complex I inhibitors [reviewed in (Sherer et al., 2002)]. Besides reduced 
ATP levels, increased ROS production due to complex I inhibition has been proposed to con-
tribute to neuronal death. This view is supported by several studies that have demonstrated 
increased oxidative damage and reduced activity of antioxidant systems in PD patients when 
compared to healthy controls [reviewed in (Henchcliffe and Beal, 2008)]. 
 
More recently, evidence for mitochondrial involvement in PD was also found in genetic mod-
els of the disease. Several genes that have been linked to PD are associated with mitochon-
dria. Some of them encode for mitochondrial proteins (PINK1, HtrA2/Omi), some for proteins 
that can be translocated to mitochondria under certain conditions (Parkin, DJ-1) and others 
for proteins that have been shown to be at least partially associated to mitochondria (α-
synuclein, LRRK2) [reviewed in (Bueler, 2009)]. Furthermore, it was reported that compro-
mised function of these proteins (or overexpression in the case of α-synuclein) results in im-
paired mitochondrial function (α-synuclein, DJ-1, PINK1, Parkin, HtrA2/Omi), changes in mi-
tochondrial morphology (PINK1, Parkin, α-synuclein, HtrA2/Omi) and increased ROS produc-
tion or increased sensitivity to oxidative stress (α-synuclein, DJ-1, PINK1, Parkin) [reviewed 
in (Bueler, 2009; Burbulla et al., 2010)]. Therefore, multiple lines of evidence, ranging from 
toxin and genetic models of PD to examination of patient material, point towards mitochon-
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drial dysfunction being a key event in disease pathogenesis. Restoring mitochondrial function 
and morphology therefore seems to be a promising target for treatment of PD. But before this 
can be achieved, we need to gain a deeper understanding of the exact mechanisms causing 
mitochondrial dysfunction. Furthermore, it needs to be clarified whether mitochondrial defects 
are really present in all cases of PD or only in a subset while in others disturbance of the cel-
lular degradation systems and accumulation of misfolded proteins is the predominant patho-
genic pathway.  
 






A major challenge in the investigation of the molecular pathways involved in PD remains the 
identification of the early events that are involved in the initiation of the disease. This is par-
ticularly difficult as PD patients develop symptoms only after a substantial amount of DA neu-
rons in the SN have already degenerated. Therefore, the establishment of model systems is 
important to study the early pathogenic mechanisms and will help to understand the physio-
logical function of the PD-related genes. Determination of the disease-initiating mechanisms 
is essential for the development of novel therapeutic strategies aiming in preventing neuronal 
death in contrast to the currently used symptomatic treatments. Moreover, knowledge about 
early cellular changes will help to define biomarkers which are able to detect PD at early 
stages where a neuroprotective treatment would be most efficient.  
 
As the cellular function and toxicity of many PD-related genes is still poorly understood, we 
decided to address these issues by using the model organism C. elegans. Due to its genetic 
tractability and the fact that worms are transparent, allowing for imaging in living animals, the 
nematode is an attractive system to examine the molecular mechanisms involved in PD 
pathogenesis. This study is focused on the investigation of two PD-related genes – 
α-synuclein (αS) and catp-6, the C. elegans ortholog of human ATP13A2(PARK9). 
 
The first chapter of this dissertation is concerned with the cellular function and toxicity of αS. 
As C. elegans lacks an ortholog of this gene, transgenic worms expressing human αS were 
investigated. The aims for this part of the thesis were: 
1) Determining whether fibrillar aggregates or rather soluble oligomeric precursors are 
responsible for toxicity of the protein. This aspect was addressed by comparing ag-
gregation properties and toxicity of different variants of αS including synthetic variants 
that stop aggregation at the stage of soluble oligomers and do not form fibrils. 
2) Investigation of the effects of αS expression on mitochondrial morphology as several 
lines of evidence suggest that mitochondrial dysfunction plays an important role in PD 
pathogenesis. Besides wt αS, familial PD mutants of the protein and a synthetic pre-
fibrillar variant were subjected to this analysis.  
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Characterization of the lysosomal P-type ATPase CATP-6 was the second project of this 
dissertation and was done by examining deletion mutants of catp-6. The scopes for this pro-
ject were as follows: 
1) Phenotypic characterization of the deletion mutants (brood size, development, 
movement) 
2) Investigation of the effects of CATP-6 loss-of-function on mitochondrial morphology 
3) Determining whether mitochondrial function is impaired in catp-6 deletion mutants 
4) Study the effect of loss of function of the lysosomal P-type ATPase on autophagy 
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Aggregation of αS in Lewy bodies (LBs) is a very characteristic histological feature in the pa-
thogenesis of PD (Baba et al., 1998; Spillantini et al., 1998; Spillantini et al., 1997; Takeda et 
al., 1998). Mutations in the αS gene (Kruger et al., 1998; Polymeropoulos et al., 1997; 
Zarranz et al., 2004) as well as duplication or triplication of the gene locus have been associ-
ated to familial forms of PD (Chartier-Harlin et al., 2004; Farrer et al., 2004; Ibanez et al., 
2004; Singleton et al., 2003). The finding that multiplication of the αS gene was leading to PD 
was not only indicative of increased expression causing toxicity but moreover that the ex-
pression level was also correlated with severity of the disease, with higher αS expression 
leading to an earlier onset and rapid progression of the disease. More recently, αS has also 
been linked to sporadic forms of PD with changes in the promoter region leading to in-
creased expression levels and representing a risk factor for the development of PD (Fuchs et 
al., 2008; Mueller et al., 2005; Pals et al., 2004) further confirming a dosage-dependent tox-
icity. Thus, αS might be the main agent causing PD. However, the mechanism causing toxici-




Fig. 4.1: HPF-EM analysis of αS aggregation in vitro.   
The pictures represent the time course of αS aggregation after putting monomeric αS into refolding buffer. 
Solutions were frozen at different time points and EM images were taken. αS immediately starts to aggregate 
into small oligomers which assemble into proto-fibrils forming annular structures (black arrows). Later on, 
stable fibrils (white arrowheads) are formed. Pictures were kindly provided by Dr. Jan Hegerman. 
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In vitro, αS rapidly aggregates to form amyloid fibrils. The process of αS aggregation in vitro, 
assessed by High-Pressure Freeze EM (HPF-EM), is shown in Fig. 4.1. When αS monomers 
are transferred to refolding buffer, they immediately start to aggregate. First, they assemble 
into small oligomeric precursors which are soluble and form annular structures. In the next 
step, the proto-fibrils start to assemble and further aggregate to fibrillar structures. In the end, 
clear fibrillar aggregates are observed. These fibrils are so-called paired helical filaments 
which are Thioflavin positive and which have also been observed in post-mortem brains of 
PD patients.  
 
For a long time, the aggregated version of αS was held responsible for causing toxicity. This 
hypothesis was based on several observations: First, PD mutants of αS were shown to be 
more prone to aggregation than the wild type variant of the gene leading to increased occur-
rence of the aggregated αS in form of amyloid fibrils (Choi et al., 2004; Conway et al., 1998; 
Greenbaum et al., 2005; Li et al., 2001; Narhi et al., 1999). Second, αS fibrils were found to 
be the major constituent of LBs (Baba et al., 1998; Spillantini et al., 1998; Spillantini et al., 
1997; Takeda et al., 1998). Third, increased expression levels of αS have been associated 
with PD and increased expression levels correlate with increased aggregation of the protein 
(Giasson et al., 1999; Uversky et al., 2001). However, it was not clear, whether indeed these 
amyloid fibrils are the toxic species or whether smaller oligomeric precursors of αS were re-
sponsible for the toxic effects. As proto-fibrils were reported to bind to membranes and form 
pores in the membranes, the question was raised whether these proto-fibrils might be the 
disease-causing agent of αS (Goldberg and Lansbury, 2000; Volles and Lansbury, 2003). 
Doubts against the hypothesis that αS fibrils are the pathogenic species were raised as in 
several animal models of αS overexpression, the rate of fibril formation did not correlate with 
the degree of toxicity (Auluck et al., 2002; Chen and Feany, 2005). It was even speculated 
that the fibrillar aggregates might be protective for the cell as they might be less reactive and 
lead to a reduced surface being in contact with the cellular components (Chen and Feany, 
2005). 
 
To identify the toxic species of αS, we used different variants of αS with altered aggregation 
properties. This project was performed in collaboration with Prof. Markus Zweckstetter (MPI 
for Biophysical Chemistry, Göttingen, Department for Protein Structure Determination Using 
NMR) and Prof. Christian Griesinger (MPI for Biophysical Chemistry, Göttingen, Department 
for NMR Based Structural Biology) who designed synthetic variants of αS that stop aggrega-
tion at the stage of proto-fibrils and do not form amyloid fibrils. The design of these pre-
fibrillar variants of αS was based on the fact that αS aggregation is dependent on the for-
mation of β-sheets. As the regions involved in β-sheet formation are known, one can try to 
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prevent this by mutating essential residues in these areas. Proline residues are known to be 
β-breaking because they are not able to form hydrogen bonds via their backbone NH-group. 
Thus, the synthetic pre-fibrillar variants were generated by introducing proline residues at 
positions of the protein that are involved in β-sheet formation. 
 
We used the nematode C. elegans as a model to study aggregation and toxicity of the differ-
ent αS variants in vivo. C. elegans has previously been used for both genetic and toxin mod-
els of PD. It has to be noted that worms do not have an ortholog of αS but worms expressing 
human wt αS or the PD mutants thereof have been used successfully before to study toxicity 
of this protein in the nematode (Cao et al., 2005; Kuwahara et al., 2006; Lakso et al., 2003; 
Springer et al., 2005; Ved et al., 2005). Furthermore, aggregation of heterologously ex-
pressed αS in body wall muscle (BWM) cells of C. elegans has been assessed in other stud-






4.2.1. Generation of synthetic αS variants that are not forming fibrils in vitro 
 
In order to assess whether fibrillar aggregates or rather smaller oligomeric variants are re-
sponsible for αS induced toxicity, five different αS variants with different propensity of forming 
fibrillar aggregates were used. Besides wild type αS, two PD mutants (A30P and A53T) ex-
hibiting increased aggregation and two synthetic variants (A56P and TP) that were designed 
to impair aggregation, were used.  
 
The synthetic variants were designed by the group of Prof. Markus Zweckstetter (MPI for 
Biophysical Chemistry, Göttingen, Department for Protein Structure Determination using 
NMR) by introducing proline residues at positions of the protein that are part of the β-sheet 
rich core which is essential for the formation of highly ordered amyloid fibrils (Karpinar et al., 
2009). The synthetic construct A56P was generated by introducing just one proline mutation 
whereas the TP (triple proline) variant is characterized by three proline mutations (A30P, 
A56P and A76P). The positions of the different mutations of the PD and synthetic variants of 
αS are indicated in Fig. 4.2A.  






Fig. 4.2: Synthetic variants of αS exhibit decreased rates of fibril formation in vitro because of impaired 
β-sheet structures.  
(A) Positions of mutations of the different variants used in this study are indicated in black for the PD mutations 
and in red for the designed mutations. Parts of the protein that are involved in the formation of β-sheets (Heise et 
al., 2005) are shown in purple. Both designed proline residues were introduced at positions that are part of the β-
sheet-rich core of αS. (B) Representation of the β-sheets formed by the different variants of αS. Fully formed β-
sheets are indicated as arrows. Impaired β-sheet structures are depicted as striped boxes. Two different β-sheet 
structures of wt αS are indicated in black. In A56P (shown in yellow) only the β-sheets in the N-terminal part of 
the protein are affected while in TP (depicted in red) also C-terminal β-sheets are impaired. (C) Formation of 
amyloid fibrils was assessed by measuring Thioflavin T fluorescence. While wt αS (black) rapidly aggregates into 
fibrillar aggregates after a short lag-phase, fibril formation is severely impaired in A56P (yellow) and absent in TP 
αS (red). Pictures were published in (Karpinar et al., 2009) and were kindly provided by Prof. Markus Zweckstet-
ter. 
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While in A56P only the β-sheet structures in the N-terminal part are affected, the TP variant 
shows severe impairment of β-sheet formation throughout the entire protein (Fig. 4.2B) 
(Karpinar et al., 2009). The formation of amyloid fibrils was severely impaired in the designed 
variants of αS as seen by the absence of Thioflavin fluorescence for TP αS and the strong 
decrease in fluorescence for A56P (Fig. 4.2C) (Karpinar et al., 2009). Wt αS rapidly starts 
forming fibrils after a short lag-phase. In contrast, the onset of fibrillization strongly delayed 
for A56P αS and was not seen within the monitored 300 min for TP αS and even not after 
two weeks of incubation. However, occurrence of amyloid fibrils could be observed after long 
incubation times of very high concentrations of TP αS indicating that the formed oligomers 
are able to further aggregate and only the rate of fibril formation is tremendously decreased 
(Karpinar et al., 2009). NMR analysis was performed by the laboratory of Prof. Markus 
Zweckstetter to investigate whether the designed αS variants were still aggregating to the 
oligomeric precursors of the fibrils and indeed, the proto-fibrils were still found for A56P and 
TP (Karpinar et al., 2009).  
 
Thus, in vitro examination of the synthetic αS variants clearly showed that they stop aggrega-
tion at the stage of soluble oligomers and that they are not forming amyloid fibrils. Therefore, 
these pre-fibrillar variants are well-suited for analyzing whether fibrils or oligomeric precur-
sors are the toxic species of αS.  
 
 
4.2.2. TP αS prevents fibril formation in C. elegans 
 
Before testing the neurotoxicity of the different αS constructs, we wanted to confirm in vivo, 
that the fibril formation was indeed absent for the designed variants. For assessing aggrega-
tion of αS in C. elegans, an αS-construct that is tagged with mYFP at the C-terminus was 
created. C-terminal fusion of YFP or GFP to αS has been done before (Gitler et al., 2009; 
Hamamichi et al., 2008; Rockenstein et al., 2005; van Ham et al., 2008) and it was recently 
shown that the tag doesn’t interfere with aggregation (van Ham et al., 2010). The αS-mYFP 
construct was expressed in C. elegans under the control of the body wall and sex muscle-
specific myo-3 promoter. Occurrence of fibrillar aggregates was assessed in the vulva mus-
cles as those cells were exhibiting high expression levels and they were easily recognized in 
every worm, so that it could be made sure that always the same cells were investigated. As 
augmented aggregation was reported for aged worms, 10 day old animals were examined. 
Representative pictures of the αS expressing vulva muscles for wt and TP αS are shown in 
Fig. 4.3A+B, respectively. Fibrillar aggregates were seen in the vulva musculature of around 
80% of the worms from two independent transgenic lines expressing the wt protein. In con-
trast, aggregates of TP were almost completely lacking with less than 10% of the worms 
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showing aggregates in two independent transgenic lines (Fig. 4.3C). If aggregates were 
found in the TP expressing animals, they were much smaller and the number of aggregates 
per cell was also diminished. Expression levels of wt and TP αS were determined by West-
ern Blot as shown in Fig. 4.3D. The fact that TP αS expression was even slightly higher than 
that of wt αS eliminated the possibility that lower concentration of the protein would account 






4.2.3. TP αS exhibits increased neurotoxicity in C. elegans 
 
After having verified that the designed TP αS mutant does not form fibrillar aggregates when 
expressed in C. elegans, we wanted to compare the toxicity of wt and PD mutant αS with that 
of the designed pre-fibrillar TP variant in vivo. If, as hypothesized, soluble oligomers of αS 
are the toxic species, one would expect that TP αS, which forms high levels of these oligo-
mers but no fibrillar aggregates, would exhibit the highest toxicity. If, in contrast, amyloid fi-
brils are the main agent causing toxicity, the PD mutants should exhibit the highest degree of 
Fig. 4.3: Formation of fibrillar aggregates is absent in C. elegans muscle cells expressing TP αS.  
(A+B) Vulva musculature of 10 day old worms expressing pmyo-3::wt αS-mYFP or pmyo-3::TP αS-mYFP, re-
spectively. Scale bars represent 10 µm. While numerous fibrillar aggregates are found in worms expressing wt 
αS (A), those aggregates are absent when TP αS is expressed (B). (C) Quantification of the occurrence of fibril-
lar aggregates in the vulva muscles of wt or TP αS expressing worms for two independent transgenic lines each. 
(D) Western blot was performed to confirm that expression levels of wt and TP αS were comparable. Pictures 
were published in (Karpinar et al., 2009) and are shown with slight modifications. 
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toxicity and TP αS, that is not forming fibrils, should be much less toxic. Thus, comparison of 
the toxicity of the different variants of αS in vivo will help to elucidate whether fibrils or rather 
soluble oligomeric precursors are the toxic species of αS. The experiments described in this 
section were done by Dr. Stefan Eimer.  
 
Dopaminergic neuron degeneration is a well-established model for determining neurotoxicity 
in C. elegans (Benedetto et al., 2010; Braungart et al., 2004; Kuwahara et al., 2006; Lakso et 
al., 2003; Locke et al., 2008; Nass et al., 2002) and was therefore chosen to assess the neu-
rotoxic effects of the different constructs. C. elegans hermaphrodites have eight DA neurons 
(Sulston et al., 1975) of which six are located in the head of the animal (ADE and CEP neu-
rons). Visualization of the DA neurons is achieved by expression of mRFP under the control 
of the DA neuron-specific dat-1 (DopAmine Transporter) promoter. Morphology of the six 
head DA neurons is shown in Fig. 4.4A. The different αS mutants were also expressed under 
the control of a dat-1 promoter. Moderate expression levels of αS were chosen, so that no 
effect on DA neuron morphology was seen in the worms expressing wt αS (Fig. 4.4A, top 
panel). In contrast, dopamine neuron degeneration was observed in DA neurons of worms 
expressing different mutants of αS (Fig. 4.4A, lower panel). The extent of degeneration 
caused by the different variants of αS was quantified by determining the percentage of 
worms that were not showing defects in neurite morphology of DA neurons in the head and 
the result is visualized in Fig. 4.4B. Unlike expression of wt αS, which leads to almost no 
neurite defects, the PD mutants A30P and A53T are causing degeneration in 40-50% of the 
worms. Remarkably, the synthetic variants A56P and especially TP are showing even more 
severe defects than the PD mutants with 60% and 80% of the animals manifesting defective 
neurites.  
 
We further investigated whether the observed defects in neurite morphology correlate with 
impaired function of these neurons. On a molecular level, the dopaminergic system of worms 
strongly resembles that of humans with dopamine transporters, receptors and metabolic 
pathways being highly conserved [reviewed in (Nass and Blakely, 2003)]. In humans, dopa-
mine signaling has been implicated in the coordination of movement and the recognition of 
reward. DA signaling in C elegans plays a role in egg-laying, defecation, the modulation of 
motor activity, response to food sources and in the habituation to touch [reviewed in 
(McDonald et al., 2006)]. Thus, also on a functional level, similarities between the dopami-
nergic systems of worms and humans exist. The food slowing response is a well-studied DA-
dependent behavior in C. elegans which can easily be assessed (Kuwahara et al., 2006; 
Sawin et al., 2000). Worms slow down their locomotion and switch from a food searching to a 
feeding behavior as soon as they encounter a food source. By assessing the speed of worms 
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in the absence and in the presence of food, one can determine the food slowing response. If 
the function of DA neurons is impaired, the worms slow down to a lesser degree when en-
countering food. Consistent with the results of the morphological defects, the slowing rate in 
response to food was most severely impaired in worms expressing TP αS. The fact that the 
pre-fibrillar variants of αS exhibit highest neurotoxicity clearly points towards oligomeric pre-
cursors and not the amyloid fibrils being the toxic species of αS. 
 
 
Fig. 4.4: Neurotoxicity is increased in the pre-fibrillar variant TP αS. 
(A) Morphology of DA neurons in the C. elegans head was visualized by expressing mRFP under the control of 
the DA neuron-specific dat-1 promoter. While moderate expression of wt αS does not produce neurite defects 
(top panel), expression of different mutants leads to neurite degeneration (lower panel). (B) Quantification of the 
degree of degeneration in worms expressing different variants of αS. Most neurite defects were observed in the 
designed variant TP αS. Two independent transgenic lines were examined for each variant and neurites of 78-80 
animals were analyzed. The error bars correspond to the standard error of the mean (SEM) and the significance 
values of the ANOVA test are indicated: *P<0.05; ***P<0.001. (C) DA neuron function was analyzed by measur-
ing the food slowing response of the worms. In accordance with the morphological defects, this DA-dependent 
behavior was most severely affected in the pre-fibrillar αS variants. For each αS variant expressed, at least two 
independent transgenic lines were tested (N = 40–50 animals per trial, 3 trails). The slowing rate corresponds to 
the average decrease in movement (body bends per min) for animals placed in food as compared with animals 
without food. Animals expressing only EGFP in dopaminergic neurons are shown as control. The errorbars cor-
respond to SEM and the significance values of the ANOVA test are indicated: *P<0.05; **P<0.01; ***P<0.001. 
Pictures were published in (Karpinar et al., 2009) and were kindly provided by Dr. Stefan Eimer. 
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4.2.4. Expression of αS leads to drastic changes of mitochondrial morphology 
in C. elegans muscle cells 
 
After having identified pre-fibrillar oligomers as toxic species of αS, the next step of my PhD 
project was to investigate the cellular mechanisms by which αS causes toxicity. As recently 
increasing evidence for the involvement of mitochondria in PD pathogenesis and other neu-
rodegenerative diseases was reported, we focused our studies on this cellular compartment. 
αS has been shown to bind to cellular membranes including the mitochondrial membrane 
(Chinta et al., 2010) and mitochondrial pathology as well as increased oxidative stress was 
described in several models upon overexpression of αS (Hsu et al., 2000; Lee et al., 2001; 
Martin et al., 2006; Poon et al., 2005). 
 
Therefore, we decided to examine the morphology of mitochondria in C. elegans muscle 
cells by fluorescence microscopy making use of TOM70-CFP (transmembrane domain of 
yeast TOM70 fused to CFP; (Labrousse et al., 1999); plasmid kindly provided by Alexander 
van der Bliek, UCLA), a marker for the mitochondrial outer membrane expressed under the 
control of a muscle-specific myo-3 promoter. Reasons for choosing BWM cells for the analy-
sis of mitochondrial morphology were the large size of these cells compared to other cell 
types – C. elegans muscle cells measure ~100 µm in length with a width of ~10 µm while 
neuronal cell bodies measure 3-5 µm in diameter – and because BWM cells show a very 
regular and stereotyped arrangement of mitochondria.  
 
The tubular morphology of mitochondria in wt worms that are not expressing αS is depicted 
in Fig. 4.5A. The nucleus of muscle cells can easily be identified due to the absence of mito-
chondria in this area. Upon expression of wt αS, two different changes in mitochondrial mor-
phology were observed. In some cells, mitochondria become fragmented forming vesicular 
mitochondria (Fig. 4.5B) that differ in diameter between cells. In other cells, the occurrence of 
very thin and elongated mitochondria was observed (Fig. 4.5C). Notably, the thin mitochon-
dria seen in muscle cells expressing αS also form more interconnected networks. While in 
mitochondria of wild type worms the luminal space inside the stained mitochondrial outer 
membranes is seen, it is not visible in the thin and elongated mitochondria.  
 
The effect of αS on mitochondrial morphology in C. elegans body wall muscles (BWMs) is 
concentration-dependent as shown in the quantification of mitochondrial morphology upon 
expression of αS in different concentrations depicted in Fig. 4.5D. Low expression levels of 
αS lead to the occurrence of fragmented and thin mitochondria in only 10-30% and 5-15% of 
muscle cells, respectively while 55-80% of the muscles are still showing wt-like morphology. 
In contrast, only around 15% of the cells exhibit wild-type like mitochondrial tubules for the 
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worms expressing high concentrations of αS. In those animals, approximately 40% of the 
cells are showing mitochondrial fragmentation and another 40% of the cells have very thin 
and elongated mitochondria. Saturation of the effects can be observed as increasing expres-
sion levels above a certain level does not lead to aggravation of the observed morphological 
changes. This suggests that mitochondrial morphology is affected by the expression of αS 
and that the severity of the effects seen, like mitochondrial fragmentation and occurrence of 





We next wanted to confirm the mitochondrial morphology defects on an ultra-structural level 
using High Pressure Freeze Electron Microscopy (HPF-EM). Indeed, EM analysis confirmed 
the effects seen with fluorescence microscopy, especially the mitochondrial fragmentation. 
As only single cross-sections of BWM cells were analyzed by EM, it was hard to detect the 
occurrence of long and thin mitochondria as one would expect them to look similar to frag-
mented mitochondria in cross-sections. A decrease in mitochondrial diameter could clearly 
be observed in αS expressing worms as shown in Fig. 4.6. In contrast, no significant chang-
es of the mitochondrial cristae structure could be observed. 
Fig. 4.5: Changes in mitochondrial morphology in C. elegans muscle cells expressing αS. 
(A-C) Mitochondrial morphology in C. elegans muscle cells was assessed by expression of αS together with the 
mitochondrial outer membrane marker TOM70-CFP (transmembrane domain of yeast TOM70 fused to CFP) 
under control of the muscle-specific myo-3 promoter. Scale bars represent 10 µm. (A) Mitochondria in wt worms 
that are not expressing αS form regular tubular structures. Upon expression of wt αS, the mitochondria become 
either fragmented (B) or for very thin, elongated and interconnected structures (C). (D) Quantification of the ef-
fect of different concentrations of wt αS on mitochondrial morphology in C. elegans muscle cells. Expression 
levels of αS were determined by Western Blot. Pictures A-C were published in (Kamp et al., 2010). 





The next step after investigation of the effects of wt αS was to determine the influence of PD 
mutants as well as the designed pre-fibrillar variant TP αS on mitochondrial morphology. The 
results of this analysis are illustrated in Fig. 4.7A. Interestingly, the synthetic TP αS, which 
stops aggregation at the stage of soluble proto-fibrils (see section 4.2.1) and exhibits in-
creased levels of toxicity (see section 4.2.2), predominantly leads to the occurrence of long 
and very thin mitochondria and not so much to mitochondrial fragmentation. Only 10-30% of 
the cells expressing TP αS show vesicular mitochondrial structures while mitochondria in 
30-50% of the cells expressing the wt version of the protein are fragmented. The number of 
cells with wt-like mitochondria is comparable in worms expressing wt and TP αS. 
Fig. 4.6: EM analysis of changes in mitochondrial morphology in C. elegans muscle cells induced by 
expression of wt αS. 
EM images of C. elegans BWM cells. The top images were taken from wild type animals that were not express-
ing αS, while the images in the bottom show BWMs of animals expressing wt αS at relatively high expression 
levels. Mitochondrial fragmentation is seen in the worms that are expressing αS confirming the results obtained 
by fluorescence microscopy. EM images were kindly provided by Dr. Jan Hegerman. 
PhD Thesis – Nora Wender Chapter I: Cellular function and toxicity of αS in C. elegans  
37 
 
The two PD mutants of αS, A30P and A53T, had similar effects on mitochondrial morphology 
than wt αS. The effect of A30P αS was even lower than that of wt αS although the expres-
sion levels were higher for A30P. It has to be noted at this point that the expression levels of 
TP αS observed for three independent transgenic lines were considerably higher than those 
for wt αS which might partially explain the different effects. Nevertheless, as we observed a 
saturation of the effects on mitochondrial morphology at the highest expression levels of our 
wt αS expressing worms, it seems rather unlikely that the discrepancy of effects seen in TP 
and wt αS is solely due to different protein concentrations in the cell. This is further supported 
by the fact that expression levels of A30P were similar to those of TP αS and still did not 
cause such severe defects on the appearance of mitochondria. We were trying to achieve 
similar expression levels of the different αS variants by injecting the same plasmid concentra-
tions for creating transgenic lines but we still saw considerable differences in the actual ex-
pression levels in our transgenic lines. In order to be able to fully exclude that the observed 
differences of mitochondrial morphologies are due to dissimilar protein concentrations, more 
lines expressing the different variants at various concentrations would need to be generated 
and analyzed for mitochondrial morphologies.  
 
EM analysis of the TP αS expressing worms confirmed the changes in mitochondrial mor-
phology towards thinner diameter that was seen in the fluorescence pictures as shown in 
Fig. 4.7B. Again, the mitochondrial cristae structure was not impaired by expression of TP αS 
similar to what was already observed for expression of wt αS. 
 
In summary, expression of wt as well as the PD mutant A53T αS leads to mitochondrial 
fragmentation and the occurrence of muscle cells with long and thin mitochondria. The other 
PD variant, A30P, seems to affect mitochondrial morphology to a lesser extent. Interestingly, 
expression of the pre-fibrillar variant TP αS, which was shown to exhibit increased neurotoxi-
city, predominantly leads to long and thin mitochondrial morphology whereas mitochondrial 
fragmentation can only be seen to a small extent.  
 






Fig. 4.7: Effect of different αS variants on mitochondrial morphology in C. elegans BWM cells. 
(A) Quantification of the relative occurrence of wt-like, fragmented or thin mitochondria. TP αS leads to 
increased occurrence of long, thin and interconnected mitochondria while the PD mutants cause similar or 
even milder defects than those seen upon expression of wt αS. Expression levels of the different variants 
were determined by Western Blot. Three independent transgenic lines were analyzed for wt and TP αS, two 
for A30P and one for A53T. (B) EM pictures of cross-sections through C. elegans BWM cells. The diameter 
of mitochondria in cells expressing TP αS is severely decreased compared to wild type worms not express-
ing αS. EM Images were kindly provided by Dr. Jan Hegerman. 
PhD Thesis – Nora Wender Chapter I: Cellular function and toxicity of αS in C. elegans  
39 
 
4.2.5. Mitochondrial fragmentation similar to that seen upon expression of αS 
also occurs during aging 
 
Seeing the drastic changes in mitochondrial morphology upon expression of αS, we were 
wondering whether similar morphological alterations could be found in aged worms. In order 
to address this question, mitochondrial morphology in 3-day old (first day of adulthood) and 
7-day-old animals (fourth day of adulthood in C. elegans is already at a post-reproductive 
stage) was investigated. This was done in both wild type worms not expressing αS and 
worms expressing wt αS. Fig. 4.8B depicts the result of this analysis. Interestingly, in the old 
wild type animals, a significant number of cells exhibited mitochondrial fragmentation with 
vesicular mitochondrial structures similar to those observed in young adult worms expressing 
wt αS (Fig. 4.8A). In contrast, aging had only a minor impact on mitochondrial morphology in 
worms expressing αS. This suggests that the mitochondrial fragmentation observed upon 
expression of αS is not an unphysiological reaction to the heterologous expression of this 
protein but rather a condition that is also found in aged nematodes. This points towards αS 





Fig. 4.8: Mitochondrial fragmentation in C. elegans muscle cells during aging. 
(A) Fragmented mitochondria are found in BWM cells of 7 day-old wild type C. elegans. Scale bar represents 
10 µm. (B) Quantification of mitochondrial morphology in young versus old worms for wild type worms (left) and 
worms expressing wt αS (right). In wild type worms not expressing αS, a considerable increase in fragmented 
mitochondria was seen during aging. In contrast, only mild changes in mitochondrial morphology were seen in 
aged αS expressing worms compared to young worms expressing αS. Pictures were published in (Kamp et al., 
2010). 
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4.2.6. Changes in mitochondrial morphology caused by expression of αS re-
semble those seen under starvation 
 
Besides checking for the influence of aging, we were also investigating how the nutrient sta-
tus of cells might influence mitochondrial morphology. It was recently described that nutrient 
deprivation leads to mitochondrial elongation. This elongation is mediated by cAMP-induced 
activity of PKA (protein kinase A) which phosphorylates the mitochondrial fission protein 
DRP-1 (dynamin related protein 1) at Ser637 thereby preventing translocation of DRP-1 to 
the mitochondria. The result is unopposed fusion and thus elongation of the mitochondria 
(Gomes et al., 2011). The authors propose that mitochondrial elongation serves as a mecha-
nism to prevent mitochondria from being cleared by autophagy which is induced upon nutri-
ent depletion. Furthermore, they show that the elongation is accompanied by an increase of 
inner membrane cristae leading to increased ATP production. If mitochondrial elongation 
during starvation is prevented, mitochondria in contrast consume cytosolic ATP resulting in a 
bioenergetics crisis and eventually in cell death. Inhibition of mitochondrial elongation during 




Fig. 4.9: Mitochondrial fragmentation in BWM cells upon starvation of wild type worms. 
The impact of starvation on mitochondria in C. elegans muscle cells was assessed by fluorescence microscopy in 
wild type worms expressing the mitochondrial marker TOM70-CFP. While under non-starved conditions mito-
chondria form tubular structures (top panel), fragmentation of the mitochondria into vesicular structures can be 
observed upon starvation (as shown in the lower panels). Scale bars represent 10 µm. 
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To examine whether similar effects on mitochondrial morphology might be observed in 
C. elegans, wild type worms expressing the mitochondrial marker TOM70-CFP in muscle 
cells were grown in the absence of food for 24 h starting from the L4 larval stage or for 52 h 
starting from L3. 
 
As presented in Fig. 4.9, starvation induces mitochondrial fragmentation in C. elegans mus-
cle cells. The resulting vesicular mitochondrial structure resembles the effects that were ob-
served in aged wild type nematodes or young adult worms expressing wt αS.  
 
 
4.2.7. Fibril formation and mitochondrial fragmentation can also be seen in 
C. elegans neurons expressing αS 
 
As in PD neurons and not muscle cells are affected, we wanted to verify that the effects of 
αS on mitochondrial morphology are not specific to muscle cells but can also be seen in neu-
rons. For this purpose I was expressing both the mitochondrial marker TOM70-CFP and 
wt αS under the control of a pan-neuronal rab-3 promoter and was imaging neurons of the 
ventral nerve cord (VNC). Also in these neurons, wt αS is forming fibrillar aggregates as 
shown in Fig. 4.10A. These aggregates strongly resemble the aggregates that were seen in 
BWM cells. In muscle cells, the fibrillar aggregates usually measure around 5-15 µm with 
some longer aggregates of around ~20 µm observed in some cells. The aggregates in the 
smaller neuronal cell bodies typically have a length of around 2-10 µm. While the fibrillar ag-
gregates in muscle cells are mostly straight, the fibrils observed in neuronal cell bodies can 
either be straight or curved with some aggregates forming almost ring-like structures around 
the nucleus. Such bended fibrils were not seen in the BWM muscle cells and they might be 
caused by the small size of the neuronal cell bodies hindering straight fibrils from growing 
above a certain size. 
 
Studying the mitochondrial morphology in VNC neurons revealed that mitochondria in the cell 
bodies of VNC neurons form long tubular (indicated by “T” above the arrowhead pointing 
towards the cell body) or ring-like structures (indicated by “R”) around the nuclei in wild type 
worms (Fig. 4.10B). Also in the neurites that are projecting below the cell bodies in the VNC 
mitochondria appear as rather short but mostly tubular structures. In agreement to the 
changes in mitochondrial morphology in C. elegans muscle cells, expression of wt αS leads 
to fragmentation of mitochondria (indicated by “F”) in both cell bodies and neurons of the 
VNC (Fig. 4.10C). Quantification of the mitochondrial morphologies was performed in two 
and three independent lines for worms without and with αS expression, respectively, and is 
depicted in Fig. 4.10D. The fact that expression of wt αS causes mitochondrial fragmentation 
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Fig. 4.10: Fibril formation and mitochondrial fragmentation in C. elegans neurons expressing wt αS. 
(A) wt αS was tagged with mYFP at the C-terminus and expressed under the control of a pan-neuronal 
rab-3 promoter. Shown are neurons of the ventral nerve cord (VNC). Formation of fibrillar aggregates of 
αS-mYFP was observed. (B) Mitochondria in the cell bodies of VNC neurons of wild type worms not ex-
pressing αS form tubular or ring-like structures around the nucleus. (C) Expression of wt αS leads to mito-
chondrial fragmentation in VNC neurons. Neuronal cell bodies in (B+C) are indicated by a white arrowhead. 
Classification of the mitochondrial morphology into the categories “ring-like” (R), “tubular” (T) or “fragment-
ed” (F) was done for each neuron and the category of the depicted neurons is indicated above the white 
arrowheads. Scale bars represent 5 µm. Pictures B-D were published in (Karpinar et al., 2009). 






4.3.1. Proline mutations in designed variants of αS prevent fibril formation  
in vitro and in vivo  
 
Post mortem analysis of brains from PD patients revealed that LBs are a characteristic fea-
ture of surviving SN neurons. As aggregated αS was reported to be the major component of 
LBs, it was assumed that fibrillar aggregates of αS cause neurotoxicity. Only in 2000, Lans-
bury and coworkers were postulating that oligomeric precursors of the fibrillar aggregates 
rather than the fibrils themselves might be the toxic species (Conway et al., 2000; Goldberg 
and Lansbury, 2000). This oligomer hypothesis was based on their observation that during 
the process of αS fibril formation, smaller oligomeric species are generated and that the rate 
of oligomer formation was increased in the A30P PD mutant (Conway et al., 1998; Conway 
et al., 2000). In contrast, only in the A53T mutant, an increased rate of fibril formation was 
observed, while several studies have demonstrated that the propensity to form fibrils is re-
duced in A30P when compared to wild type (Conway et al., 1998; Conway et al., 2000; Li et 
al., 2001). This indicates that at least in the case of A30P, disease pathogenesis is not direct-
ly correlated with increased formation of amyloid fibrils. The observation that αS oligomers 
can bind to liposomes and form pores in membranes thereby causing increased membrane 
permeability was providing further evidence for pathogenic effects of the pre-fibrillar species 
of αS (Volles et al., 2001). As it was not possible to directly assess in vivo, whether the oc-
currence of oligomeric αS correlates with toxicity, for many years there was still debate on 
which is the toxic species of αS. By using synthetic variants of αS which were designed to 
interfere with fibril formation and that instead promote oligomerization, we were able, for the 
first time, to clearly show in vivo that pre-fibrillar αS is exhibiting increased toxicity. 
 
In vitro studies performed in the labs of Prof. Markus Zweckstetter and Prof. Christian 
Griesinger were confirming that the proline residues that were introduced in the designed 
variants A56P and TP (A30P/A56P/A76P) were indeed interfering with the formation of 
β-sheets and thus led to severely reduced rates of fibrillization (Fig. 4.2). Especially for TP no 
fibril formation as assessed by Thioflavin T fluorescence could be observed even after two 
weeks of incubation under conditions for which wt αS rapidly starts forming fibrils after a lag 
phase of approximately 20 h (Karpinar et al., 2009). Dynamic light scattering and NMR stud-
ies revealed that the soluble oligomers which precede the occurrence of amyloid fibrils during 
the course of αS aggregation are still present for A56P and TP (Karpinar et al., 2009). To 
exclude that these soluble oligomers that were observed for A56P and TP are “off-pathway” 
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oligomers, which have different characteristics than the oligomers seen in wt αS and thus 
prevent the aggregation into fibrillar structures, incubations with high levels of protein and 
long incubation times were performed. Consistent with the oligomers of A56P and TP being 
“on-pathway”, they could assemble to fibrils under these conditions (Karpinar et al., 2009). 
Furthermore, oligomers of TP αS were able to seed the aggregation of wt αS, also supporting 
that they are “on-pathway” to fibrils (Karpinar et al., 2009). In agreement with the in vitro ex-
periments, we were able to show that the designed variants are not forming fibrillar aggre-
gates in vivo in contrast to wt αS (Fig. 4.3). Interestingly, we see fibrillar aggregates of 
wt αS-YFP in the muscles of transgenic worms used in this study while inclusions observed 
in previously reported strains expressing αS in C. elegans muscle cells were appearing as 
rather amorphous plaque-like structures (Hamamichi et al., 2008; van Ham et al., 2008). One 
explanation for this difference could be different αS constructs used, but all three strains are 
expressing αS fused to YFP or GFP at the C-terminus. Yet, it is conceivable that different 
linkers were used when creating the fusion proteins and that this might affect the aggregation 
properties. Furthermore, we used a myo-3 promoter instead of the unc-54 promoter that was 
used in the other studies. Both are strong promoters driving expression in the body wall and 
sex muscles of C. elegans, but the myo-3 promoter leads to a more stable expression 
throughout development while expression under the control of the unc-54-promoter results in 
very mosaic bursts of high expression levels particularly during early larval stages (S. Eimer, 
unpublished observation). To clarify this issue, it would be necessary to express our αS-YFP 
construct under the control of the unc-54 promoter and investigate the aggregates formed 
upon expression of this construct. Aggregate formation was studied in the vulva musculature 
and not in body wall muscles (BWMs) in our study but we find fibrillar aggregates also in the 
BWMs of our strains and even in neurons (Fig. 4.9). As aggregation of αS in vitro also yields 
in fibrillar aggregates, we are assuming that αS-YFP in our model is also forming amyloid 
fibrils. As the fibrils formed in vitro have a diameter of only around 10 nm (Choi et al., 2004; 
Conway et al., 1998; Giasson et al., 1999; Narhi et al., 1999) and conventional light micros-
copy is diffraction limited to approximately 200 nm, we cannot test whether the dimension of 
the fibrils observed in C. elegans lies in the range of the in vitro fibrils. Thus, to test whether 
the fibrils seen in fluorescence microscopy are indeed made up of amyloid fibrils, it would be 
necessary to use EM or super-resolution imaging techniques like STED, STORM or PALM 
allowing a resolution of down to 20 nm. Alternatively, staining the worms with Thioflavin T as 
described by Ved et al. (Ved et al., 2005), could be used to shed light on this aspect. Thiofla-
vin T belongs to the group of benzothiazole dyes and exhibits fluorescence upon interaction 
with amyloid fibrils which is based on intercalation of Thioflavin T within the amyloid fibrils 
(Hudson et al., 2009). Although the amyloid fibrils cannot directly be identified in fluores-
cence pictures of αS-YFP aggregates, the results of the in vitro analysis of TP αS and the 
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fact that the introduction of proline residues in the TP variant abolishes the occurrence of 
these fibrils, clearly argues for the presence of amyloid fibrils. This was in agreement with 
work done in mammalian cell culture where fibril formation of the designed TP αS variant 
also prevented the formation of fibrillar aggregates (Karpinar et al., 2009). Thus, while wt αS 
is forming fibrillar aggregates in vitro and in vivo, the designed variant TP αS stops at a pre-
fibrillar level, namely soluble oligomers. As it is not forming amyloid fibrils, it is a valuable tool 
for directly assessing the toxicity of oligomeric αS in vivo. 
 
 
4.3.2. TP αS exhibits increased neurotoxicity in C. elegans 
 
By comparing the toxicity of the designed pre-fibrillar αS variants with that of wt or familial PD 
mutant αS in C. elegans dopaminergic (DA) neurons, we could show that oligomeric species 
rather than fibrils are causing toxicity (Fig. 4.4) and thereby provide strong evidence for the 
oligomer hypothesis postulated by Lansbury and colleagues (Conway et al., 2000; Goldberg 
and Lansbury, 2000). Modest expression of wt αS does not lead to detectable neurite defects 
and also does not impair the worm’s slowing in response to food, a behavior controlled by 
the dopaminergic system. This indicates that neither morphology nor function of the DA neu-
rons was compromised. In contrast, expression of the PD mutants A53T and A30P induces 
defects in the neurites and these defects correlate with impaired function of the neurons as 
seen by reduced slowing of the worms when they encounter food. No obvious differences in 
toxicity between A53T and A30P could be observed in our model. Increased toxicity of A53T 
when compared to A30P had previously been reported in a study using transgenic mice (Lee 
et al., 2002) but we were not able to reproduce these results. However, a similar extent of 
neurodegeneration of A53T and A30P αS was also seen in another model of transgenic 
worms expressing αS in DA neurons (Kuwahara et al., 2006), indicating that the two PD vari-
ants are exhibiting similar levels of toxicity in C. elegans. Interestingly, the designed pre-
fibrillar αS variants A56P and TP exhibited a significantly increased neurotoxicity compared 
to both wt and familial PD mutants. This was seen both on a morphological as well as a func-
tional level. TP αS was the most toxic variant with the effects on DA neurite morphology and 
on the food slowing response being much more pronounced than for A56P which still had 
some residual propensity to form amyloid fibrils. This strongly indicates that oligomeric pre-
cursors rather than αS fibrils are causing neuronal toxicity. The increased toxicity of PD mu-
tants compared to wt αS is in line with this as increased oligomerization had been described 
for both mutants (Conway et al., 2000; Karpinar et al., 2009; Li et al., 2001). The fact that 
A53T and A30P cause neurodegeneration to a similar extent also argues for oligomers and 
not fibrils being the toxic species as A53T has a higher rate of fibril formation than A30P. 
Therefore, if fibrils were causing toxicity one would expect A53T to induce more severe de-
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fects. In agreement with these findings, experiments done in Drosophila and rat primary cor-
tical neurons also demonstrated that TP αS exhibits the highest toxicity followed by A56P 
and the PD mutants all of which were causing increased defects when compared to wt αS 
(Karpinar et al., 2009). 
 
Our results are in line with earlier experiments that had provided evidence for the oligomer 
hypothesis. The observation that chaperone expression was leading to decreased αS toxicity 
in Drosophila without changing the occurrence of fibrillar aggregates was indicating that the 
chaperones were acting on soluble αS oligomers and that those could be the toxic species 
(Auluck et al., 2002). Moreover, preventing phosphorylation of αS at Ser129 led to increased 
aggregate formation but was reducing toxicity in Drosophila, also arguing against fibrillar ag-
gregates causing toxicity (Chen and Feany, 2005). A recently published study was using a 
similar approach of structure-based design than the one that we have presented to create αS 
mutants (E57K and E35K) which promote the formation of oligomeric αS without further ag-
gregating to amyloid fibrils. Besides these fibrillar mutants, they were using a C- and N-
terminally truncated variant of αS (αS 30-110) that is characterized by an increased rate of 
fibrillization as well as the three known PD mutants A30P, A53T and E46K and wt αS and 
were examining the toxicity of the different variants in rats. Thus, using an in vivo mammalian 
system they were able to confirm our results by showing increased toxicity of oligomeric αS 
compared to fibril forming species (Winner et al., 2011). They also showed that that the toxic 
oligomeric species bind to membranes forming pore-like structures suggesting that thereby 
induced changes in permeability and integrity of cellular membranes are causing toxicity. 
 
The finding that oligomeric forms rather than the amyloid fibrils are causing neurotoxicity 
seems not to be unique to PD but it was also proposed for other neurodegenerative diseases 
like Alzheimer’s disease and Huntington’s disease. All of these diseases belong to the group 
of amyloid diseases which are characterized by the presence of fibrillar protein aggregates. 
While in PD αS is the aggregating protein, fibrillar aggregates of β-amyloid and huntingtin are 
found in Alzheimer’s disease and Huntington’s disease, respectively. Besides the insoluble 
fibrils, soluble oligomeric species have been described for all three diseases and it was pos-
tulated that these pre-fibrillar aggregates are responsible for toxicity [reviewed in (Glabe, 
2006)]. 
 
The relevance of soluble oligomers for PD pathogenesis was further emphasized by the find-
ing that levels of oligomeric αS are elevated in patients suffering from PD (Sharon et al., 
2003). Moreover, it was reported that auto-oxidation of dopamine leads to a stabilization of 
oligomeric αS (Conway et al., 2001; Norris et al., 2005), an observation that might explain the 
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particular vulnerability of DA neurons of the substantia nigra. The finding that pre-fibrillar 
species of αS are responsible for αS-induced neurotoxicity also has implications for PD 
treatment. Thus, preventing the oligomerization of αS seems to be a promising target for PD 
therapy. When searching for possible substances that could prevent aggregation of αS, one 
therefore has to be very careful that not only the more easily detectable insoluble fibrils dis-
appear but that also the small soluble precursors are not formed in the presence of the drug. 
As oligomers and not fibrils seem to be the toxic species of αS, it might even be neuroprotec-
tive to trigger aggregation of small oligomers to larger fibrillar aggregates though it is not sure 
whether huge inclusion bodies in the cell might not lead to compromised function to some 
extent as well. Besides that, changing the equilibrium from oligomeric to fibrillar aggregates 
might also induce an increased formation of new oligomers from monomeric αS so that the 
toxic load might stay unchanged. Therefore, it seems more promising to screen for sub-
stances that block the conversion of monomeric αS to oligomers or that trigger formation of 
non-toxic oligomeric variants. As it has been postulated that toxicity of the oligomers might 
be induced by interaction with cellular membranes, another possibility to interfere with toxicity 
would be finding molecules that are able to bind to the oligomers and hinder them from bind-
ing to phospholipids. Transgenic worms expressing oligomer forming TP αS as described in 
this study might be a valuable tool to screen for therapeutic drugs that prevent toxicity in-
duced by oligomeric αS species. 
 
 
4.3.3. Expression of αS leads to drastic changes of mitochondrial morphology 
in C. elegans muscle cells and neurons 
 
After having identified soluble oligomers as toxic species of αS, we were aiming in under-
standing the mechanism how αS mediates toxicity on the cellular level. In the past years, 
increasing evidence for involvement of mitochondria in the pathogenesis of PD [reviewed in 
(Bueler, 2009; Burbulla et al., 2010)] and other neurodegenerative diseases [reviewed in 
(Chen and Chan, 2009; Knott et al., 2008)] was found. Furthermore, a link between αS and 
this cellular compartment was reported. Several studies have found that αS localizes to mito-
chondrial membranes (Chinta et al., 2010; Devi et al., 2008; Li et al., 2007; Nakamura et al., 
2008; Parihar et al., 2008) leading to increased oxidative stress (Hsu et al., 2000; Parihar et 
al., 2008; Poon et al., 2005; Smith et al., 2005), reduced activity of complex I of the respirato-
ry chain (Chinta et al., 2010; Devi et al., 2008), cytochrome c release and induction of apop-
tosis (Parihar et al., 2008; Smith et al., 2005) as well as changes in mitochondrial morpholo-
gy (Hsu et al., 2000). To examine whether αS expression affects mitochondria in our 
C. elegans model, we were using confocal microscopy and HPF-EM to study the morphology 
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of mitochondria in worms expressing different concentrations of wt αS as well as the above 
described pre-fibrillar variant TP and the familial PD mutants A30P and A53T. 
 
Expression of wt αS in C. elegans muscle cells strongly influences mitochondrial morphology 
(Fig. 4.5). Mitochondria in the BWMs of wild type worms form tubular structures in a regular 
arrangement in parallel to the myo-filaments. Upon expression of wt αS, mitochondria be-
come either fragmented or form networks of long, thin and highly interconnected mitochon-
dria. Mitochondrial fragmentation leads to vesicular shape of the mitochondria of varying di-
ameter. While in some cells all the mitochondria appear to be fragmented, in other cells only 
long, thin and interconnected mitochondria can be observed and there were also cells in 
which both fragmented and elongated structures are present.  
 
HPF-EM analysis confirmed the effects of αS on mitochondrial morphology that were seen 
with fluorescence microscopy on an ultra-structural level (Fig. 4.6). Mitochondria in BWM 
cells expressing wt αS have a clearly reduced diameter compared to those in in wild type 
worms. In contrast, no obvious defects in cristae structure were observed upon expression of 
wt αS. As only single sections were analyzed by EM it is difficult to assess differences be-
tween fragmented and long and thin mitochondria as the latter ones would only differ from 
the fragmented ones if they were cut longitudinally. Thus, the complementary analysis by EM 
and confocal microscopy is most powerful in dissecting different aspects of mitochondrial 
morphology changes. While confocal microscopy gives a good overview of the overall mor-
phology and distribution of mitochondria in the entire 3D volume of the cell and thus enables 
us to distinguish between elongated, network-like and fragmented, vesicular morphologies, 
HFP-EM provides us with information on the ultra-structural changes like cristae structure 
and mitochondrial diameter. Another advantage of EM analysis is that it facilitates the inves-
tigation of various cellular compartments. While for confocal microscopy markers for every 
compartment would need to be used and thus various transgenic lines would need to be cre-
ated, all compartments are readily visible in EM pictures. While changes in mitochondrial 
morphology were easily seen in the EM pictures of muscles expressing wt αS, no obvious 
structural changes in other cellular compartments were observed. αS in our model seems to 
rather specifically affect the structure of mitochondria without changing the morphology of 
other organelles. This is in contrast to previous studies which reported Golgi fragmentation 
upon expression of αS (Gosavi et al., 2002; Lee et al., 2006). It is possible that the effects on 
Golgi morphology differ between different cell types and organisms. Furthermore, we did not 
do a detailed analysis of all compartments but were rather looking for gross morphological 
changes. Thus, more subtle changes on the Golgi could have been missed. In a recent 
study, Nakamura et al. also showed that αS expression causes mitochondrial fragmentation 
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without affecting the morphology of other organelles which is in line with our observation 
(Nakamura et al., 2011). As described above, expression of wt αS led to mitochondrial frag-
mentation in some cells, whereas networks of long and thin mitochondria where found in 
others. It is not clear what determines whether cells become fragmented or rather elongated 
in the presence of αS and whether one of the two effects precedes the other. We sought to 
investigate the latter aspect by expressing different concentrations of αS. We were hypothe-
sizing that, if one of the effects is occurring earlier, this one might predominantly be seen with 
low expression levels of αS. Though, even with low concentrations, both morphologies could 
be observed and no obvious change in the relative occurrence of the two morphologies com-
pared to higher αS concentrations could be detected (Fig. 4.5). Although the different ex-
pression levels did not affect the ratio between elongated thin and fragmented mitochondria, 
we were still able to determine that the effect of αS on mitochondrial morphology is concen-
tration-dependent. In worms expressing αS at low concentrations, mitochondria in 60-80% of 
the cells are still showing wt-like morphology. In contrast, wt-like mitochondria are present in 
only 10-20% of the worms expressing αS at high levels. Furthermore, we found a saturation 
effect as increasing αS above a certain level did not cause an aggravation of the phenotypes 
anymore. As the analysis of different concentrations of αS did not answer our question 
whether fragmentation and elongation are consecutive events, we thought of other ways to 
investigate this aspect and decided to investigate mitochondrial morphology in aged worms 
expressing αS. At 20 °C, wild type C. elegans have a mean lifespan of about 2-3 weeks and 
take 3 days to reach adulthood. We were expecting that, if one of the morphological changes 
was preceding the other, the late-stage morphology should be more abundant in 7-day-old 
worms. Investigation of aged worms expressing αS revealed that both fragmented and elon-
gated mitochondria are still present at late stages (Fig. 4.8). The relative occurrence of frag-
mented mitochondria was slightly increased compared to young worms expressing αS but as 
mitochondrial fragmentation also occurs in aged worms without expression of αS, this effect 
might rather be due to the aging process itself and independent of αS expression. These 
results suggest that both events – mitochondrial fragmentation and the formation of networks 
of long and thin mitochondria – are occurring in parallel to each other and are not necessarily 
consecutive events. It remains to be determined which factors are determining which mor-
phological changes of the mitochondria are induced by αS and it will also be interesting to 
examine whether one of the two conditions is more harmful to the cell. It is possible that dif-
ferent species of αS (monomer vs. different oligomeric forms or fibrils) are affecting mito-
chondrial morphology in different ways and examination of the effects of different variants of 
αS might therefore help to get a better understanding of this aspect. 
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Therefore, we examined the mitochondrial morphology in muscle cells expressing different 
αS mutants. Besides wt αS and two PD mutants (A30P and A53T) the designed pre-fibrillar 
TP variant was included in this analysis. The effect of A53T αS is very similar to the one seen 
for wt αS with both fragmentation and elongation to thin tubular structures being observed 
and only 20% of cells exhibiting wt-like mitochondrial morphology. In contrast, the second PD 
mutation, A30P, seems to be less deleterious with changes of mitochondrial morphology oc-
curring in only 40-70% of the cells even though the expression levels, as analyzed by West-
ern blot, were markedly higher than for wt or A53T (Fig. 4.7A). The ratio of mitochondrial 
fragmentation and elongation in the affected cells is similar to the ones upon expression of wt 
or A53T αS. 
 
Interestingly, expression of the mainly oligomeric TP αS predominantly leads to long, thin 
and interconnected mitochondria and less mitochondrial fragmentation is observed (Fig. 
4.7A). The total amount of cells in which mitochondrial morphology is affected by TP αS is 
comparable to the one of wt αS. Analysis of mitochondria of worms expressing TP αS was 
also done by HPF-EM (Fig. 4.7B). A drastic decrease in mitochondrial diameter was ob-
served for TP as compared to wild type worms and in longitudinal sections even elongated 
thin mitochondria were found. Again, as for wt αS, no obvious changes in the cristae struc-
ture were observed upon expression of TP αS. It has to be noted that expression levels of TP 
αS were much higher in all three transgenic lines than in the lines expressing wt αS so that it 
cannot be completely excluded that increased concentration of TP αS is the reason for dif-
ferent extents of mitochondrial changes. We tried to generate lines of comparable expression 
levels by injecting the same plasmid concentrations for all constructs but the number of cop-
ies of a gene in extrachromosomal arrays in C. elegans is determined stochastically. Howev-
er, when examining the effect of different concentrations of wt αS, we observed a saturation 
of the effects at a certain concentration, arguing against increased concentrations of TP αS 
being able to explain the differences in morphology. Furthermore, expression levels of the 
PD mutant A30P were in the range of those of TP αS and still did not induce such strong 
effects. In the meantime, transgenic lines expressing TP αS at lower concentrations were 
generated with help of David Vasmer, a lab rotation student. Even with these lower concen-
trations, the predominant morphology of the mitochondria in muscle cells seems to be long, 
thin and interconnected tubules. Therefore, we propose a model in which differences in the 
effects between wt and TP αS are originating from different properties and/or amounts of the 
oligomeric species that are formed by the two proteins. As discussed in the previous sections 
of this chapter, TP αS differs from the wt protein in its aggregation properties. While wt αS 
forms amyloid fibrils, aggregation of TP αS stops at the stage of soluble oligomers (Fig. 4.2 
and 4.3). We also showed that TP αS leads to increased neurotoxicity in C. elegans DA neu-
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rons (Fig. 4.4). Hence, one possibility would be that oligomeric species like the ones formed 
by TP αS bind to mitochondria in a way in which they can induce elongation to very thin tu-
bules and as these oligomeric species are present in lower amounts for wt αS, mitochondrial 
elongation is observed to a lower extent. Another scenario would be that pre-fibrillar TP αS 
induces toxicity in the cells through a mechanism that is independent of its direct effects on 
mitochondria and that these “pre-damaged” cells react to binding of αS to the mitochondria 
with different changes in mitochondrial morphology. 
 
Another important aspect that might explain differences in the effects of the various mutants 
on mitochondrial morphology is their propensity to bind membranes. It has been shown that 
the ability of A30P to bind to membranes is reduced when compared to wt αS (Karpinar et 
al., 2009; Perrin et al., 2000). Therefore, if αS affects mitochondrial morphology by a mecha-
nism that involves binding of the protein to the mitochondrial membrane, this should lead to 
milder effects than in the case of wt αS and A53T which bind to membranes more efficiently. 
Indeed, we see similar changes in mitochondrial morphology for wt and A53T, while mito-
chondria in cells expressing even higher levels of A30P show only minor defects. The mem-
brane binding properties of TP αS have been determined in vitro in the lab of Prof. Markus 
Zweckstetter and were found to be similar to those of A30P αS or even a bit lower (Karpinar 
et al., 2009). This is surprising as we see drastic changes in mitochondrial morphology to-
wards networks of long and thin mitochondria for TP αS. This could mean that either the 
binding of TP αS in vivo differs from the one in vitro – also the composition of mitochondrial 
membranes could differ significantly from the membranes used for the in vitro studies – or 
mitochondrial elongation is caused by indirect effects of TP αS on mitochondrial morphology. 
Further investigations of the ability of TP αS to bind to mitochondria in vivo, for example by 
using immuno-EM, are needed in order to be able to decipher the mechanism by which TP 
αS leads to mitochondrial elongation. Furthermore, it would be interesting to study the effect 
of αS variants that lack the ability to bind membranes and see whether they can still influence 
mitochondrial morphology. If this is the case, this would argue for more indirect effects of αS 
on mitochondrial dynamics. If such mutants would, in contrast, not affect mitochondrial mor-
phology anymore, this would clearly indicate that αS influences mitochondrial morphology 
through direct binding to the mitochondrial membrane. Moreover, investigating the effects of 
E46K αS, another PD mutant, could be helpful in deciphering the role of membrane binding 
for mitochondrial morphology as this mutant was shown to exhibit increased phospholipid 
binding properties (Choi et al., 2004). We are currently creating transgenic lines expressing 
E46K αS and it will be very interesting whether increased mitochondrial fragmentation will be 
observed in these strains. 
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Notably, expression levels in our transgenic worms were much higher for TP and A30P than 
for wt and A53T αS despite the fact that the same plasmid concentrations were used when 
generating the transgenic worms. Although the expression levels in different transgenic lines 
can vary with the same injection mix, it is unusual that the expression of all three independ-
ent lines for TP and the two lines of A30P αS are 3-7-fold higher than all three lines of wt αS 
and the line expressing A53T. Thus, it is possible that increased stability of TP and A30P αS 
contributes to the increased protein levels. Effects of αS on cellular degradation systems 
including both UPS and autophagy, have been described (Cuervo et al., 2004; Martinez-
Vicente et al., 2008; Snyder et al., 2003; Winslow et al., 2010) and it is possible that the dif-
ferent αS species affect these systems to a different extent. Further investigations will be 
needed to figure out whether this is the reason for divergent protein levels of TP and wt αS in 
our transgenic C. elegans strains. To do so, one would need to use inhibitors for proteasomal 
and autophagic degradation and investigate whether under these conditions wt αS levels are 
increasing to a similar level than those seen for TP αS. 
 
Our collaborators in the lab of Prof. Christian Haass (LMU Munich) were investigating the 
effect of αS overexpression on mitochondrial morphology in SH-SY5Y cells. In line with our 
observations, they see mitochondrial fragmentation upon expression of wt and PD mutant αS 
(Kamp et al., 2010). In their system, no differences in the effects of wt and PD mutant αS 
were observed (Kamp et al., 2010). They were also expressing β-synuclein (βS), a homolog 
of αS that lacks a stretch of hydrophobic amino acids in the central region which is present in 
αS. Similar to αS, βS also binds to membranes (Varkey et al., 2010) but it differs from αS in 
the propensity to aggregate. Due to lack of the central hydrophobic region, βS is not prone to 
aggregation (Biere et al., 2000; Giasson et al., 2001; Serpell et al., 2000; Uversky et al., 
2002). Strikingly, mitochondrial fragmentation was also seen upon expression of βS (Kamp 
et al., 2010), indicating that binding of monomeric species of synucleins inhibits membrane 
fusion. It is possible that oligomeric αS can also bind to mitochondrial membranes but affects 
morphology in a different way, rather producing long tubular structures as seen in the oligo-
mer-promoting variant TP αS. Work in the lab of Christian Haass also revealed that binding 
of αS to mitochondrial membranes inhibits fusion rather than promoting fission as seen in cell 
fusion assays where differently labeled mitochondria did not mix when αS was expressed 
(Kamp et al., 2010). They could also show that cellular ATP levels and mitochondrial mem-
brane potential are not affected by αS overexpression, indicating that it is unlikely that mito-
chondrial defects are responsible for the changes in mitochondrial dynamics (Kamp et al., 
2010). Moreover, they found that the effect of αS on mitochondrial morphology were inde-
pendent of the mitochondrial dynamics genes Mfn1, Mfn2, OPA1 and Drp1 and that the lev-
els of these proteins as well as OPA1 processing were not changed by αS (Kamp et al., 
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2010). Therefore, it seems likely that binding of αS directly inhibits fusion of the membranes 
rather than disturbing the function of the proteins regulating mitochondrial dynamics. 
 
Recently, another study was published in which the effects of different αS constructs on mi-
tochondrial morphology were assessed in mammalian cells, both in vitro and in vivo. In 
agreement with our observations they also described mitochondrial fragmentation upon ex-
pression of wt αS and did not see strong effects on the morphology of other organelles 
(Nakamura et al., 2011). Interestingly, similar to what we had reported for C. elegans BWMs, 
they also saw weaker effects of A30P αS on mitochondrial dynamics, indicating that reduced 
membrane binding as described for A30P (Choi et al., 2004; Karpinar et al., 2009) prevents 
αS from influencing mitochondrial morphology. In line with membrane binding playing an es-
sential role for the induction of mitochondrial fragmentation, mutated variants of αS that fail to 
associate to membranes do not induce fragmentation (Nakamura et al., 2011). Nakamura et 
al. also report that βS can also induce mitochondrial fragmentation but that the effects are 
not as prominent as for αS and only negligible effects were found upon expression of γ-
synuclein (Nakamura et al., 2011). Our collaborators in the lab of Prof. Christian Haass, in 
contrast, had observed the same degree of fragmentation for both α- and βS (Kamp et al., 
2010). Further investigation of this aspect will be needed as it might give insight into which 
species of synuclein (monomers or oligomers) is causing the effects. As βS has markedly 
reduced aggregation propensity, fragmentation to the same levels as for αS would argue for 
monomeric variants as inducers of fragmentation while reduced levels in the case of βS as 
reported by Nakamura et al. would argue in favor of oligomeric species being responsible for 
mitochondrial fragmentation. In agreement with the results of the cell culture studies per-
formed in the lab of Prof. Christian Haass, no changes in mitochondrial membrane potential, 
superoxide levels or oxygen consumption were seen in cells expressing αS (Nakamura et al., 
2011) arguing for mitochondrial changes being induced specifically by the interaction of αS 
with mitochondria rather than through compromised mitochondrial function. While EM analy-
sis of the mitochondria in our C. elegans model as well as in the SH-SY5Y cells expressing 
αS did not reveal any abnormalities in mitochondrial cristae structure (Kamp et al., 2010), 
Nakamura at al. observe disordered cristae in both cell culture and transgenic mice. In sum-
mary, mitochondrial fragmentation has been observed by us in C. elegans muscle cells, 
mammalian cell culture (Kamp et al., 2010) and by Nakamura et al., in mammalian cell cul-
ture and transgenic mice (Nakamura et al., 2011). Direct binding of αS to mitochondrial 
membranes seems to be responsible for induction of fragmentation but further studies, inves-
tigating in more detail how different monomeric and oligomeric forms influence mitochondrial 
dynamics, are needed. This is particularly important as the oligomer promoting variant TP αS 
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seems to affect mitochondria in a different way and is rather inducing mitochondrial elonga-
tion and network formation than mitochondrial fragmentation. 
 
When examining mitochondrial morphology of aged worms in the post-reproductive phase, 
we observed fragmented, vesicular mitochondria in about 40% of the cells (Fig. 4.8). This 
indicates that mitochondrial fragmentation is part of the physiological mitochondrial aging 
process. As the same amount of fragmented mitochondria is observed in young adult worms 
expressing wt αS, it is tempting to speculate that αS accelerates the physiological aging pro-
cess. In αS expressing worms, an increase in the portion of fragmented mitochondria with 
aging can also be found. This effect, though, is not as pronounced as in wild type worms. 
While mitochondrial fragmentation seems to be a common feature of mitochondrial aging in 
wild type worms, in the aged wild type animals, only very few cells show long and thin mito-
chondria like the ones observed upon expression of wt or even more pronounced upon ex-
pression of TP αS. As we did not follow the complete aging process – we were just examin-
ing 7-day old compared to 3-day old worms – and given that the mean life span of C. elegans 
is 12-18 days, it is conceivable that such alterations emerge only in later stages of the aging 
process. On the other hand it is also possible that these alterations are not part of the physio-
logical aging process but rather unique effects of expression of αS. 
 
Mitochondrial fragmentation similar to that seen upon expression of wt αS has been reported 
to be an early sign of apoptosis [reviewed in (Youle and Karbowski, 2005)] and it will there-
fore be interesting to follow these cells over time and determine whether they indeed are un-
dergoing cell death. Furthermore, mitochondrial fragmentation could facilitate mitochondrial 
clearance via mitophagy and massive loss of mitochondria might be detrimental to the cell 
(Gomes et al., 2011). Moreover, inhibition of fusion has been shown to induce deficiencies in 
the respiratory chain, probably because lack of fusion prevents complementation between 
mitochondria [reviewed in (Otera and Mihara, 2011)]. But also the elongated and thin mito-
chondria that were found in TP αS expressing cells could compromise mitochondrial function 
as fragmentation of mitochondria is a prerequisite for mitophagic clearance for damaged mi-
tochondrial components (Twig et al., 2008b) and accumulation of damaged material might 
compromise mitochondrial function. Furthermore, mitochondrial elongation induced by ex-
pression of TP αS could be particularly problematic in neurons as they rely on transport of 
mitochondria along the neurites which is hindered by very large mitochondrial networks [re-
viewed in (Westermann, 2010b)]. In contrast, it was also reported that mitochondrial elonga-
tion can serve as a protective mechanism against apoptosis [reviewed in (Youle and 
Karbowski, 2005)] and excess mitophagy as it was reported for conditions of nutrient depri-
vation (Gomes et al., 2011). Therefore, an interesting question to be addressed in future 
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studies is how the changes in mitochondrial morphology affect the cellular fitness. In this re-
spect, it will be particularly interesting to compare mitochondrial function and cellular fitness 
between cells with fragmented mitochondria and those in which mitochondria are forming 
elongated networks. Yet, it will be challenging to investigate this aspect as the methods 
commonly used for assessing mitochondrial function rely on measurements of whole animals 
(oxygen consumption, ATP levels, ROS production) or are based on investigation of isolated 
mitochondria that have been extracted from whole worms. We are currently generating 
worms expressing different αS from a ubiquitous promoter so that we could at least investi-
gate the overall effects of different αS variants on mitochondrial morphology. However, to 
clearly determine the correlation of morphology and function, techniques will have to be es-
tablished that allow assessment of mitochondrial function in individual cells as we have ob-
served that the effect of αS expression on mitochondrial morphology varies between cell 
types and even between cells of the same tissue.  
 
It had been reported that the nutrient status of cells has an important impact on mitochondrial 
dynamics with starvation causing the occurrence of elongated mitochondria (Gomes et al., 
2011). We were thus investigating whether this is also the case for mitochondria in 
C. elegans BWM cells. As we saw mitochondrial elongation upon expression of wt αS and 
even more pronounced when TP αS was expressed, we were hypothesizing that the underly-
ing mechanism could be similar to what is happening under conditions of nutrient deprivation. 
Gomes et al., had reported that depletion of nutrients leads to cAMP-induced activation of 
PKA which phosphorylates the mitochondrial fission protein DRP-1. As a consequence, 
DRP-1 is residing in the cytosol and cannot promote mitochondrial fission. It was furthermore 
shown that this mechanism serves to protect mitochondria from being degraded via autoph-
agy which is induced upon starvation. It was reported that autophagy is also induced upon 
expression of αS (Stefanis et al., 2001; Xilouri et al., 2009) and it was even shown that mas-
sive mitochondrial degradation via αS-induced autophagy might cause cell death and that 
inhibiting the targeting of mitochondria to autophagosomes is protective (Choubey et al., 
2011). Thus, mitochondrial elongation in cells expressing αS could also serve as a mecha-
nism to protect the cells against massive degradation of mitochondria. In contrast to the ob-
servations in mammalian cell culture, we did not see mitochondrial elongation in muscle cells 
of wild type worms starved for 24-52 h but we rather found fragmented mitochondria in mus-
cle cells of these animals (Fig. 4.9). It remains to be determined whether mitochondrial elon-
gation upon starvation is only observed in some cell types or whether we did not find the right 
starvation conditions and time windows. Concerning the starvation conditions, the effect 
might differ depending on which nutrients are depleted, e.g. whether worms are depleted 
from amino acids or from glucose. Nevertheless, even if mitochondrial elongation was not 
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found upon nutrient deprivation of nematodes, the mechanism inducing elongation upon ex-
pression of wt αS could still be analogous to the one that had been described in cell culture 
by Gomes et al. and could be protective by preventing excess mitochondrial degradation and 
also ensuring sufficient supply with ATP. 
 
After having studied mitochondrial morphology in C. elegans BWMs we also examined the 
effects of αS expression on mitochondrial dynamics in neuronal cells and found that severe 
mitochondrial fragmentation is induced by expression of wt αS (Fig. 4.10). While ring-like and 
tubular morphology of the mitochondria was seen in wild type worms, punctate structures 
were found in the cells expressing αS. Also in the neurites, mitochondrial length was drasti-
cally reduced upon expression of αS. This indicates that αS leads to mitochondrial fragmen-
tation in a tissue-independent manner in C. elegans. On the contrary, formation of networks 
of long and thin mitochondrial tubules as seen in BWMs was not observed in the neurons. It 
is possible that this morphology would have detrimental effects to nerve cells as they are 
very dependent on transport of mitochondria along their processes and it is easier to 
transport smaller structures than long and extended networks. This could also be a possible 
explanation of why in the SH-SY5Y cell line only mitochondrial fragmentation was observed 
when expressing αS. As SH-SY5Y cells are a neuroblastoma cell line, mitochondrial dynam-
ics might resemble the one of neuronal cells rather than that of other cell types and thus mi-
tochondrial elongation mechanisms might not be very pronounced. We did not study mito-
chondrial morphology in neurons of worms expressing TP αS but it would be very interesting 
to see whether this variant also induces fragmentation when expressed in neurons as in the 
case of wt αS or whether then also mitochondrial elongation would be observed. If mitochon-
drial elongation was found in neurons upon expression TP αS, this might explain the in-
creased neurotoxicity of this variant. 
 
To conclude, we have shown that expression of αS affects mitochondrial morphology in 
C. elegans muscle cells and neurons. While in neurons αS predominantly induces mitochon-
drial fragmentation, in muscle cells, besides fragmentation, formation of long and thin tubules 
can be seen in some cells. This mitochondrial elongation is furthermore the predominant 
morphology found when the pre-fibrillar TP αS is expressed suggesting that oligomeric forms 
of αS might affect mitochondrial morphology in a different way than monomeric αS. Given the 
observation that in cell culture, βS leads to mitochondrial fragmentation similar to αS, it 
seems likely that binding of monomeric forms of αS to mitochondria is causing fragmentation 
because βS does not form aggregates. Studies in cell culture point towards αS inhibiting 
membrane fusion rather than promoting fission (Kamp et al., 2010). How mitochondrial elon-
gation is triggered by expression of TP αS and also to some extent by wt αS will be an inter-
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esting target for future investigations. The observation that binding of αS to mitochondria 
induces changes in mitochondrial morphology might be of great relevance for the pathogen-
esis of PD as increased levels of mitochondria-associated αS have been found in the SN of 
PD patients (Devi et al., 2008). Re-establishing the balance between mitochondrial fission 
and fusion might be a promising target for the establishment of new treatments for PD. 
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5. Chapter II: Cellular function and toxicity of catp-6 





In humans, mutations in ATP13A2/PARK9 have been identified as the cause of Kufor-Rakeb 
syndrome (KRS) (Ramirez et al., 2006), a rare form of Parkinsonism that is characterized by 
pyramidal degeneration, dementia and supranuclear gaze palsy in addition to typical parkin-
sonian motor symptoms (Behrens et al., 2010; Najim al-Din et al., 1994; Ramirez et al., 2006; 
Williams et al., 2005). C. elegans catp-6 has been shown to be the ortholog of ATP13A2 
(PARK9) (Gitler et al., 2009). While the initially described mutations in ATP13A2 in KRS pa-
tients were homozygous or compound heterozygous mutations resulting in truncated variants 
of the protein due to frame shifts or splicing variants (Ramirez et al., 2006), more recently 
also heterozygous frame shift mutations and missense mutations, either homo- or heterozy-
gous, were found in patients suffering from early onset PD (Di Fonzo et al., 2007; Djarmati et 
al., 2009; Fong et al., 2011; Lin et al., 2008) and some of them have been proposed as risk 
factors for developing sporadic PD (Chen et al., 2011; Di Fonzo et al., 2007). Phenotypes in 
patients with missense mutations seem to be milder than for frame shift mutations and splic-
ing variants and mostly lead to development of typical parkinsonian signs without additional 
symptoms as seen in KRS patients (Lees and Singleton, 2007). 
 
ATP13A2 belongs to the P5 subfamily of P-type ATPases (Kuhlbrandt, 2004; Moller et al., 
2008; Schultheis et al., 2004) for which the substrate specificity remains unclear. It was pro-
posed that ATP13A2 is involved in transporting divalent cations like Cd2+ and Mn2+ as in-
creased sensitivity to these cations was observed in yeast in deletion mutants of Ypk9, the 
yeast ortholog of ATP13A2 (Gitler et al., 2009; Schmidt et al., 2009). Studies in mice re-
vealed that ATP13A2 is ubiquitously expressed with strong expression in the brain, predomi-
nantly in neurons and particularly high expression levels were found in DA neurons of the SN 
(Ramonet et al., 2012; Schultheis et al., 2004). Interestingly, elevated levels of ATP13A2 
were found in the SN of PD patients (Ramirez et al., 2006; Ramonet et al., 2012), indicating 
that this gene not only plays a role in familial PD but changes in the expression level might 
also provide a link to the more common sporadic forms of the disease. A recent study inves-
tigating the temporal expression pattern of ATP13A2 expression in mice found that the high-
est expression levels were reached at the time of neurogenesis and it overlapped with the 
time window in which the midbrain including basal ganglia and striatum are forming. As these 
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are the structures that are mainly affected in PD this further substantiates the link between 
ATP13A2 and PD. 
Lysosomal localization has been reported for wt ATP13A2 (Park et al., 2011; Ramirez et al., 
2006; Ramonet et al., 2012; Schroder et al., 2007; Tan et al., 2011; Ugolino et al., 2011) and 
it was shown that truncation of the protein by mutations in KRS patients leads to retention in 
the ER (Ramirez et al., 2006; Tan et al., 2011; Ugolino et al., 2011). This accumulation of 
unstable mutant ATP13A2 induces the unfolded protein response in the ER (Park et al., 
2011) and renders cells more vulnerable to ER stress induced by tunicamycin (Park et al., 
2011; Ugolino et al., 2011). Moreover, it was reported that the half-life of mutant ATP13A2 is 
reduced when compared to the wild type protein (Ugolino et al., 2011) and degradation stud-
ies have revealed that it is degraded by the proteasome (Park et al., 2011; Ramirez et al., 
2006; Ugolino et al., 2011) and that mutant ATP13A2 is cleared via the ERAD (ER associat-
ed degradation) pathway (Park et al., 2011; Ugolino et al., 2011). 
 
While many studies have been published on linkage analysis between ATP13A2 and PD, not 
much is known about the cellular function of this protein and the pathogenic mechanisms 
leading to disease when mutated. Only recently, a number of studies have begun to shed 
light on the cellular role of ATP13A2 and on how mutant ATP13A2 causes toxicity. Given the 
genetic tractability of C. elegans and the finding that many PD-associated genes are con-
served between humans and C. elegans, we decided to use this nematode as a model sys-
tem to gain insight into the cellular function of ATP13A2. C. elegans has three orthologs of 
ATP13A2: CATP-5, CATP-6 and CATP-7. Heinick et al. have reported that CATP-5 is local-
ized to the plasma membrane in intestinal cells and the excretory cell (Heinick et al., 2010) 
and as both expression pattern and subcellular localization of CATP-5 differ from ATP13A2, 
it seems rather unlikely that they are isofunctional homologs. As a functional link between 
CATP-6 and αS had been previously reported with co-expression of CATP-6 ameliorating 
αS-induced toxicity in yeast, C. elegans and rat primary neuronal cultures (Gitler et al., 









5.2.1. Gene structure of catp-6 
 
The C. elegans catp-6 gene spans 7.2 kb of genomic DNA and consists of 21 exons. It is 
located on chromosome IV and two deletion mutants for this gene are available. The gene 
structure as well as the position of the deletions are depicted in Fig. 5.1. The gene is the 
ortholog of human ATP13A2(PARK9) and the two proteins have the same domain structure. 







5.2.2. Deletion of catp-6 leads to egg laying defects, causing a reduction in 
brood size 
 
The first aspect of the mutant analysis was a phenotypic characterization which revealed that 
both deletion mutants of catp-6 are egg laying defective (Egl). This can be seen in DIC pic-
tures of the worms by an accumulation of eggs in the uterus of the mutants as shown in 
Fig. 5.2A+B. Due to the egg laying deficiency of the mutants, the eggs reside longer in the 
uterus than in wild type nematodes so that eggs of later developmental stages can be found 
in utero. In wild type worms, eggs reside in the uterus for approximately 150 minutes until 
they have reached approximately 30 cell stage (Hirsh et al., 1976). The embryonic develop-
ment then continues outside of the uterus until eventually L1 larvae are hatching about 14 h 
post-fertilization (Sulston et al., 1983). In the catp-6 mutants in contrast, eggs are retained in 
the uterus so that the embryonic development continues inside the hermaphrodite parent and 
– if the Egl phenotype is severe – the larvae eventually even hatch inside their parent which 
results in a “bag-of-worms” phenotype that leads to death of the parent. The egg laying de-
fect in catp-6 mutants is accompanied by morphological abnormalities of the vulva namely a 
protruding vulva (pVul) phenotype as depicted in Fig. 5.2C. pVul phenotypes mostly result 
from failures of the vulva tissue to connect properly to the uterus during development, which 
is normally important to allow for the passage and delivery of fertilized eggs. Vulva-uterine 
connection defects can at least in part explain the observed egg laying defect.  
Fig. 5.1: Gene structure of catp-6 and position of deletions.  
Exons are depicted as black boxes and introns are represented as black lines. The catp-6 gene consists of 
21 exons (black boxes) and spans 7.2 kb of genomic DNA. The position of tm3190 and ok3473 deletions is 
indicated as red lines. 







After identifying Egl and pVul phenotypes in catp-6 deletion mutants we decided to determine 
the brood size of catp-6 mutants, which was done by our research technician Dr. Sabine Kö-
nig. While wild type C. elegans hermaphrodites on average give rise to around 300 progeny 
(278±5), the brood size of the deletion mutants catp-6(tm3190) and catp-6(ok3473) was 
38±40 and 92±42, respectively, meaning a reduction of the brood size by 60% in the case of 
catp-6(tm3190) and 85% in the case of catp-6(ok3473) (Table 5.1).  
 
 











% sterile N brood size 
wild type N2 100 0 0 0 10 2785 
catp-6(ok3473) 0 14 68 18 22 3840 
catp-6(tm3190) 25 17 58 0 24 9242 
 
Fig. 5.2: catp-6 deletion mutants have an egg-laying defect and protruding vulva phenotype.  
(A-C) DIC pictures of wild type and catp-6 worms. (A) DIC pictures of whole worms were taken from adults 
24 h post-L4 stage. Scale bars represent 100 µm. (B) Pictures of the uterus were taken from adults 48 h post-
L4 stage. catp-6 worms are Egl (egg laying defective) and accumulate eggs in the uterus. Therefore, eggs of 
later developmental stages are seen in the uterus. Scale bars represent 50 µm. (C) Pictures of the vulva were 
taken from young adult worms and reveal that catp-6 worms show a pVul (protruding vulva) phenotype. Scale 
bars represent 50 µm. 
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In addition to the Egl and pVul phenotypes, we also detected that catp-6 mutations can lead 
to low levels of sterility. 18% of catp-6(ok3473) worms were sterile while none of the 
catp-6(tm3190) mutants or wild type worms were found to be sterile. Around 15% of both 
catp-6 mutants were exhibiting a partial Egl phenotype and another 60-70% of these mutants 
show strong Egl and pVul phenotypes. This indicates that catp-6 plays a role for the devel-
opment of the C. elegans reproductive tissues and that loss of function of catp-6 results in 
morphological and functional defects in the reproductive apparatus leading to severely re-
duced brood sizes. 
 
 
5.2.3. Postembryonic development is delayed in catp-6 
 
When culturing catp-6 mutants we observed that they develop more slowly and reach adult-
hood at later time points. Therefore, we were quantifying the time of postembryonic devel-
opment (PED) by determining how long it took freshly laid eggs to develop to adults capable 
of producing eggs themselves. In order to avoid effects of a delayed embryonic development, 
only worms that had reached the L1 stage 12 hours after the eggs had been laid were sub-
jected to the analysis. For wild type worms it took 69±5 h (mean±SD) to reach adulthood and 
a significant delay of the PED development was seen in both catp-6 deletion strains which 
were reaching adulthood after 98±6 and 92±11 h (Fig. 5.3). Besides the delayed PED in 
catp-6, we also observed that the development of the mutants was very asynchronous with 
some few worms reaching adulthood after 72 and 84 h for catp-6(tm3190) and 
catp-6(ok3473), respectively, while the slowest growing worms became adults only after 120 
and 144 h. Notably 6% of the catp-6 larvae were arresting at the L1 stage and did not devel-
op any further. This suggests that loss of function of catp-6 not only slows down PED in 
C. elegans but to some extent even causes lethality at early larval stages.  
 
 
Fig. 5.3: Postembryonic development is delayed in catp-6 
deletion mutants. 
Postembryonic development was assessed by determining the 
time required for freshly laid eggs to develop to adulthood. It is 
delayed in both catp-6 alleles. The error bars correspond to the 
standard error of the mean (SEM) and the significance values of 
one way ANOVA test with Dunnet’s multiple comparison analy-
sis are indicated: **P<0.01. 
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5.2.4. catp-6 mutants display locomotion defects due to muscular dysfunction 
 
When raised on plates with bacterial food, catp-6 animals appeared lethargic as compared to 
wild type. Thus, we were assessing the locomotion of catp-6 mutant animals. C. elegans lo-
comotion is characterized by sinusoidal movements of the worm and can be quantified by 
determining the number of body bends per minute with one body bend corresponding to a 
completed sinusoidal wave. Movement analysis in young adult C. elegans revealed that lo-
comotion is impaired in catp-6 (Fig. 5.4A). While the number of body bends per minute is 21 





The movement defect in catp-6 could result either from defects in morphology or function of 
body wall muscles or from defects in neurotransmission from the presynaptic site. In order to 
distinguish between these two possibilities we tried to rescue the locomotion defects by ex-
pressing the wild type catp-6 cDNA under control of the muscle-specific myo-3 promoter. If 
reduced locomotion is caused by muscular dysfunction due to lack of functional CATP-6, it 
should be possible to rescue the defect by restoring CATP-6 function specifically in the body 
wall muscles (BWMs). In order to exclude that overexpression of catp-6 already has an influ-
ence on locomotion we first generated a transgenic line expressing catp-6 from a muscle-
Fig. 5.4: catp-6 worms have a movement defect which can be rescued by expression of catp-6 in mus-
cle cells and which is already apparent at larval stages. 
(A) Movement is significantly reduced in young adult catp-6 deletion mutants. This effect can be rescued by 
expression of wild type catp-6 from a muscle-specific myo-3 promoter. Error bars correspond to the standard 
error of the mean (SEM) and significance values of one way ANOVA with Tukey’s multiple comparison analy-
sis are indicated: ***P<0.001; ns P>0.05. (B) A significant movement defect of catp-6 deletion mutations is 
already present at larval stages. Error bars correspond to the standard error of the mean (SEM) and signifi-
cance values of one way ANOVA with Dunnett’s multiple comparison analysis are indicated: **P<0.01. 
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specific myo-3 promoter in the wild type background. As shown in Fig. 5.4A, no change in 
locomotory rates was observed in these worms when compared to wild type. The extrachro-
mosomal array containing the rescue construct myo-3::catp-6 was then crossed into the 
catp-6(ok3473) deletion mutant and locomotion was restored to wild type levels (20 and 18 
body bends per minute). This indicates that indeed the locomotion defect of catp-6 is caused 
by a muscular requirement for CATP-6 function. In order to assess whether this muscular 
defect is resulting from a degenerative process with increasing age we decided to perform a 
movement assay on L3 larvae. This experiment was performed together with Victor Bustos, a 
lab rotation student in the lab. As shown in Fig. 5.4B the movement defect of both catp-6 
mutants is already apparent at this larval stage indicating that loss of catp-6 in BWMs causes 




5.2.5. catp-6 is expressed in multiple tissues  
 
To further understand which tissues in C. elegans require CATP-6 function, we determined 
the catp-6 expression pattern. For this purpose, GFP was expressed under the control of a 
4 kb catp-6 promoter fragment ranging from the Start ATG to position -4 kb. Cloning of this 
construct was performed by Katrin Schwarze, a former technician of our lab. The expression 
of this reporter construct was very weak but could be observed in the pharynx, nerve ring as 
well as in some structures in the tail. High expression was furthermore seen in body wall 
muscles (BWMs) and in the vulva tissue. catp-6 expression in muscles and vulval tissues fits 
well with the Egl and pVul phenotypes and with the impaired movement of catp-6 deletion 
mutants. Given that the expression of the reporter construct was very weak, it is likely that 
we were only detecting expression in tissues which are expressing catp-6 at high levels and 
that catp-6 is expressed in other tissues as well.  
 






5.2.6. The structure of muscle fibers is normal in catp-6 
 
Since we showed that catp-6 expression in BWMs is required for normal locomotion, we 
wanted to determine whether lack of CATP-6 function leads to morphological defects in 
BWMs. Therefore, we analyzed whether the organization of myofilaments is changed in 
catp-6 mutants. For this purpose, we used a translational fusion of GFP with MYO-3, a myo-
sin heavy chain protein, as marker for thick filaments in BWMs. This experiment was per-
formed by Dr. Sabine König, research technician in our lab. As depicted in Fig. 5.6, no differ-
ences in the myofilament structures between catp-6 mutants and wild type could be ob-
Fig. 5.5: catp-6 expression pattern.  
For expression pattern analysis, a transcriptional reporter was used. GFP expression driven by the catp-6 pro-
moter is visible in pharynx, nerve ring, tail as well as in BWM cells and in the vulva. Scale bars represent 10 µm. 
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5.2.7. catp-6 mutants show vulva muscle defects 
 
The egg laying defect of catp-6 mutants indicates that the egg laying apparatus in the mu-
tants is disturbed. As several structures are involved in the egg laying process, we were in-
terested in understanding which components are affected by loss of catp-6. A scheme of the 
C. elegans egg laying apparatus is depicted in Fig. 5.7. First of all, vulva and uterus are es-
sential for egg laying and the establishment of the vulva-uterine connection also plays a criti-
cal role (Newman and Sternberg, 1996). Furthermore, the sex muscles, which comprise eight 
vulval and eight uterine muscles, are very important as their contraction leads to opening of 
the vulva and contraction of the uterus thus promoting egg laying [reviewed in (Schafer, 
2005)]. Finally, innervation of the sex muscles by two hermaphrodite specific neurons (HSN) 
and six ventral cord (VC) motoneurons is a prerequisite for proper egg laying [reviewed in 





Fig. 5.6: Myofilament organization in BWM cells is not affected in catp-6 deletion mutants. 
Thick filaments in C. elegans BWMs were visualized using a MYO-3-GFP fusion. The myofilament structure is 
not affected by loss of function of CATP-6. Scale bars represent 10 µm. Images were kindly provided by 
Dr. Sabine König. 
Fig. 5.7: C. elegans egg laying apparatus. 
Several structures are involved in the egg laying 
process. Besides the uterus and the vulva, the 
vulva and uterine muscles as well as innervation 
by the HSN neurons are essential parts of the 
egg laying system. Reprinted by permission from 
Cold Spring Harbor Laboratory Press:  
Cold Spring Harbor Symposia on Quantitative 
Biology V.57, Clark et al., copyright (1992). 
doi:10.1101/SQB.1992.057.01.041 (Clark et al., 
1992). 
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A large part of the Egl phenotype of catp-6 mutants most likely arises from defects in the vul-
va-uterine connection which in most cases leads to a pVul phenotype. However, in addition, 
14% and 17% of the catp-6(ok3473) and catp-6 (tm3190) mutants, respectively, are Egl 
without displaying a pVul phenotype. This strongly suggests that there might be additional 
defects within the egg laying system that are contributing to the Egl defect. Based on the 
requirement of CATP-6 activity in the BWMs for proper locomotion we reasoned that catp-6 
animals might also have defective sex muscles. It has been shown that a set of eight vulva 
muscles is strictly required for normal egg laying and vulva muscles have been reported to 
be more important for the egg laying process than the uterine muscles [reviewed in (Schafer, 
2005)]. Cases in which vulva muscles are partly missing or misaligned and improperly at-
tached to the vulva cells lead to defects in egg laying (Eimer et al., 2002). To determine 
whether part of the Egl defect of catp-6 mutant animals is caused by defective sex muscles, 
we visualized the sex muscles by GFP. The ceh-24 promoter drives expression of GFP in the 
eight vulval muscles. In wild type worms, the eight vulva muscles visualized by ceh-24::gfp 
expression are arranged around the vulva opening as two x-shaped sets of four mono-
nucleated smooth muscles, termed vm1 and vm2 (Fig. 5.8A). When imaged from the ventral 
side, the two x-shaped sets of vulva muscles are laying on top of each other and the nuclei of 






As depicted in Figure 5.8A, the muscles are very regularly and symmetrically arranged in 
wild type worms and the muscles are well attached to the vulva enabling opening of the vulva 
upon contraction. In contrast, an irregular arrangement of the vulva muscles is seen in 36% 
of the catp-6 mutants (Fig. 5.8B; Table 5.2). Furthermore, in 10% of the mutant worms, the 
vulva muscles are not properly attached to the vulva (Fig. 5.8B; Table 5.2) and, most re-
markably, in more than 50% of the mutants at least one of the eight vulva muscles is missing 
(Fig. 5.8C; Table 5.2). 
Fig. 5.8: Vulva muscle defects in catp-6 deletion mutants. 
Vulva muscles were imaged in worms expressing ceh-24::gfp. The vulva is depicted from a ventral view and 
the nuclei of the muscle cells appear as bright spots. In wild type worms, the eight vulva muscles are regularly 
arranged in cross-shape (A). In catp-6 mutants, several defects of the muscles can be observed. These include 
defects in the attachment of the muscles to the vulva and irregular muscle arrangement (B) as well as lack of at 
least one of the eight vulva muscles (C). Scale bars represent 20 µm. 
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Table 5.2: Vulva muscle defects in catp-6. 
Genotype 
 
% Muscles not 
properly attached 
to vulva 
% Irregular  
muscle arrange-
ment 
% Lacking at least 
one vulva muscle 
N 
wild type N2 0 0 4 25 
catp-6(ok3473) 10 38 52 27 
 
The vulva muscle defects together with the pVul phenotype, which is indicative of a defective 
vulva-uterine connection, might be the reason for highly penetrant egg-laying defects present 
in catp-6 deletion mutants. As the Egl phenotype of catp-6 worms is quite strong and as we 
have not checked for changes in other components of the egg laying apparatus we cannot 
exclude that additional defects in uterine muscles, the structure of the vulva or problems with 
neuronal input from HSN or VC also have minor contributions to impaired egg laying in  
catp-6 mutants.  
 
 
5.2.8. Mitochondrial morphology is severely affected in muscle cells of catp-6 
mutants 
 
The defects in the vulva muscles as well as the impaired movement of catp-6 mutants that 
was also resulting from muscular defects brought us to investigate the BWM cells on a cellu-
lar level. Since we had observed severe changes in mitochondrial morphology in muscle 
cells upon expression of αS as described in Chapter I and given the reported functional link 
between αS and CATP-6 (Gitler et al., 2009), we decided to analyze mitochondrial morphol-
ogy in catp-6 mutants. Mitochondria in catp-6 mutants were severely affected, with 60% of 
the cells showing networks of very long and thin mitochondria. The mitochondria in these 
cells were also more interconnected than in wild type muscles and showed an irregular ar-
rangement with condensed mitochondrial structures around the nucleus. In contrast, mito-
chondria in wild type worms were very regularly arranged, forming tubular structures in which 
an intraluminal space was clearly visible. In order to determine whether loss of function of 
catp-6 was indeed responsible for the changes in mitochondrial dynamics of the mutants, we 
tried to rescue the phenotypes by expressing the wild type catp-6 cDNA in the BWM muscle 
cells. First, we created transgenic worms expressing catp-6 from a muscle-specific myo-3 
promoter in a wild type background. This extrachromosomal array was able to rescue the 
locomotion defects of catp-6 mutants but did not cause any locomotion defects when ex-
pressed in wild type animals in addition to endogenous catp-6 (Fig. 5.4). In agreement with 
this, most of the cells in these transgenic animals displayed wild type-like mitochondrial mor-
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phology and only 15% were showing slightly elongated mitochondria, indicating that weak 




Fig. 5.9: Mitochondrial elongation and perinuclear clustering in catp-6 deletion mutants. 
Mitochondria in BWM of young adult worms were visualized by expressing CFP targeted to the outer mitochon-
drial membrane by fusion to the TM domain of yeast TOM70. Mitochondria in wild type worms form regularly 
arranged tubules. In catp-6 mutants, mitochondria are longer, thinner and more interconnected and are clustering 
around the nucleus. Overexpression of catp-6 in muscle cells of wild type worms does not induce severe changes 
of mitochondrial morphology, but expression of catp-6 in muscle cells of the deletion mutants rescues the mito-
chondrial morphology defects. Scale bars represent 10 µm. Quantification of mitochondrial morphology was done 
by determining the relative occurrence of “wild type-like”, “long, thin and interconnected” as well as “fragmented” 
mitochondria. The numbers of muscle cells analyzed are indicated above the bar graph. 
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Next, we crossed these worms expressing catp-6 only in BWM cells into the catp-6 mutant 
background and found that indeed, mitochondrial morphology is rescued by restoring 
CATP-6 function specifically in BWM cells. More than 60% of the rescued BWM cells dis-
played now a wild type-like morphology. Thus, we could clearly show that loss of function of 




5.2.9. Mitochondrial morphology is already affected at larval stages in catp-6 
 
Having seen the defects in mitochondrial morphology in adult catp-6 mutants, we sought to 
determine whether they are already present at larval stages as we had observed that move-
ment was already affected in L3 larvae of catp-6. Therefore, we imaged mitochondria in 
BWMs of L3 larvae. As depicted in Fig. 5.10, mitochondrial clustering around the nucleus can 
already be observed at this larval stage. As already seen in the adult worms, long and very 
thin mitochondria are the predominant mitochondrial structures and are seen in almost 60% 
of the cells while only 20% of cells show wild-type like mitochondrial morphology. This sug-
gests that mitochondrial morphology is already affected by loss of function of catp-6 in devel-





Fig. 5.10: Changes in mitochondrial morphology and perinuclear clustering are already present in L3 
larvae of catp-6 mutants. 
Mitochondrial outer membrane in BWM cells of L3 larvae was visualized by expression of the previously 
described pmyo-3::tom70-cfp construct. Already at this larval stage, mitochondria of catp-6 mutants are 
longer and thinner than in wild type and are accumulating in close proximity of the nucleus. Scale bars rep-
resent 10 µm. Quantification of mitochondrial morphology was done by determining the relative occurrence 
of “wild type-like”, “long, thin and interconnected” as well as “fragmented” mitochondria. The numbers of 
muscle cells analyzed are indicated above the bar graph. 
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5.2.10. EM analysis reveals collapsing of mitochondria and loss of mitochon-
drial cristae in catp-6 mutants 
 
After having observed severe changes in mitochondrial morphology and arrangement by 
confocal microscopy, we decided to investigate these changes on an ultra-structural level by 
High-Pressure-Freeze (HPF) Electron Microscopy (EM). EM analysis was performed by 




Fig. 5.11: EM analysis of mitochondria in BWMs of catp-6 mutants. 
(A) Tomograms of mitochondria in longitudinal sections of BWM cells of young adult wild type and catp-6 
worms. Mitochondria in catp-6 mutants are collapsed in the middle so that the membranes are coming in direct 
contact with each other. Cristae are lacking in those collapsed regions. (B) Histogram of mitochondrial profile 
areas in cross-sections through BWM cells of young adult worms. In catp-6 deletion mutants, smaller mitochon-
drial structures are seen in the cross sections when compared to wild type. Pictures were kindly provided by 
Dr. Jan Hegermann. 
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Tomograms of mitochondria in longitudinal sections of BWM cells revealed that mitochondria 
in catp-6 mutants are collapsed in the middle with the two inner membranes coming in direct 
contact to each other without any luminal space separating them (Fig. 5.11A). The collapsed 
regions are completely devoid of cristae structures. It needs to be determined whether loss of 
cristae is causative for the collapse. 
 
To get an estimate of the diameter of mitochondria in wild type worms and catp-6 mutants, 
the profile area of cross-sectioned mitochondria was analyzed. The histogram of the profile 
areas of mitochondria in cross sections of BWM cells is shown in Fig. 5.11B. This distribution 
was clearly shifted to smaller sizes in catp-6 mutant animals as compared to wild type. While 
in wild type worms most of the mitochondrial profile areas were between 0.12 and 0.16 µm², 
the most abundant profile areas in catp-6 mutants were between 0.04 and 0.08 µm². Given 
the fact that no cristae are present at collapsed regions of the mitochondria, cross sections 
through these regions might not be identified as mitochondria. Therefore, those very small 
profile areas are likely to be missed in the profile area analysis. The results of the HPF-EM 
analysis of mitochondria in muscle cells of catp-6 deletion mutants fit nicely to the changes in 
mitochondrial morphology that were seen in the fluorescence images and indicate that 
CATP-6 plays a role in maintaining mitochondrial cristae structure and morphology. 
 
 
5.2.11. The mitochondrial fission protein DRP-1 is clustering in close proximity 
to the nucleus in BWM cells of catp-6 mutants 
 
As we had observed that mitochondria in catp-6 mutants are longer, thinner and form a high-
ly interconnected network in contrast to those of wild type muscles, we wanted to understand 
which mechanism mediates these changes in mitochondrial morphology. Mitochondria are 
very dynamic organelles that are steadily fusing and dividing [reviewed in (Bereiter-Hahn and 
Voth, 1994; Detmer and Chan, 2007; Westermann, 2010b)]: Mitochondrial morphology varies 
between different cell types and can be adjusted to the cellular status [reviewed in 
(Kuznetsov et al., 2009; Sauvanet et al., 2010)]. A well-adjusted balance between fission and 
fusion is very important for mitochondrial function and several proteins are coordinating mito-
chondrial dynamics [reviewed in (Detmer and Chan, 2007; Westermann, 2010b)]. DRP-1 
(Dynamin Related Protein 1) plays a crucial role for mitochondrial fission (Smirnova et al., 
2001). Cytosolic DRP-1 can associate to mitochondria and oligomerization at the mitochon-
drial outer membrane leads to formation of ring-like structures around the mitochondrial tu-
bules. GTP hydrolysis then induces scission of the mitochondrial membranes and thus leads 
to mitochondrial fission. Loss of DRP-1 function inhibits the fission of the mitochondrial outer 
membrane resulting in the occurrence of elongated mitochondria. Thus, inactivation of 
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DRP-1 shifts the balance between mitochondrial fission and fusion towards fusion. Further-
more, clustering of highly interconnected mitochondrial tubules around the nucleus was de-
scribed in cells expressing dominant negative DRP-1 (Smirnova et al., 2001; Smirnova et al., 
1998). As these mitochondrial phenotypes observed in cells lacking functional DRP-1 strong-
ly resemble the mitochondrial morphology that we observed in catp-6 mutants, we decided to 
have a closer look at the distribution of the DRP-1 protein in catp-6 mutants.  
 
For this purpose, we generated a fusion protein of DRP-1 tagged with TagRFP at the 
N-terminus and expressed this construct along with the previously described TOM70-CFP 
marker for the mitochondrial outer membrane in BWM cells. N-terminal fusion of a fluores-
cent protein to DRP-1 was done before in C. elegans and it was shown that the tag does not 
interfere with mitochondrial association of DRP-1 (Labrousse et al., 1999). Furthermore, the 
fusion protein seems to be functional as increased mitochondrial fragmentation was seen 
upon overexpression of tagged DRP-1 although the activity of the fusion protein seems to be 
reduced compared to untagged DRP-1 (Labrousse et al., 1999). As described previously 
(Labrousse et al., 1999), puncta of the TagRFP-DRP-1 fusion protein can be seen in wild 
type worms and these punctate structures are equally distributed throughout the cell 
(Fig. 5.12A). In contrast, large clusters of DRP-1 spots are seen in catp-6 deletion mutants. 
These DRP-1 clusters mostly are found in close proximity to the nucleus. Expression of wild 
type catp-6 in muscle cells, which was able to rescue mitochondrial morphology as described 
in section 5.2.8 of this chapter, also restores normal TagRFP-DRP-1 distribution. Overex-
pression of catp-6 in wild type worms does not affect DRP-1 localization and as previously 
described also does not induce severe changes in mitochondrial morphology.  
 
Quantification of TagRFP-DRP-1 clusters as depicted in Fig. 5.12B reveals that large DRP-1 
clusters close to the nucleus are seen in 89% of muscle cells in catp-6 deletion mutants while 
they were almost never seen in wild type worms. Expression of catp-6 under a muscle spe-
cific myo-3 promoter is sufficient to restore normal DRP-1 distribution decreasing the relative 
amount of observed DRP-1 clusters to 11% of muscle cells in catp-6 mutants. This demon-
strates that loss of CATP-6 function causes the changes in DRP-1 distribution. Since in 
catp-6 mutant animals the mitochondrial morphology resembles the one present in drp-1 mu-
tants (Labrousse et al., 1999), it is likely that the observed DRP-1 clustering goes along with 
DRP-1 inactivation in catp-6 mutants. Thus, loss of CATP-6 function probably disturbs proper 
function of DRP-1 and thereby induces mitochondrial elongation and perinuclear clustering. 




Fig. 5.12: Changes in mitochondrial morphology and distribution of the mitochondrial fission 
protein DRP-1 in muscle cells of catp-6 mutants. 
(A) The mitochondrial fission protein DRP-1 was tagged N-terminally with TagRFP and expressed from 
a muscle-specific myo-3 promoter along with TOM70-CFP for visualization of mitochondria. In wild type 
cells, DRP-1 occurs as puncta that are equally distributed throughout the cell. In contrast, clustering of 
DRP-1 especially in close proximity to the nucleus was observed in catp-6. Expression of catp-6 in 
muscle cells of the deletion mutants restores normal DRP-1 distribution. Overexpression of catp-6 in 
wild type worms does not affect DRP-1 distribution. Scale bars represent 10 µm. (B) Quantification of 
DRP-1 clustering. Numbers of muscle cells analyzed are indicated above the bar graph. 
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5.2.12. RNAi against mitochondrial dynamics genes 
 
To get a more detailed understanding of how the balance between mitochondrial fission and 
fusion is affected by deletion of catp-6, we decided to investigate the impact of the individual 
mitochondrial dynamics genes by RNAi. The RNAi hypersensitive eri-1(mg366) strain was 
used as sensitized background for the RNAi experiments. We created transgenic worms ex-
pressing the mitochondrial marker TOM70-CFP and the TagRFP-DRP-1 fusion protein in 
muscle cells in order to see how silencing of the dynamics genes changes mitochondrial 
morphology and DRP-1 distribution in wild type worms and in the catp-6 mutants. Four genes 
were chosen for analysis: two genes that are involved in mitochondrial fission (drp-1 and 
fis-1) and two genes that mediate mitochondrial fusion (fzo-1 and eat-3). drp-1 is the 
C. elegans ortholog of mammalian Drp1 (Dynamin Related Protein 1) (Labrousse et al., 
1999) and fis-1 is one of two orthologs of mammalian Fis1 in C. elegans. In the mammalian 
system, Fis1 is involved in coordinating DRP-1 assembly at the mitochondria [reviewed in 
(Chen and Chan, 2004)]. Yet, whether this function is conserved in C. elegans remains to be 
determined (Westermann, 2010a). fzo-1 is the only C. elegans ortholog of the mammalian 
Mitofusins (Mfn1 and Mfn2) which mediate fusion of the mitochondrial outer membrane [re-
viewed in (Mozdy and Shaw, 2003; Westermann, 2010a)]. Inner membrane fusion in 
C. elegans is triggered by eat-3, the ortholog of mammalian Opa1 (Kanazawa et al., 2008). 
 
Silencing of the fission gene drp-1 in wild type worms leads to the occurrence of 
mitochondrial blebs that are connected by very thin tubules (Fig. 5.13). The fact, that the 
RFP fluorescence signal of the TagRFP-DRP-1 fusion protein disappeared upon RNAi 
treatment against drp-1, was reconfirming that the drp-1 RNAi was working well. The 
structural changes that were observed upon knockdown (KD) of drp-1 in wild type worms had 
been described in previous studies investigating drp-1 mutants (Labrousse et al., 1999) and 
performing RNAi experiments against drp-1 in C. elegans muscle cells (Head et al., 2011) 
and it was shown that the bleb-like structures are filled with mitochondrial matrix indicating 
that fission of the inner mitochondrial membranes can still take place while the outer 
membranes cannot undergo fission upon drp-1 KD (Labrousse et al., 1999). Interestingly, 
mitochondrial morphology after silencing of drp-1 resembles the elongated structures that we 
had observed in catp-6 mutants but the bleb-like structures that were found upon drp-1 KD 
are absent in catp-6 deletion mutants. Remarkably, KD of drp-1 expression in catp-6 deletion 
mutants also did not induce the occurrence of the bleb-like structures (Fig. 5.13). No gross 
changes in mitochondrial morphology were seen upon RNAi treatment against drp-1 in the 
catp-6 mutants and mitochondrial elongation was still apparent. This suggests that DRP-1 
function is largely absent in catp-6 mutants. Therefore, it is likely that the DRP-1 clustering in 
catp-6 mutants is a sign of DRP-1 inactivation in these mutants.  






As shown in Fig. 5.13, mitochondria in wild type worms in which fis-1 expression was 
knocked down by RNAi are longer and more interconnected than without RNAi treatment 
supporting a role of fis-1 in mitochondiral fission in C. elegans. Remarkably, DRP-1 spots at 
the mitochondria are still detectable after fis-1 RNAi KD indicating that in C. elegans, fis-1 is 
not required for mediating DRP-1 oligomerization at the mitochondria. Though, as the spots 
seen in fis-1 KD worms are smaller in size than in wild type, a supportive role of fis-1 for 
clustering seems plausible. In catp-6 mutants, mitochondrial morphology is not altered by 
Fig. 5.13: Effect of silencing of mitochondrial dynamics genes on mitochondrial morphology in wild 
type worms and catp-6 mutants. 
RNAi experiments were performed in an eri-1(mg366) which is a sensitized background for RNAi. The empty 
L4440 vector which was used as control does not lead to changes in mitochondrial morphology and DRP-1 
distribution. TOM70-CFP was used as mitochondrial marker and TagRFP-DRP-1 was co-expressed along with 
this marker in BWM cells. Young adult worms were used for imaging. RNAi against the mitochondrial fission 
gene drp-1 leads to disappearance of the RFP signal indicating that RNAi was working. Knockdown (KD) of 
drp-1 in wild type worms leads to occurrence of blebs that are still connected by thin threads of outer mito-
chondrial membrane. In catp-6 mutants, knockdown of drp-1 does not aggravate mitochondrial morphology. 
No blebs are seen upon drp--1 KD in catp-6 mutants. RNAi against the fission gene fis-1 leads to mitochondrial 
elongation in wild type worms but does not have any impact on mitochondrial morphology or DRP-1 clustering 
in catp-6. KD of the mitochondrial fusion genes eat-3 and fzo-1 induces mitochondrial fragmentation in both 
wild type and catp-6. Scale bars represent 10 µm. 
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knockdown of fis-1 expression and also the large clusters of DRP-1 in proximity to the 
nucleus are unaffected by RNAi against fis-1 (Fig. 5.13). The fact that RNAi against the two 
fission genes fis-1 and drp-1 has no effect on mitochondrial morphology in catp-6 deletion 
mutants suggests that the pathway mediating mitochondrial fission via drp-1 and fis-1 is 
already inhibited in catp-6 mutants so that silencing of components of this pathway has no 
additive effect on mitochondrial morphology in catp-6. 
 
In contrast to the mitochondrial fission genes, silencing of the fusion genes fzo-1 and eat-3 
affects mitochondrial morphology in wild type worms and catp-6 mutants in the same way 
and induces mitochondrial fragmentation in both cases. Interestingly, occurrence of DRP-1 
clusters around the nucleus in catp-6 mutants is manifestly reduced upon silencing of fzo-1 
and further investigation is needed to determine how fzo-1 knockdown affects DRP-1 
localization.  
 
The results of the RNAi experiments indicate that the balance of mitochondrial dynamics is 
shifted towards increased fusion in catp-6 mutants. As silencing of components of the 
mitochondrial fission machinery does not aggravate mitochondrial morphology in the 
mutants, it seems plausible that the effects seen in the mutants are caused by inhibition of 
the fission machinery. RNAi-mediated KD of components of the mitochondrial fusion 
machinery reverses mitochondrial morphology in catp-6 mutants towards fragmentation 
indicating that an inhibition of the fusion machinery might be able to reverse DRP-1 
inactivation. In agreement with this view is the fact that in fzo-1 RNAi treated catp-6 mutant 
animals discrete TagRFP-DRP-1 puncta can be seen instead of large DRP-1 clusters 
characteristic for catp-6. Thus, fine tuning the mitochondrial fission-fusion dynamics by 
decreasing mitochondrial fusion rates might facilitate the restoration of a more wild type-like 
mitochondrial morphology in catp-6 mutants. 
 
 
5.2.13. Changes in mitochondrial morphology in neurons of catp-6 worms 
 
To determine whether deletion of catp-6 also affects mitochondrial morphology in other tis-
sues, we were investigating mitochondrial morphology and TagRFP-DRP-1 distribution in 
motoneurons of the ventral nerve cord (VNC). Similar to what we had seen in muscle cells, 
perinuclear accumulation of mitochondria was seen in neurons of catp-6 mutants (Fig. 5.14). 
Furthermore, TagRFP-DRP-1 puncta in the cell bodies are bigger and increased in number 
when compared to wild type neurons. Mitochondria in neuronal cell bodies of wild type 
worms form tubular or ring-like structures around the nucleus while in catp-6 mutants con-
densed mitochondrial structures on either side of the nucleus are predominating. Also in the 
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neurites, which are projecting underneath the cell bodies, mitochondrial morphology is af-
fected by loss of CATP-6 function. In wild type worms, mitochondria in the neurites are most-
ly seen as elongated tubular structures. In contrast, mitochondria in the neurites of catp-6 
mutants are often seen as punctate structures indicating mitochondrial fragmentation. But 
besides these fragmented mitochondria also some elongated and very thin tubular mito-
chondria can be found resembling the long and thin mitochondria that we had seen in BWM 
cells. This suggests that also in neurons, deletion of catp-6 leads to severe changes in mito-
chondrial morphology. The fact that mitochondrial morphology in neurites is differently affect-
ed by DRP-1 loss of function than in neuronal cell bodies and muscle cells might be due to 
special requirements on mitochondrial motility in the processes. Several features like peri-
nuclear aggregation of mitochondria, increased DRP-1 clusters in proximity to the nucleus 
and occurrence of long and thin mitochondria are shared between muscle cells and neurons 
of catp-6 deletion mutants. Nevertheless, some tissue-specific phenotypes can also be ob-
served – mitochondrial fragmentation as seen in the neuronal processes was not apparent in 
muscle cells and the network formation that we had observed in muscle cells was not found 
in the neurons. These differences likely result from different demands on mitochondrial mor-






Fig. 5.14: Changes in mitochondrial morphology in neurons of catp-6 mutants. 
Changes in mitochondrial morphology were also observed in neurons of the ventral nerve cord of catp-6. As de-
scribed for muscle cells, mitochondria were labeled with TOM70-CFP and DRP-1 was visualized by a TagRFP-
Tag. While mitochondria in wild type worms form ring-like tubular structures around the nucleus, mitochondria are 
rather forming clumped aggregates at both sides of the nucleus in catp-6 mutants. Single neurons marked by the 
white boxes are also shown enlarged in the panels on the right. Changes in mitochondrial morphology are also 
seen in the neurites of catp-6 with mitochondria being either fragmented (marked by arrowheads) or longer and 
thinner than in wild type (marked by arrows). Scale bars represent 5 µm. 
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5.2.14. Deletion of catp-6 leads to impaired mitochondrial function 
 
Having observed drastic changes in mitochondrial morphology in catp-6 deletion mutants we 
were interested whether these structural changes go along with deficiencies in mitochondrial 
function. Therefore, we decided to collaborate with the group of Prof. Peter Rehling (Depart-
ment of Biochemistry II, Georg-August-University Göttingen) to isolate mitochondria from wild 
type worms and catp-6 mutants and investigate the function of these isolated mitochondria 
by applying biochemical assays. For mitochondrial isolation, we cultured large quantities of 
worms and brought the worm pellets to the lab of Prof. Peter Rehling where Dr. Jan Dudek 
was performing the isolation of the mitochondria as well as the functional assays.  
 
The first step in assessing the functionality of mitochondria in catp-6 mutants was to deter-
mine the mitochondrial membrane potential (ΔΨm). The mitochondrial membrane potential is 
build up as a consequence of proton pumping from the mitochondrial matrix to the inter-
membrane space by the respiratory chain (see Fig. 2.4). Thereby, a pH and electrical gradi-





Fig. 5.15: Mitochondrial membrane potential is reduced in catp-6 mutants. 
Mitochondrial membrane potential was assessed by measuring fluorescence of DiSC3 which is quenched by 
the mitochondrial membrane potential. In the first seconds, no fluorescence is detected as only buffer is meas-
ured. Addition of the dye then leads to rapid increase of the signal to maximum fluorescence. The fluorescence 
decreases upon addition of mitochondria due to quenching of the fluorescence. As malate and succinate are 
added to the reaction, the mitochondrial membrane potential builds up during the measurement and leads to a 
further decrease in fluorescence. When a stable fluorescence is reached, KCN is added to the solution leading 
to a specific inhibition of complex IV and therefore an increase in fluorescence. The membrane potential, as 
determined by the difference in quenching between active and KCN-inhibited mitochondria, is reduced in mito-
chondria of catp-6 mutants. Three independent measurements each were performed for wild type and catp-6 
mitochondria and 100 µg of mitochondria were used per experiment. Images were kindly provided by Dr. Jan 
Dudek. 
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ΔΨm can be assessed by the use of lipophilic cationic dyes which easily penetrate cellular 
membranes and are attracted by the potential across the mitochondrial inner membrane. At 
the concentration used in this experiment, the ΔΨm-sensitive dye DiSC3(5) is quenched by 
ΔΨm leading to a decreased fluorescence with increasing ΔΨm. The results of the ΔΨm 
measurements are illustrated In Fig. 5.15. ΔΨm was calculated as the difference between 
mitochondrial quenching of active and KCN-intoxicated mitochondria. As shown in Fig. 5.15, 
ΔΨm in mitochondria of catp-6 mutants is reduced to 69% when compared to wild type. This 
shows that ΔΨm is severely affected in deletion mutants of catp-6 which is indicative of com-
promised mitochondrial function. 
 
Therefore, we decided to investigate whether the mitochondrial respiratory chain is affected 
by loss of function of CATP-6. The respiratory chain is organized in supercomplexes which 
are well studied in yeast and mammals. Complex IV assembles with complex III and com-
plex I interacts with complex III as well as several copies of complex IV. The complexes can 
be separated on BN-PAGE (Blue Native gel electrophoresis) and the activity of respiratory 
chain complexes can be assessed by in-gel-activity-stains. For staining of complex IV, re-
duced cytochrome c (cyt c) was added in the gel. Oxidation of cyt c by complex IV is sup-
ported by the diaminobenzidine specifically reducing cyt c. Thereby generated oxidized dia-




The gel picture is depicted in Fig. 5.16 and shows that the composition of complex IV is 
changed in deletion mutants of catp-6. Higher molecular weight supercomplexes are destabi-
lized in the mutants resulting in an increase in lower molecular weight supercomplexes which 
is an indication for a dramatic remodeling of the respiratory chain. Further analysis is needed 
Fig. 5.16: Composition of complex IV of the respiratory chain is 
changed in catp-6 mutants. 
Mitochondrial respiratory chain complexes of solubilized mitochondrial mem-
branes were separated by BN-PAGE (Blue Native Polyacrylamide gel elec-
trophoresis). To stain for complex IV, reduced cytochrome c (cyt c) was add-
ed. Oxidation of cyt c by complex IV leads to precipitation of oxidized dia-
minobenzidine (brown). The staining reveals that some assembly forms of 
complex IV have taken over a prominent activity in catp-6 (indicated by black 
arrowheads) while other components show a reduced activity when com-
pared to wild type. The image was kindly provided by Dr. Jan Dudek. 
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to determine whether the components, that show a reduced diaminobenzidine staining, are 
less active than in wild type or whether the respective protein levels are reduced. As few 
studies have been published on the composition of respiratory chain complexes in 
C. elegans and as only a limited number of antibodies for the C. elegans respiratory chain 
complexes are available so far, additional investigations will be needed to elucidate the iden-
tity of the different bands that are stained in the gel. 
 
To gain further insight into the respiratory activity of mitochondria in catp-6 mutants, we de-
cided to determine oxygen consumption of catp-6 mutant worms. Electrons that are trans-
ferred through the different complexes of the respiratory chain are transferred to molecular 
oxygen in complex IV of the respiratory chain. Therefore, the consumption of molecular oxy-
gen reflects the activity of the respiratory chain. Oxygen consumption measurements were 
performed by me with help of Dr. Jan Dudek using micro-scale oxygraphy for determining the 
oxygen consumption rate (OCR) and showed that oxygen consumption is increased in catp-6 




One possible explanation for the increased oxygen consumption could be that catp-6 mu-
tants try to compensate for respiratory deficiencies for example by upregulating mitochondrial 
mass or by remodeling the respiratory chain. Alternatively, increased oxygen consumption 
could be caused by less efficient electron transfer at the respiratory chain and consequently 
increased ROS generation. Therefore, further experiments need to be carried out in order to 
determine whether mitochondrial mass is changed in the mutants. In this context we will also 
analyze oxygen consumption in isolated mitochondria as it allows us to normalize oxygen 
consumption to mitochondrial mass and elucidate whether mitochondrial respiration rates are 
really increased in catp-6 mutants or whether this is due to an increased mitochondrial mass. 
Fig. 5.17: Increased oxygen consumption 
in catp-6 mutants. 
Oxygen consumption of whole worms was 
measured using a Seahorse 96-well-plate 
analyzer. Oxygen consumption was first as-
sessed at basal levels, then after addition of 
the mitochondrial uncoupler FCCP and finally 
after blocking complex IV by addition of sodi-
um azide (NaN3). Oxygen consumption rates 
in two alleles of catp-6 were significantly in-
creased at basal levels and in contrast to wild 
type worms decreased upon addition of 
FCCP. 
Fig. 5.18: Mitochondrial stress 
response is pecifically a tivated in 
deletion mutants of catp-6. 
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5.2.15. The mitochondrial stress response is induced in catp-6 mutants 
 
As we could show that both mitochondrial function and morphology, were clearly impaired in 
catp-6 deletion mutants, we were wondering whether these deficiencies would also cause an 
increased induction of the mitochondrial stress response. The mitochondrial stress response 
is induced by an increased load of misfolded proteins in the mitochondria (Zhao et al., 
2002)[reviewed in (Broadley and Hartl, 2008)] similarly to other cellular unfolded protein re-
sponses in the cytosol (UPRcyt) and in the endoplasmic reticulum (UPRER). As defects in sev-
eral components of the respiratory chain can lead to an increased production of reactive ox-
ygen species (ROS) (Chen et al., 2003b; Kondo et al., 2005; Kudin et al., 2004; Senoo-
Matsuda et al., 2001; St-Pierre et al., 2002), increased oxidative damage to mitochondrial 
proteins could be a consequence of compromised mitochondrial function in catp-6. Oxidative 
damage to the proteins could lead to the accumulation of misfolded proteins in the mitochon-
dria and thus induce the mitochondrial stress response. In C. elegans, the mitochondrial 
stress response results in increased expression of the mitochondrial chaperones hsp-6 
(C. elegans ortholog of mammalian Hsp70) and hsp-60 (C. elegans ortholog of mammalian 
Hsp60) (Yoneda et al., 2004). Therefore, to assay mitochondrial unfolded protein stress, we 
used a reporter driving GFP expression under the control of the hsp-6 promoter which was 
previously described (Yoneda et al., 2004). Interestingly, a strong GFP signal was observed 
in the catp-6 mutants under normal conditions at which wild type worms exhibit only a very 
faint GFP signal in the tail region (Fig. 5.18A).  
 
Induction of the mitochondrial stress response in wild type worms by treatment with the ROS 
generator paraquat, which causes increased oxidative stress, leads to GFP expression simi-
lar to that of catp-6 mutants that were grown in the absence of paraquat. Further treatment of 
catp-6 mutants with paraquat increased expression of the hsp-6::gfp reporter construct even 
further so that the signal is three-fold higher than that of the paraquat-treated wild type 
worms. Western Blot analysis of GFP expression confirmed the results obtained by fluores-
cence microscopy (Fig. 5.18B). This suggests that the mitochondrial stress response is in-
trinsically active in catp-6 mutants and can be even further activated under conditions of in-
creased oxidative stress.  






Fig. 5.18: Mitochondrial stress response is specifically activated in deletion mutants of catp-6. 
(A-F) Induction of cellular stress responses was assessed using GFP reporter constructs. GFP expression was 
determined by fluorescence microscopy (A, C, E) and Western Blot (B, D, F). GFP fluorescence is shown in the 
top panels of (A, C, E) while in the lower panels GFP and bright-field pictures are overlaid. Scale bars represent 
100 µm. Western Blots were quantified by calculating the GFP/tubulin ratio and then normalizing the values for 
all strains and conditions to the uninduced wild type GFP/tubulin ratio. Induction of the stress responses was 
done by exposing worms to paraquat, tunicamycin or by exposure to elevated temperature. (A-B) Induction of 
the mitochondrial UPR was assessed by determining GFP expression from the reporter construct hsp-6::gfp. 
(C-D) Induction of the endoplasmic reticulum UPR was assessed by determining GFP expression from the 
reporter construct hsp-4::gfp. (E-F) Induction of the cytosolic UPR was assessed by determining GFP expres-
sion from the reporter construct hsp-16.2::gfp. catp-6 mutants show an intrinsic activation of the mitochondrial 
UPR while ER and cytosolic stress responses are normal. 
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In order to exclude that the observed induction of the mitochondrial stress response in catp-6 
mutants is a rather unspecific reaction due to a more generalized morbidity of the mutants, 
we also examined other cellular stress responses like the UPRcyt and UPRER. hsp-16.2::gfp 
was used as a reporter for the cytosolic heat shock response and hsp-4::gfp as reporter for 
the UPRER (Calfon et al., 2002; Link et al., 1999). Induction conditions in these cases were 
heat shock (6 h at 30 °C) for the cytosolic UPR and treatment with tunicamycin for the 
UPRER. Both fluorescence microscopy and Western Blot analysis did not show an intrinsic 
activation of these stress response pathways in the catp-6 mutants and GFP expression from 
the reporter constructs upon induction of the stress responses was the same in catp-6 mu-
tants than in wild type worms (Fig. 5.18C-F). This clearly indicates that the mitochondrial 
stress response is specifically induced in the mutants probably due to increased oxidative 
stress. 
 
A closer look at the expression of the hsp-6::gfp reporter revealed that a number of tissues 
show strong fluorescence and that the expression pattern differs between individual worms 
(Fig. 5.19). Among the tissues that seem to be most affected are the pharynx, muscle cells, 
as well as structures in the vulva region, uterus and gonads. Interestingly, several of these 
tissues (Vulva, muscle cells, pharynx) were also among the tissues that we had identified in 
the expression pattern analysis of catp-6. Furthermore, the tissues that are showing a strong 
induction of the mitochondrial stress response also coincide with the phenotypes of catp-6 







Fig. 5.19: Several tissues of catp-6 mutants show a strong induction of the mitochondrial stress re-
sponse. 
Induction of the mitochondrial stress response in catp-6 mutants was visualized using the hsp-6::gfp reporter. 
Among the tissues that are showing a strong GFP signal are the pharynx, muscle cells, the vulva region as 
well as structures in the gonads. The pattern of induction of the mitochondrial stress response varies between 
individual worms. Scale bars represent 50 µm. 
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5.2.16. catp-6 mutants exhibit increased sensitivity to oxidative stress and a 
reduced life span 
 
We were hypothesizing that activation of the mitochondrial stress response in catp-6 mutants 
was due to increased oxidative stress resulting from defects in the respiratory chain. If the 
levels of reactive oxygen species (ROS) were increased in the deletion mutants, one would 
expect the worms to show increased sensitivity to treatment with substances that are leading 
to increased oxidative stress. Therefore, we decided to assess survival upon paraquat treat-
ment. Paraquat induces massive superoxide production by redox-cycling. Paraquat forms a 
cation radical upon one-electron reduction and electron transfer from this radical to molecular 
oxygen leads to generation of superoxide and at the same time to the regeneration of the 
original paraquat molecule which can then start a new redox-cycle (Bus and Gibson, 1984). 
Paraquat sensitivity was assessed by growing worms on NGM plates containing 150 mM 
paraquat starting from L4 stage and assessing survival after two days of paraquat treatment. 
While all of the wild type worms were surviving this treatment, both catp-6 deletion mutants 
showed a strongly reduced survival rate of about 60% of wild type (Fig. 5.20A). This indi-
cates that the deletion mutants are about twice more sensitive to oxidative stress probably 






Fig. 5.20: catp-6 mutants show increased sensitivity to paraquat and a reduced life span. 
(A) catp-6 deletion mutants show reduced survival after two days of treatment with 150 mM paraquat. (B) Life 
span is reduced in two alleles of catp-6. To avoid death of catp-6 mutants due to their Egl phenotype, life span 
was assessed in a glp-4(bn2) background in which gonad formation can be prevented by shifting the worms to 
the non-permissive temperature between L2 larval stage and late L4 stage. Two independent lines for each 
allele were analyzed. 
 
PhD Thesis – Nora Wender Chapter II: Cellular function and toxicity of catp-6 in C. elegans  
86 
 
According to the oxidative damage theory of aging, increased oxidative stress accelerates 
the aging process and causes a reduction in life span (Harman, 1956)[reviewed in (Beckman 
and Ames, 1998)]. The fact that catp-6 mutants show an induction of the mitochondrial stress 
response and increased sensitivity to oxidative stress suggests that oxidative stress levels 
are increased in the mutants and it was therefore tempting to speculate that life span in these 
worms could be affected. Hence, we analyzed lifespan in two deletion mutants of catp-6. As 
catp-6 mutants have a strong Egl phenotype which might lead to premature death because 
of egg accumulation and hatching of larvae inside the parent, we decided to use a glp-4(bn2) 
background for the assays. Switching glp-4 worms to the non-permissive temperature of 
25 °C during postembryonic development prevents the formation of gonads in the worms. 
The results of the life span analysis are depicted in Fig. 5.20B and show a marked reduction 
in life span in both catp-6 deletion mutants. While the maximum life span was unchanged, 
mean life span of the mutants (8 days for both alleles) was reduced when compared to wild 
type (10 days). 50% of wild type worms were dead after 10 days of adulthood. In the mu-
tants, this was already the case after 7 or 8 days for catp-6(ok3473) and catp-6(tm3190), 
respectively. This suggests that deletion of catp-6 leads to an accelerated aging process 
possibly by eliciting mitochondrial dysfunction and increased ROS production. 
 
 
5.2.17. Increased activation of AMPK and induction of autophagy in catp-6 de-
letion mutants 
 
Having seen the morphological and functional defects of mitochondria in catp-6 mutants, we 
were wondering whether this also affects the cellular energy status. If ATP production is di-
minished in catp-6 mutants, this should also lead to an increase of the AMP/ATP ratio in the 
cell. AMPK (AMP-activated protein kinase) senses an increase in the AMP/ATP ratio. Thus, 
a rise in the AMP/ATP ratio leads to activation of AMPK via phosphorylation of Thr172 by 
LKB1 (Liver kinase B1; PAR-4 in C. elegans) (Hawley et al., 1996; Lee et al., 2008; Shaw et 
al., 2004). Therefore, a phosphorylation specific antibody can be used as indirect readout of 
the energy status of the cell. Western blot analysis of worm lysates showed that the levels of 
phosphorylated AMPK are augmented in catp-6 mutants. While only a slight increase was 
observed for the tm3190 allele, the levels of p-AMPK were doubled in catp-6(ok3473) when 
compared to wild type (Fig. 5.21). 
 
 







Due to the lack of an antibody against unphosphorylated AMPK we cannot exclude that the 
levels of total AMPK are affected by catp-6 loss-of-function but the increase in phosphory-
lated AMPK hints at a reduction of cellular ATP levels. This would be in line with the func-
tional and morphological defects that were seen in the mutants. Nevertheless, further inves-
tigation of the overall AMPK levels are needed to confirm this hypothesis. 
 
Phosphorylation of AMPK has an activating role for cellular catabolic processes while it leads 
to inhibition of anabolic pathways [reviewed in (Mihaylova and Shaw, 2011)]. One of the ef-
fects of AMPK activation is induction of autophagy. This is mediated by inhibition of the 
mTOR-Raptor complex (mTORC1) which acts as inhibitor of autophagy. Recently, also a 
more direct influence of AMPK on autophagy has been reported as it was shown that AMKP 
can activate ULK1 (Unc-51-like kinase 1) which leads to induction of mitophagy (Egan et al., 
2011a; Kim et al., 2011). Given the increased phospho-AMPK levels in the catp-6 mutants, 
we decided to investigate whether increased autophagy can be observed in catp-6. We used 
a previously described reporter strain expressing the GFP-tagged LGG-1 under the control of 
the endogenous lgg-1 promoter (Kang et al., 2007; Melendez et al., 2003). LGG-1 is the 
C. elegans ortholog of yeast ATG8 (autophagy related protein 8) and mammalian LC3 (Mi-
crotubule-associated protein 1 light chain 3 alpha). As these proteins are conjugated to PE 
(phosphatidyl ethanolamine) in the autophagosomal membrane, they are commonly used as 
marker for autophagosomal structures.  
Fig. 5.21: Increased phosphorylation of AMPK in catp-6 mutants. 
(A) Western Blot of worm lysates using an antibody against phosphorylated AMPK shows an increased signal 
for catp-6 mutants. (B) For quantification, a total of four samples from two blots were analyzed. The ratio of 
p-AMPK and tubulin signal was determined for each lane and the mean of the four samples was calculated. 
These mean ratios were then normalized to the wild type value to determine AEUs. Phosphorylation is slightly 
increased in catp-6(tm3190) and a more pronounced increase was seen in the ok3473 allele. 
 






When examining eggs that are expressing the GFP-LGG-1 fusion protein, we observed a 
marked increase in the number and size of GFP-LGG-1 puncta in eggs of catp-6 mutants as 
shown in Fig. 5.22. The increase in autophagic foci could either result from increased induc-
tion of autophagy or from decreased clearance. Increased autophagy induction would be in 
line with the increased levels of phosphorylated AMPK but further experiments need to be 
done in order to be able to distinguish between these two scenarios. When investigating au-
tophagy in catp-6 mutants, the increase in autophagic foci was most prominent in eggs of the 
150-300 cell stage. We also tried to investigate autophagy in larval stages but there the re-
sults were more ambiguous. While in some of the experiments we saw increased number of 
autophagic foci in the seam cells, we were not able to reproduce these results in all experi-
ments. The reason for this ambiguity might be that we could not control for all parameters 
that influence autophagy and further investigations are needed to determine which factors 
are responsible for the divergence between experiments. Therefore, at the moment we can-
Fig. 5.22: Increased induction of autophagy in eggs of catp-6 mutants. 
Eggs of the 150-300 cell stage were analyzed for the number and size of autophagic foci using a reporter strain 
expressing GFP-LGG-1. Scale bars represent 10 µm. Both number and size of the foci were found to be in-
creased in catp-6 mutants Two independent lines of catp-6 expressing GFP-LGG-1 were analyzed. Error bars 
correspond to the standard error of the mean (SEM) and significance values of One-way ANOVA with Dunnett’s 
multiple comparison analysis are indicated: **P<0.01, *P<0.05, ns P>0.05. 
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not take a firm stand on whether autophagy is up-regulated in catp-6 mutants at later devel-
opmental stages or in adult worms. It is possible that chronic stimulation of autophagy might 
lead to compensatory mechanisms that inhibit autophagy or prevent its excessive degrada-
tion. Furthermore, it could be that the worms that reach these stages and that have not died 
during embryonic or early postembryonic development have developed some compensatory 
mechanisms and that the worms showing more severe phenotypes die before reaching these 
stages. In accordance with this, we found severe defects in some of the eggs in catp-6 
(Fig. 5.23). These eggs have abnormal appearance in both bright-field images as well as in 
GFP-LGG-1 fluorescence pictures. Some of the eggs show an abnormal shape and are 
smaller and more round than for wild type worms. In other eggs, amorphous structures are 
visible. Moreover, some abnormal GFP-LGG-1 positive structures are found in these eggs 
which we have never observed in wild type eggs. Given the severe morphological defects of 
these eggs it seems very likely that those eggs are dead or about to die. This sheds new light 
on the brood size data as the decreased number of progeny for catp-6 could at least in part 
be due to embryonic lethality. Therefore, it will be very interesting to study embryonic devel-







Fig. 5.23: Deletion of catp-6 causes egg defects. 
Morphological abnormalities were seen in eggs of catp-6 deletion mutants. Bright-filed images are shown in 
the top panels and the lower panels depict fluorescence of GFP-LGG-1. The egg in (A) is smaller and more 
roundish than eggs of wild type worms which have an ovoid shape. Amorphous structures are seen in the 
bright-field pictures of (B) and (C) and several anomalous structures are seen in the fluorescence pictures. 
Scale bars represent 10 µm. 
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5.2.18. No excessive apoptosis in the germline of catp-6 
 
As a last aspect of the characterization of catp-6 mutants, we studied germline apoptosis. 






Apoptosis in the C. elegans germline occurs as an intrinsic feature of oogenesis inde-
pendently of the BH3-only protein EGL-1 which is involved in the regulation of somatic apop-
tosis in C. elegans (Gartner et al., 2008). The key components of the apoptotic machinery 
are the same for the germline as for somatic cells. For visualization of apoptotic corpses in 
the germline, a previously described reporter strain expressing plim-7::ced-1-gfp 
(Schumacher et al., 2005) was used. Apoptotic cells in the germline are engulfed by the so-
matic sheath cells. CED-1 is a protein that is expressed at the membrane of the sheath cells 
and is clustering when the sheath cells are engulfing apoptotic corpses (Zhou et al., 2001). 
As the lim-7 promoter drives expression of the translational fusion protein CED-1-GFP in the 
somatic gonad, apoptotic corpses are marked by a ring of fluorescence surrounding the 
corpses (Schwartz, 2007). The number of apoptotic corpses in the germline was not changed 
in catp-6 mutants. This suggests that regulation of apoptosis in the germline is not affected 
by deletion of catp-6 and that the reduced brood size cannot be explained by massive dying 
of germ cells but is rather caused by the Egl and pVul phenotypes or by increased embryonic 
lethality. 
Fig. 5.24: No increase in germline apoptosis in catp-6 mutants. 
Apoptotic corpses in the germline of young adult worms were visualized by expression of plim-7::ced-1-gfp. 
Bright-field images are shown in the top and GFP fluorescence is displayed in the lower panels. Apoptotic corps-
es are indicated by white arrowheads. Scale bars represent 20 µm. The overall number of corpses per gonad arm 
is not changed in catp-6 mutants.  
 
Fig. 5.25: Formation of the vulva-uterine connection in C. elegans. 





5.3.1. Multiple factors contribute to the reduced brood size of catp-6 mutants 
 
The brood size of catp-6 mutants was found to be severely reduced when compared to wild 
type worms and this decreased fecundity was accompanied by egg laying (Egl) defects and 
a protruding vulva phenotype (pVul) (Fig. 5.2 and Table 5.1). C. elegans fertility depends on 
the cooperative function of several tissues. Oocytes are produced in the gonad where they 
are fertilized by passage through the spermatheca (Hirsh et al., 1976). Fertilized eggs then 
enter the uterus where they undergo the first rounds of cell division approximately to the 
30 cell stage of embryonic development (Hirsh et al., 1976). Through a concerted action of 
uterine and vulval muscles, eggs are then expelled through the vulva opening to the outside. 
During its reproductive period, a C. elegans hermaphrodite typically produces about 300 
progeny (Hirsh et al., 1976). The number of progeny is limited by the number of sperm that 
each hermaphrodite produces during early stages of sexual development (Hirsh et al., 1976). 
Decreased brood size could therefore either be caused by a low number of sperm or by a 
massive loss of oocyte forming germ cells. This would, consequently, lead to a decreased 
total number of fertilized oocytes. As no increase in the number of apoptotic corpses was 
seen in the germline of catp-6 mutants, it is unlikely that loss of germ cells accounts for the 
reduced number of progeny of catp-6 mutant hermaphrodites. More likely as a cause of the 
reduced brood size is the egg laying defect in combination with the pVul phenotype of catp-6 
mutants. Furthermore, the accumulation of eggs in the uterus argues for a normal egg pro-
duction and problems with egg laying. Egg laying relies on contraction of vulval and uterine 
musculature which requires innervation by HSN and VC motoneurons and a proper vulva-
uterine connection. In catp-6 hermaphrodites, a severe egg laying defect causes fertilized 
eggs to be retained within the uterus. In cases of a steric blockade of the vulval opening as a 
result of the pVul, eggs cannot be laid at all. Therefore, the progeny hatches inside the par-
ent, eventually killing it. Since the capacity of the uterus is limited, this severely restricts the 
number of progeny that can be produced. 
 
The fact that a protruding vulva is seen in some of the catp-6 mutants hints at defects in the 
vulva-uterine connection, which is partially composed by the utse cell (uterine seam cell). 
The utse cell connects the vulval epidermis to the uterus and is also important for attachment 
of the uterus to the lateral epidermis. Therefore, the utse cell structurally prevents eversion of 
the vulva (Newman et al., 1996). Formation of the connection between vulval and uterine 
lumen requires coordinated specialization of the two tissues (Fig. 5.25). The first step in this 
process is fate determination of the anchor cell (AC) which depends on LIN-12 (C. elegans 
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Notch homolog) and which takes place early in uterine development (Kimble, 1981; Seydoux 
and Greenwald, 1989). This process functions according to the lateral inhibition principle and 
results in one of two initially equivalent cells becoming a ventral uterine (VU) precursor cell 
while the other is acquiring anchor cell (AC) fate. The anchor cell subsequently induces a 
number of cells in the epidermis to become vulva precursor cells (VPCs) via LIN-3 (epider-
mal growth factor)/LET-23 (receptor tyrosine kinase) signaling (Aroian et al., 1990; Hill and 
Sternberg, 1992; Katz et al., 1995; Kimble, 1981; Sternberg and Horvitz, 1986) and then in-
duces a subset of VU cells to become π cells which will form the uterine part of the vulva-
uterine connection (Newman et al., 1995) (Fig. 5.25a). Induction of the π cells involves  





After having induced VPCs and π cells, the anchor cell builds a barrier between vulva and 
uterine cells thus allowing the two tissues to differentiate independent from each other 
(Newman and Sternberg, 1996). The VPCs then differentiate to form the vulva while π cells 
give rise to two different types of uterine cells that are involved in forming the connection be-
tween vulva and uterus – utse and uv1 cells (Newman et al., 1996) (Fig. 5.25b). The utse 
cells fuse to form a multinucleated syncytium to which the anchor cell finally also fuses 
(Newman et al., 1996). A thin laminar process is formed by the utse which separates vulva 
and uterus and which is broken by the first egg being laid (Newman and Sternberg, 1996) 
(Fig. 5.25c). Besides forming this thin lamina, the utse is also making connections to the epi-
thelial seam cells thus preventing eversion of vulva and uterus (Newman and Sternberg, 
Fig. 5.25: Formation of the vulva-uterine connection in C. elegans.  
(a) Uterine π cells (red) are induced via signaling from the AC (green). (b) Division of the π cells gives rise 
to uv1 cells (ventral daughters) and utse cells which fuse to form a syncytium. (c) Schematic representation 
of a cross-section of an L4 larva in which formation of the vulva-uterine connection is completed. The utse 
(red) has fused to form a thin layer between vulva and uterus and is also forming connections to the seam 
cells (yellow). Uv1 cells (dark red) are forming the connection of utse and the dorsal vulva cells, VulF (blue) 
and VulE (cyan). Reprinted from Current Biology, 10, Newman et al., The Caenorhabditis elegans hetero-
chronic gene lin-29 coordinates the vulval-uterine-epidermal connections, p. 1479-1488, Copyright (2000), 
with permission from Elsevier. (Newman et al., 2000). 
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1996). Failure in formation of the utse causes a pVul phenotype as seen in catp-6 worms 
indicating that the mutants have problems with either induction or differentiation of the π 
cells. uv1 cells, the second cell type generated by the π cells, are connecting dorsal vulval 
cells and utse by forming adherens junctions to both (Newman et al., 1996). As many steps 
in the formation of the vulva-uterine connection rely on cell-cell signaling between different 
tissues and lineages and as the signaling is transient in nature (Huang and Hanna-Rose, 
2006), it is important that development of the different tissues is well-synchronized. Huang 
and Hanna-Rose have described a cog-3 mutant (connection of gonad defective; new gene 
name pnc-1) which fails to form a vulva-uterine connection because development of the 
uterus in these worms is delayed relative to vulval development (Huang and Hanna-Rose, 
2006). As differentiation of the uv1 cells depends on signaling between vulval cells which 
express LIN-3 (EGF) and uterine π cells expressing the LET-23 EGF receptor, asynchrony in 
development of the two tissues disturbs this signaling as LIN-3 expression by vulval cells 
happens at a time when the π cells are not ready yet to respond to this signal (Huang and 
Hanna-Rose, 2006). Formation of the vulva-uterine connection in catp-6 mutants could result 
from similar effects of asynchronous development. We have found that postembryonic de-
velopment is strongly delayed in catp-6 (Fig. 5.3) and it is tempting to suggest that not all 
tissues are affected to the same extent by this delayed development. This may prevent ade-
quate cell-cell signaling and thus disturb the formation of the vulva-uterine connection. Inter-
estingly, we found strong expression of catp-6 in the vulva indicating that this tissue might be 
particularly sensitive to deletion of catp-6, which could cause a stronger delay in the devel-
opment of this tissue when compared to others including the uterus. This would be in line 
with the hypothesis of asynchronous development interfering with the formation of the vulva-
uterine connection. It would be interesting to have a closer look at the developmental delay 
and to check whether vulva and uterus development are shifted in time. If, as in the case of 
cog-3 mutants, vulval development is proceeding faster than the development of the uterus 
one might try to rescue the effect by ectopic expression of LIN-3 in the appropriate time win-
dow or by expression of a LET-23 gain-of-function as in the case of cog-3 this was sufficient 
to rescue the uv1 fate defect (Huang and Hanna-Rose, 2006).  
 
Besides the pVul phenotype, we found several defects in the vulva muscles of catp-6 mu-
tants, which are also likely to contribute to the Egl defect and the reduced brood size. The 
vulva muscle defects observed were ranging from irregular arrangement of the muscles rela-
tive to the vulva and defects in the attachment of the muscle cells to the lack of one or more 
vulva muscles (Fig. 5.8 and Table 5.2). Similar defects have been described for mutants in 
the Notch pathway in C. elegans, lin-12 and sel-12 (Eimer et al., 2002). C. elegans vulva 
muscles belong to the mesodermal M lineage which gives rise to body wall muscle (BWM) 
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cells, coelomocytes (CC) and sex myoblast (SM) cells. The sex muscles including both vulva 
and uterine muscles originate from the sex myoblast (SM) cells, which are at first located in 
the tail of the worm and during the L2 larval stage migrate towards the site where the vulva 
will be formed. The vulva muscles in catp-6 that are not properly attached to the vulva and 
show irregular arrangement have migrated successfully towards the vulva region and are 
able to differentiate into muscle cells but probably have defects in cell-cell signaling which 
would normally ensure correct positioning and alignment of the muscles relative to the vulva. 
This is required for a proper connection between vulva and vulva muscles and thus for prop-
er egg laying. As described above, asynchrony in the development of different tissues – in 
this case probably the vulva and sex muscles – would be a possible explanation for the de-
fective signaling resulting in defects in muscle morphology. The observation that in around 
50% of catp-6 worms at least one vulva muscle is missing could be either due to migration 
defects of the SM cells or could be caused by defects in the SM fate determination. While 
migration defects with differentiated vulva muscles residing in the tail region of the worm 
have been found in sel-12 mutants (Eimer et al., 2002), a fate determination defect was seen 
in lin-12 mutants, where instead of acquiring SM fate, the cells were adopting CC fate result-
ing in missing vulva muscles and increased numbers of CCs (Greenwald et al., 1983). 
C. elegans CCs are scavenger cells that continuously endocytose the body cavity fluid. Wild 
type worms have six CCs and increased numbers of CCs were found in lin-12 null mutants. 
Therefore, it would be interesting to determine the number of CCs in catp-6 mutants and look 
for the presence of vulva muscles expressing the marker hlh-8::gfp in the tail region of the 
worm as these experiments would allow to distinguish between the two scenarios. In either 
case, defective signaling due to asynchronous development could be disrupting the signaling 
that induces SM fate or that controls migration of the sex muscles. Interestingly, all the sig-
naling steps that might be affected in catp-6 mutants (π cell fate determination, SM fate de-
termination, SM migration, control of arrangement of vulva muscles and attachment to the 
vulva) rely on LIN-12 (Notch) signaling. Thus, another explanation for the defects seen in the 
mutants would be that loss of CATP-6 function somehow disrupts LIN-12/Notch signaling 
during the development of the egg laying system. Further investigations are needed in order 
to determine whether and how the lysosomal P-type ATPase CATP-6 could affect LIN-12 
signaling. 
 
A third factor that, in addition to the defects in vulva muscles and the vulva-uterine connec-
tion, is likely to contribute to the reduced brood size of catp-6 mutants is embryonic lethality. 
We have observed severe morphological defects in embryos of different developmental 
stages (Fig. 5.23) indicating that loss of CATP-6 function also causes embryonic lethality. We 
have shown that dying embryos display excessive induction of autophagy. However, during 
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larval development and in the adult stage, autophagy is not strongly up-regulated anymore. 
This suggests that there might be a crisis during early embryonic development in catp-6 mu-
tant embryos where additional energy has to be generated through autophagy. catp-6 mutant 
embryos that are able to overcome this crisis display slow rates of development but are able 
to mostly reach the reproductive stage. These adult catp-6 mutant animals exhibit mostly 
normal rates of autophagy suggesting that they are able to down-regulate excessive autoph-
agy during postembryonic development. However, there seems to be a proportion of embry-
os that do not manage to generate enough energy for embryonic development through au-
tophagy and subsequently die. This is consistent with the fact that those embryos that show 
the brightest and largest number of GFP-LGG-1 positive puncta are destined to die. Exces-
sive induction of autophagy has been linked to cell death in C. elegans in previous studies 
(Kang et al., 2007). Therefore, it will be interesting to assess embryonic development in the 
mutants to determine how many worms are affected by the embryonic lethality. 
 
In conclusion, we have shown that three independent defects contribute to the reduced 
brood size in catp-6: a defective vulva-uterine connection, defects in vulva muscles as well 
as embryonic lethality. The defects of the egg laying apparatus could all be explained by ei-
ther defective Notch signaling or asynchronous development of different tissues and cell lin-




5.3.2. Reduced locomotion of catp-6 is based on muscular defects that are al-
ready apparent at larval stages 
 
We observed that catp-6 mutants have impaired locomotory activity when compared to wild 
type worms (Fig. 5.4). As the movement defect was already apparent at larval stages, it 
seems not to be the consequence of a degenerative process. We did not find any abnormali-
ties in structure and arrangement of the myofilaments (Fig. 5.6) but when investigating mito-
chondrial morphology in body wall muscle (BWM) cells of the mutants, we found severe 
changes with networks of long, thin and interconnected mitochondria and perinuclear cluster-
ing of mitochondria (Fig. 5.8, Fig. 5.11). Overexpression of CATP-6 specifically in muscle 
cells of the mutants rescued both mitochondrial morphology (Fig. 5.8) and movement 
(Fig. 5.4). This indicates that the movement defect is caused by a muscular dysfunction due 
to loss of CATP-6 function rather than by problems with neuronal input to the BWMs. This is 
in line with the expression pattern of CATP-6, which showed expression of CATP-6 in muscle 
cells (Fig. 5.5). Whether the changes in mitochondrial morphology in BWMs in catp-6 dele-
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tion mutants are causative for the impaired locomotion of the worms or whether both move-
ment defects and changes mitochondrial dynamics result from a yet undetermined effect of 
loss of function of CATP-6 needs to be subjected to further investigations. It would be inter-
esting to investigate how shifting mitochondrial dynamics towards increased fission in catp-6 
mutants – as it has been achieved by RNAi against the mitochondrial fusion genes fzo-1 and 
eat-3 (Fig. 5.12) – affects movement in the mutants. As we have observed a functional im-
pairment of the mitochondria in catp-6 mutants (Fig. 5.15-17) in addition to the morphological 
changes, it is questionable whether changing the balance of mitochondrial fission/fusion 




5.3.3. Deletion of catp-6 leads to changes in mitochondrial morphology  
 
We have found drastic changes in mitochondrial morphology of catp-6 mutants both in mus-
cle cells as well as in neurons. Mitochondria in the muscles of catp-6 mutants were much 
thinner, longer and more interconnected than in wild type and perinuclear clustering of mito-
chondria was observed (Fig. 5.9). Neurons lacking CATP-6 function display aggregation of 
mitochondria in the neuronal cell bodies with large clusters of mitochondria observed next to 
the nucleus (Fig. 5.14). In the neurites, mitochondrial fragmentation but also some long and 
very thin tubules were observed. 
 
Very recently, a number of studies have reported changes in mitochondrial morphology upon 
siRNA mediated KD of ATP13A2, the human ortholog of catp-6, in cell culture. Mitochondrial 
fragmentation has also been reported in cultured neurons (Ramonet et al., 2012), SH-SY5Y 
cells (Gusdon et al., 2011) and in fibroblasts of KRS patients carrying mutations in the 
ATP13A2 gene (Grunewald et al., 2012). The mitochondrial fragmentation observed in these 
models is in contrast to the elongated thin and interconnected mitochondria that we have 
observed in the muscle cells of catp-6 worms (Fig. 5.9). As we have seen mitochondrial 
fragmentation in neurons of C. elegans catp-6 mutants (Fig. 5.14), it might depend on the cell 
type in which way mitochondrial dynamics are changed upon loss of CATP-6/ATP13A2. It is 
known that mitochondrial dynamics differs between cell types as a consequence of variable 
metabolic demands [reviewed in (Kuznetsov et al., 2009; Sauvanet et al., 2010)]. Therefore, 
it seems plausible that the effects of CATP-6 inactivation on mitochondrial morphology also 
vary between cell types.  
 
Interestingly, mitochondrial elongation, network formation and perinuclear clustering in BWM 
cells of catp-6 mutants were accompanied by changes in the localization of the mitochondrial 
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fission protein DRP-1 which aggregates in large clusters in close proximity to the nucleus in 
catp-6 mutants while individual, equally distributed puncta are seen in wild type muscles 
(Fig. 5.12). DRP-1 in wild type worms is recruited to sites on mitochondria where fission is 
going to take place and it oligomerizes around the mitochondria before it helps constricting 
the membranes and dividing the mitochondrion (Labrousse et al., 1999). The sites of DRP-1 
oligomerization at the mitochondria are visible as defined puncta in wild type worms. The fact 
that DRP-1 is forming large aggregates in catp-6 mutants suggests that normal DRP-1 medi-
ated mitochondrial fission is prevented in the mutants as DRP-1 is “trapped” in the aggre-
gates and cannot oligomerize at sites of fission. Inhibition of fission would also be consistent 
with the very long mitochondrial tubules observed in the mutants. Drp1 activity is regulated 
by posttranslational modifications and the phosphorylation status of Ser637 in the GED do-
main (GTPase effector domain) plays a very important role in determining fission activity of 
the protein. The GED domain of Drp1 is located at the C-terminus and is involved in both 
intra- and intermolecular interaction with other Drp1 molecules and these interactions are 
important for stimulation of GTPase activity and oligomerization, respectively (Zhu et al., 
2004). Two independent studies have shown that Ser637 in the GED domain is phosphory-
lated by the cAMP-dependent protein kinase (PKA) resulting in decreased GTPase activity. 
They also demonstrated that a phosphomimetic Ser637Asp mutation leads to inhibition of 
mitochondrial fission resulting in elongated mitochondria (Chang and Blackstone, 2007; 
Cribbs and Strack, 2007). Cribbs and Strack also showed that Ser637 is dephosphorylated in 
a Ca2+-dependent manner by calcineurin and that this dephosphorylation promotes mito-
chondrial fission as seen in cells expressing a Ser637Ala mutant Drp1, which cannot be 
phosphorylated. Cereghetti et al. reported that dephosphorylation of Ser637 by calcineurin 
enables translocation of Drp1 to the mitochondria and that the anti-fission effect of phospho-
mimetic Ser637Asp mutation is caused by failure of Drp1 to associate with mitochondria ra-
ther than with decreased GTPase activity (Cereghetti et al., 2008). Considering this phos-
phorylation-dependent activity of Drp1, mitochondrial elongation and aggregation of DRP-1 in 
the cytosol of catp-6 mutants could be explained by increased phosphorylation of DRP-1, 
preventing its translocation to the mitochondria and thus fission. Increased Ser637 phos-
phorylation could be caused by a rise in cAMP levels and thus increased PKA activity or by 
reduced activity of calcineurin. This is interesting as it suggests that DRP-1 inactivation and 
mitochondrial elongation could be protective for the cells. We are currently working on de-
termining the phosphorylation status of TagRFP-DRP-1 in catp-6 mutants by immuno-
precipitation and subsequent mass spectroscopic analysis, in order to check whether the 
hypothesis of increased Ser637 phosphorylation holds true. Furthermore, we are planning to 
examine the effects of RNAi against tax-6 (C. elegans calcineurin ortholog) and kin-1 
(C. elegans ortholog of PKA) on mitochondrial morphology in catp-6 mutants and wild type 
PhD Thesis – Nora Wender Chapter II: Cellular function and toxicity of catp-6 in C. elegans  
98 
 
worms. If increased phosphorylation of DRP-1 Ser637 causes mitochondrial morphology 
defects and DRP-1 aggregation in the mutants, RNAi against kin-1 should ameliorate mito-
chondrial morphology in the mutants by preventing phosphorylation while RNAi against tax-6 
should lead to changes in mitochondrial morphology in wild type worms resembling those 
seen in catp-6 mutants by preventing dephosphorylation. Similarly, treating catp-6 mutants 
with H-89, an inhibitor of PKA, should rescue mitochondrial morphology and DRP-1 localiza-
tion. In this context it would also be interesting to investigate mitochondrial morphology in 
worms expressing a tax-6/calcineurin gain-of-function, which should show increased frag-
mentation, or in deletion mutants of tax-6/calcineurin, which should exhibit mitochondrial 
elongation as seen in catp-6 worms. And finally expressing tax-6/calcineurin gain-of-function 
in catp-6 mutants should rescue mitochondrial morphology if indeed increased Ser637 phos-
phorylation is the cause for mitochondrial elongation.  
 
To determine how the mitochondrial fission-fusion dynamics are affected in catp-6 mutants, 
we performed RNAi against components of the mitochondrial dynamics machinery in catp-6 
mutants. We found that silencing of the fission genes drp-1 and fis-1 does not lead to aggra-
vation of mitochondrial morphology in catp-6 (Fig. 5.13). This is in line with our hypothesis 
that DRP-1 activity is prevented in the mutants by increased DRP-1 phosphorylation, so that 
loss of the protein does not lead to additional anti-fission effects. Interestingly, silencing of 
DRP-1 in wild type worms leads to matrix-filled blebs that are connected by very thin tubules 
of outer mitochondrial membrane indicating that fission of the inner membrane can still occur 
in these cells. In contrast, these blebs are not seen in catp-6 mutants indicating that fission of 
the inner mitochondrial membrane (IMM) is also inhibited in the mutants, which cannot be 
explained by inactivation of DRP-1 alone. This is very interesting as it has been proposed 
that a distinct machinery for division of the IMM exists but the components of this machinery 
have not been found yet (Labrousse et al., 1999). RNAi against the mitochondrial fusion 
genes fzo-1 and eat-3 induced mitochondrial fragmentation in both wild type worms and 
catp-6 mutants. From this data it is hard to judge whether increased mitochondrial fusion 
could also contribute to mitochondrial elongation in catp-6 mutants as loss of the fusion 
genes is shifting the balance between fission and fusion towards increased fission and thus 
can counteract mitochondrial elongation caused by either increased fusion or inhibited fission 
in the mutants. In order to distinguish between the two scenarios that could lead to mito-
chondrial elongation in catp-6 – increased fusion or inhibited fission – it would be necessary 
to follow mitochondrial dynamics by live cell imaging.  
 
Whether the changes in mitochondrial morphology in catp-6 mutants are detrimental to the 
cell or whether they rather are a compensatory mechanism preventing massive mitochondrial 
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degradation and maximizing the ATP production remains to be determined. Parone et al. 
have shown that inhibiting mitochondrial fission by depletion of Drp1 in HeLa cells causes 
loss of mtDNA, impaired mitochondrial respiration, reduced ATP levels and increased au-
tophagy (Parone et al., 2008). In contrast, Cribbs and Strack have reported that decreased 
fission due to phosphorylation of Drp1 at Ser637 leads to protection of cells against treat-
ment with inducers of apoptosis such as staurosporine, a protein kinase inhibitor, as well as 
against H2O2 (Cribbs and Strack, 2007). A protective function of mitochondrial elongation has 
also been shown for conditions of nutrient deprivation (Gomes et al., 2011). Gomes et al. 
have demonstrated that starvation induces phosphorylation of Drp1 by PKA via increased 
cAMP levels thus inhibiting mitochondrial fission and preventing mitochondria from being 
degraded via autophagy which is induced by nutrient depletion. Preventing mitochondrial 
elongation during starvation by inhibition of PKA or deletion of Opa1 leads to decreased via-
bility of the cells (Gomes et al., 2011). PKA-mediated mitochondrial elongation not only 
serves as a protective mechanism to prevent massive mitochondrial degradation but also 
helps to sustain cellular ATP levels by higher number of cristae and thus more efficient oli-
gomerization of the ATP synthase (Gomes et al., 2011). Thus, further investigations are 
needed to determine whether mitochondrial elongation in catp-6 mutants also serves to pro-
tect the cells against oxidative stress, autophagic degradation and to ensure sufficient ATP 
supply. For this purpose it might be interesting to analyze the effects of KD of the fusion 
genes eat-3 or fzo-1 in catp-6 deletion mutants on mitochondrial function, ATP levels, oxygen 
consumption but also the sensitivity towards oxidative stress. As we have shown that silenc-
ing of these genes prevents mitochondrial elongation in the mutants, these studies would 
help to determine how elongation influences mitochondrial function. 
 
Perinuclear clustering has been described to occur during mitophagy, a mechanism leading 
to selective degradation of damaged mitochondria (Okatsu et al., 2010). The two PD-related 
proteins PINK1 and Parkin play an important role in targeting damaged mitochondria with low 
membrane potential to autophagic degradation (Geisler et al., 2010; Matsuda et al., 2010; 
Narendra et al., 2008; Narendra et al., 2010; Vives-Bauza et al., 2010b). Okatsu et al. de-
scribe that induction of mitophagy by treating cells with the mitochondrial uncoupler CCCP 
leads to accumulation of aggregated mitochondria in close proximity to the nucleus. They 
furthermore show that this perinuclear clustering is dependent on Parkin-mediated ubiquityla-
tion, p62 and microtubule transport and propose that the mechanism leading to juxtanuclear 
mitochondrial aggregation is analogous to aggresome formation, a mechanism by which the 
cell sequesters misfolded proteins into large aggregates which accumulate next to the nucle-
us where they are subsequently degraded by autophagy (Okatsu et al., 2010). The fact that 
we also see perinuclear clustering in catp-6 mutants could hint at increased induction of mi-
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tophagy which would be in line with the reduction in membrane potential and increased oxi-
dative stress that we have found in mitochondria of the deletion mutants, as those are known 
to be triggers for mitophagy. It is possible though, that loss of function of the lysosomal 
P-type ATPase CATP-6 impairs lysosomal function and thus clearance of mitochondria via 
mitophagy. In this case, induction of mitophagy in the mutants due to mitochondrial defects 
would cause mitochondrial aggregates in proximity to the nucleus that cannot be cleared and 
thus become even more pronounced. If damaged mitochondria are not cleared properly, this 
could contribute to increased oxidative stress in the mutants as damaged mitochondria are 
known to produce more ROS. Another condition for which perinuclear clustering of mito-
chondria has been reported is mitoptosis (programmed mitochondrial death), which is a rela-
tively novel concept of mitochondrial clearance independent from extramitochondrial proteins 
[reviewed in (Apostolova et al., 2011)]. During this process, mitochondria form clusters in the 
perinuclear region, so called “mitoptotic bodies” which are surrounded by a membrane and in 
which the mitochondria are degraded. In catp-6 mutants, we see some large spots with 
strong TOM70-CFP staining close to the nucleus, which resemble inclusion bodies (Fig. 5.9). 
Those could be mitoptotic bodies as the TOM70-CFP signal is not limited to the outer mem-
brane in these structures but rather stains the whole structure indicating that they have lost 
the normal mitochondrial structure possibly by degradation of the mitochondrial components. 
It would be interesting to investigate these formations by Electron microscopy to determine 
the ultra-structural nature of these mitochondrial accumulations in the perinuclear region. 
 
In summary, we have shown that deletion of catp-6 leads to changes in mitochondrial mor-
phology and that mitochondrial elongation in the mutants is possibly induced by PKA-
mediated inhibition of DRP-1 fission activity. Whether mitochondrial elongation is causing 
impaired mitochondrial function by hindering the elimination of damaged mitochondria or 
whether it is rather a compensatory mechanism to maintain cellular ATP production and to 
protect against massive loss of mitochondrial mass by autophagic degradation will be the 
subject of future studies. 
 
 
5.3.4. Impaired mitochondrial function in catp-6 deletion mutants 
 
Besides morphological changes we also observed effects on mitochondrial function in catp-6 
mutants. The mitochondrial membrane potential (ΔΨm) is strongly reduced and catp-6 mu-
tants show higher oxygen consumption rates. Furthermore, we found that the assembly of 
complex IV of the respiratory chain is changed in catp-6 mutants. It has to be noted that the 
functional assays were performed on whole worms (oxygen consumption) or on isolated mi-
tochondria that were also extracted from whole worms. Therefore, the results display overall 
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effects of a mixture of mitochondria from different tissues. As we had observed different ef-
fects of CATP-6 loss-of-function on mitochondrial morphology in different tissues, i.e. muscle 
cells and neurons, it is possible that mitochondrial function is also affected in different ways 
in these cells. It would be desirable to assess mitochondrial function in a tissue-specific way 
or ideally even in individual cell as this would allow correlations between mitochondrial mor-
phology and function but methods for such analyses are not available up to present.  
 
As ΔΨm is built up as a consequence of the proton pumping activity of the respiratory chain 
which is coupled to the electron transfer activity, loss of ΔΨm in catp-6 mutants indicates a 
dysfunction of the electron transfer chain (ETC). Alternatively, differences in the membrane 
permeability could also disturb the proton gradient. In a recent study, Grünewald et al. have 
investigated mitochondrial membrane potential in fibroblasts from KRS patients carrying mu-
tations of the human catp-6 ortholog ATP13A2. They demonstrated that loss of ATP13A2 
function significantly reduces ΔΨm analogous to what we see in catp-6 mutants (Grunewald 
et al., 2012). 
 
Whether the changes in the composition of complex IV, that we have seen using in-gel-
activity-staining in blue native poly-acrylamide gel electrophoresis (BN-PAGE), contribute to 
the reduced ΔΨm will need to be determined. Complex IV is the cytochrome c (cyt c) oxidase 
which accepts electrons from cyt c and transfers them to molecular oxygen thus generating 
H2O. This process is coupled to transport of protons from the mitochondrial matrix to the in-
termembrane space. Thus, it is possible that changes in complex IV can lead to decreased 
proton pumping and thus could contribute to a reduction in membrane potential. Neverthe-
less, proton pumping also occurs at complexes I and III so that a reduced proton gradient 
could also result from defects in these processes (compare Fig. 2.4). Furthermore, reduced 
efficiency in any of the complexes would go along with decreased proton pumping, so that it 
is difficult to infer form a loss in ΔΨm in which way ETC function is compromised. Besides a 
failure in proton pumping, leak of protons through the membrane due to changes in permea-
bility of the membrane could be the cause for a reduction in ΔΨm. Although it needs to be 
determined what causes the decreased ΔΨm in catp-6 mutants, loss of ΔΨm hints at re-
duced ability of the mitochondria to produce ATP as the proton gradient is the driving force 
for ATP production. The fact that we observed increased phosphorylation of AMPK in catp-6 
mutants supports the notion of reduced ATP levels. We are planning to directly assess the 
ATP content of catp-6 mutants and compare it to that of wild type worms by using commer-
cially available kits that are based on luciferase activity which is dependent on the ATP con-
centration.  
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Astonishingly, we found that oxygen consumption of catp-6 mutant worms is increased when 
compared to wild type which at first sight seems contradictory to the reduced membrane po-
tential and presumable deficiencies of the respiratory chain. A possible explanation for the 
increased oxygen consumption rates could be increased mitochondrial mass in the mutants. 
Increasing mitochondrial mass could either be a compensatory mechanism of the cells to 
counteract mitochondrial deficiencies and to sustain sufficient ATP supply or it could simply 
be the consequence of failure to degrade mitochondria. Defects in mitophagy in catp-6 mu-
tants could result from loss of function of the lysosomal P-type ATPase and could even be 
causative to the mitochondrial dysfunction that we observe in the mutants. Mitophagy is a 
mechanism for the cell to eliminate dysfunctional mitochondria [reviewed in (Wang and 
Klionsky, 2011)] which is extremely important given the fact that defective mitochondria are 
producing higher amounts of ROS thereby causing damage to many cellular components. 
Therefore, deficient mitophagy might cause on the one hand mitochondrial dysfunction but 
on the other hand might also affect general fitness of the cell due to increased oxidative 
stress which would explain the phenotypes that we have seen in catp-6 mutants. Due to lack 
of specific markers for mitophagy, we are currently not able to directly assess whether this 
process is affected in catp-6 mutants but we will try to get an estimate of mitochondrial mass 
by quantifying the number of mtDNA copies using real-time PCR, as increased mitochondrial 
mass would explain why more oxygen is consumed by the mutants. In this respect, we will 
also determine oxygen consumption in isolated mitochondria of catp-6 mutants, as this al-
lows us to normalize oxygen consumption rates to mitochondrial mass. If the increased con-
sumption that we have observed for measurement with whole animals cannot be reproduced 
in the isolated mitochondria this would support the hypothesis that increased mitochondrial 
mass accounts for the elevated oxygen consumption rates. In a very recent study Gusdon et 
al. report that siRNA-mediated knockdown of ATP13A2 in SH-SY5Y cells leads to increased 
oxygen consumption and they show that this goes along with increased mitochondrial mass 
(Gusdon et al., 2011) which supports our model. They also investigated ATP levels in these 
cells and find that they are comparable to wild type suggesting that either mitochondria in 
these cells are less efficient in producing ATP although they are consuming more oxygen or 
that the cell consumes more ATP and thus a surplus of respiration is needed to maintain the 
same ATP levels. Similarly, increased oxygen consumption and even reduced ATP levels 
were found in fibroblasts of KRS patients carrying a mutation in ATP13A2 and also in this 
case an increased mitochondrial mass, as seen by increased mtDNA copy numbers, was 
reported (Grunewald et al., 2012). The fact that loss of function of ATP13A2 in cell culture 
affects mitochondrial function in a very similar way than deletion of catp-6 in C. elegans sug-
gests that the two proteins indeed are orthologs exhibiting similar cellular functions. 
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To conclude, mitochondrial membrane potential is compromised in catp-6 mutants indicating 
that mitochondrial function is impaired. Moreover, we observed changes in the composition 
of complex IV and it remains to be determined whether those might account for functional 
deficits. Intriguingly, the mutants displayed increased oxygen consumption rates possibly due 
to increased mitochondrial mass. Whether deletion of catp-6, a lysosomal ATPase, affects 
mitochondrial degradation and thereby causes accumulation dysfunctional mitochondria will 
be the subject of future studies. 
 
 
5.3.5. catp-6 mutants show an increased sensitivity towards oxidative stress, 
activation of the mitochondrial stress response and a reduced lifespan 
 
We have found that catp-6 mutants exhibit an increased sensitivity towards oxidative stress 
induced by paraquat and also see a strong expression of the mitochondrial chaperone hsp-6 
under basal conditions without extrinsically inducing oxidative stress indicating that the mito-
chondrial stress response is intrinsically activated. The mitochondrial stress response is in-
duced by high loads of misfolded proteins in the mitochondria and leads to increased ex-
pression of the mitochondrial chaperone hsp-6 (C. elegans ortholog of the mitochondrial form 
of mammalian Hsp70) which helps to restore proper folding of the proteins (Yoneda et al., 
2004). The fact that this pathway is activated in catp-6 deletion mutants indicates that en-
hanced misfolding of mitochondrial proteins takes place. This could be caused by increased 
production of reactive oxygen species (ROS) as oxidative stress causes oxidative damage to 
proteins which can perturb proper folding. It was shown that the majority of ROS in the cell is 
generated at complexes I and III of the respiratory chain (Chen et al., 2003b; St-Pierre et al., 
2002) and that dysfunction or inhibition of several components of the respiratory chain leads 
to higher amounts of ROS being produced (Kudin et al., 2004). As we have seen changes in 
the composition of complex IV and a markedly reduced membrane potential in catp-6 mu-
tants, it is possible that mitochondrial dysfunction of the deletion mutants is accompanied 
with an increased production of ROS and thus more oxidative damage to mitochondrial pro-
teins and induction of the mitochondrial unfolded protein response.  
 
Also the increased sensitivity to oxidative stress induced by treatment with paraquat is in line 
with increased ROS levels in catp-6 mutants. If the basal ROS production is increased in the 
mutants, the ROS generated by paraquat are adding onto these basal levels so that a critical 
threshold that cannot be handled anymore by the cellular antioxidant systems is reached 
earlier. We are currently working on determining whether the level of ROS produced by 
catp-6 mutants is indeed increased when compared to wild type. This can either be done by 
PhD Thesis – Nora Wender Chapter II: Cellular function and toxicity of catp-6 in C. elegans  
104 
 
the use of fluorescent probes like 2,7-dichlorodihydrofluorescein-diacetate (H2-DCF-DA) that 
detect ROS (Schulz et al., 2007) or by expression of mitochondrially-targeted roGFP, a GFP 
variant that is sensitive to oxidative stress and has a different emission spectrum in the re-
duced than in the oxidized state (Dooley et al., 2004; Morgan et al., 2011). It is possible that 
the increase in ROS levels is not very prominent under basal conditions as several antioxi-
dant systems exist in the cell like superoxide dismutases (SODs), catalases, glutathione 
(GSH), GSH peroxidase and GSH reductase that help to detoxify the ROS thus preventing 
massive damage to cellular macromolecules. However, when these systems are already fully 
challenged under basal conditions, additional induction of oxidative stress by treatment with 
paraquat will overwhelm the system so that not all ROS cannot be cleared as seen by the 
increased sensitivity of catp-6 mutants to paraquat. Therefore, besides measuring ROS lev-
els in the mutants, it will also be interesting to investigate the activity of the antioxidant sys-
tems as an increase in their activity could hint at increased ROS production even if the basal 
ROS levels are not changed significantly. In this context we are currently working on generat-
ing transgenic animals expressing a sod-3::gfp reporter for mitochondrial superoxide dis-
mutase activity in wild type worms and catp-6 mutants. This reporter will tell us whether SOD 
activity is intrinsically activated in the mutants due to increased ROS production and if this is 
not the case it will also be a valuable tool to determine whether SOD activity in the mutants 
can be induced upon induction of oxidative stress. This is interesting as an alternative expla-
nation for increased ROS levels in the mutants could be failure of ROS scavenging instead of 
increased ROS generation.  
 
If our hypothesis that catp-6 mutants have a higher load of ROS is correct, this would also be 
an explanation for the reduction in lifespan of the mutants. Back in 1956 Harman postulated 
for the first time that free radicals play a major role in determining the life span of an organ-
ism (Harman, 1956). Later on, it was assumed that the respiratory rate could be negatively 
correlated to life span as several long lived mutants were found to exhibit a slow respiratory 
rate and as less ROS will be produced by decreased respiratory chain activity (Dillin et al., 
2002; Van Voorhies, 2002). The identification of mutants that – although exhibiting reduced 
metabolic rates – show a reduction in life span (Hartman et al., 2001; Kayser et al., 2004) 
disproved this hypothesis. The two mutants that were exhibiting decreased respiratory activi-
ty and shortened lifespan in C. elegans are gas-1 and mev-1, components of complexes I 
and II, respectively (Ishii et al., 1998; Kayser et al., 1999). Remarkably, both mutants were 
found to exhibit higher levels of ROS when compared to wild type (Kayser et al., 2004; 
Senoo-Matsuda et al., 2001), with high levels of ROS having a negative impact on life span. 
Further support for this theory came from the observation that treatment of C. elegans with 
SOD and catalase mimetics or antioxidants such as Coenzyme Q10 or Vitamin E can confer 
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a life span extension (Ishii et al., 2004; Melov et al., 2000). Nevertheless, the impact of ROS 
on lifespan seems to be more complicated as it was recently proposed, that low levels of 
ROS are important for several signaling cascades and that therefore complete abolishment 
of ROS could also have detrimental effects for the cell [reviewed in (Sohal and Orr, 2012)]. 
Interestingly, one of the above mentioned mutants, mev-1, shares several phenotypes of 
catp-6 mutants. Besides reduced life span and increased sensitivity to oxidative stress, 
mev-1 worms are also characterized by a strongly reduced brood size (Ishii et al., 1990) and 
a loss of mitochondrial membrane potential (Senoo-Matsuda et al., 2003). It is quite remark-
able that deletion of the lysosomal P-type ATPase catp-6 leads to similar effects than loss of 
a component of the mitochondrial respiratory chain. It will be interesting to see whether the 
effects of catp-6 deletion are also acting via dysfunction of complex II of the respiratory 
chain. Moreover, we are planning to investigate mitochondrial morphology in mev-1 mutants 
to see whether also mitochondrial morphology and DRP-1 localization are similarly affected 
in the two mutants. 
 
In conclusion, we find that catp-6 mutants display increased sensitivity to oxidative stress as 
well as induction of the mitochondrial stress response suggesting that ROS production is 
increased in the mutants which might also explain the shortened life span. 
 
 
5.3.6. Increased activation of AMPK is not accompanied by increased basal 
autophagy 
 
As we had observed both morphological and functional defects in mitochondria of catp-6 mu-
tants, we were aiming in understanding the impact of these changes on cellular function and 
homeostatic signaling. As mitochondrial dysfunction is usually accompanied by a decrease in 
cellular ATP levels, we were reasoning that this could lead to induction of AMP-activated 
protein kinase (AMPK), which is phosphorylated – and thereby activated – at Thr172 by 
LKB1 (PAR-4 in C. elegans) in response to decreased ATP levels and thus a rise in the 
AMP/ATP ratio (Hawley et al., 1996; Lee et al., 2008; Shaw et al., 2004). In line with our hy-
pothesis that mitochondrial dysfunction causes a reduction in ATP production, we found 
higher levels of phosphorylated AMPK in catp-6 mutants. Interestingly, it was shown that 
AMPK can also be activated by ROS either directly or via ATM (ataxia telangiectasia mutat-
ed), a factor that normally is involved in the cellular damage response and resides in the nu-
cleus but that is translocated to the cytoplasm during oxidative stress [reviewed in (Scherz-
Shouval and Elazar, 2011)]. Cytoplasmic ATM then activates AMPK and thereby induces 
autophagy [reviewed in (Scherz-Shouval and Elazar, 2011)]. Whether increased phosphory-
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lation of AMPK in catp-6 mutants occurs in response to ATP depletion or as a result of in-
creased oxidative stress or a combination needs to be assessed in future studies. As we are 
planning to determine both ATP and ROS levels in the mutants this might help to get an idea 
what is causative for AMPK activation. 
 
AMPK is an important regulator of cellular metabolism and its activation leads to inhibition of 
anabolic processes while catabolic pathways are stimulated [reviewed in (Hardie, 2004; 
Mihaylova and Shaw, 2011)]. Activated AMPK leads to induction of autophagy by inhibition of 
the mTOR (mammalian target of Rapamycin)/Raptor complex which itself has an inhibitory 
effect on autophagy [reviewed in (Jung et al., 2010)]. Besides inhibiting mTOR, phosphory-
lated AMPK can also stimulate autophagy via activation of ULK1 (mammalian ortholog of 
yeast Atg1), a serine-threonine kinase involved in initiation of autophagy (Egan et al., 2011b; 
Kim et al., 2011). In line with increased AMPK phosphorylation we found more autophagic 
foci in eggs of catp-6 mutants. It remains to be determined whether this is indeed caused by 
increased induction of autophagy as a decreased clearance of autophagosomes could also 
explain this effect. While we could easily detect increased amounts of autophagic foci in em-
bryos of catp-6 mutants, the effect was not as clear in older worms. This could be due to the 
fact that embryos in which autophagy is strongly induced are not surviving and die at early 
stages. In line with this we have found morphologically abnormal eggs in catp-6 mutants that 
most probably die as embryos. It is thus conceivable that those worms that are surviving 
have developed compensatory mechanisms that prevent excessive autophagic activity that 
could lead to cell death. Conflicting data has been published about the effects of knockdown 
of ATP13A2, the human ortholog of catp-6, in cell culture. While Ramonet et al. reported in-
creased clearance of autophagosomes but no change in induction of autophagy upon loss of 
ATP13A2 (Ramonet et al., 2012), another study described that KD of ATP13A2 leads to a 
defect in both autophagy induction and autophagic degradation so that basal levels of au-
tophagy are not changed (Gusdon et al., 2011). The fact that both studies do not see a 
change of basal autophagy is in line with our observation in catp-6 mutants at post-
embryonic stages and a more detailed examination of autophagic degradation and induction 
processes is required to fully understand the role of CATP-6 in regulation of autophagy. 
 
Interestingly, besides its role in regulating macroautophagy, AMPK has also been linked to 
mitochondrial degradation. Activation of ULK1 by AMPK has been attributed an important 
role in the regulation of mitophagy (a specialized form of autophagy) and loss of ULK1 as 
well as loss of the AMPK recognition motif in ULK1 leads to impaired function and morpholo-
gy of mitochondria (Egan et al., 2011a; Egan et al., 2011b). Whether increased activation of 
AMPK is involved in mediating mitochondrial dysfunction and disturbing mitochondrial dy-
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namics in catp-6 mutants has to be determined. Furthermore, it would be interesting to spe-
cifically analyze mitophagy in catp-6 mutants, however, such markers are currently not avail-
able in C. elegans. Apart from inducing mitochondrial degradation, in mammals, AMPK can 
also stimulate mitochondrial biogenesis by up-regulating PGC-1α (peroxisome-proliferator-
activated receptor coactivator 1α), a transcription coactivator involved in regulating cellular 
energy metabolism [reviewed in (Hardie, 2011)]. This is particularly interesting as we have 
hypothesized that mitochondrial mass is increased in catp-6 mutants and increased mito-
chondrial biogenesis mediated by activation of AMPK could explain this effect. 
 
In summary, we have found increased induction of autophagy in embryos lacking CATP-6 
function. This up-regulation of autophagy is likely to be caused by increased AMPK activity in 
catp-6 mutants. During larval development and in adult catp-6 mutant worms, autophagy was 
only slightly elevated despite increased levels of active phospho-AMPK. It is therefore likely 
that compensatory mechanisms prevent chronic activation of autophagy as excessive au-
tophagy leads to cell death (Kang et al., 2007). Besides its stimulatory effect on autophagy, 
AMPK is involved in the regulation of many other cellular processes including mitochondrial 
biogenesis and degradation via mitophagy. Thus, it will be interesting to determine whether 
activation of AMPK plays a role in mediating the effects of catp-6 deletion on mitochondrial 
function and morphology.  
 
 
5.3.7. Deletion of the lysosomal P-type ATPase CATP-6 causes mitochondrial 
defects – novel link between lysosomes and mitochondria 
 
Our results have shown that deletion of the lysosomal P-type ATPase has a strong impact on 
both mitochondrial function and morphology. The fact that only the mitochondrial stress re-
sponse was activated in the mutants but no induction of other cellular stress responses was 
observed, indicates that loss of function of CATP-6 rather specifically affects mitochondria. It 
was previously reported that lysosomal dysfunction in lysosomal storage diseases causes 
mitochondrial defects including fragmentation and impaired Ca2+-buffering capacity (Jennings 
et al., 2006). Disturbance of lysosomal function has furthermore been shown to cause accu-
mulation of autophagosomes due to both increased autophagy activation and decreased 
clearance (Cao et al., 2006; Fukuda et al., 2006; Settembre et al., 2008; Vergarajauregui et 
al., 2008). As the clearance of damaged mitochondria relies on autophagic degradation [re-
viewed in (Wang and Klionsky, 2011)] and given the autophagic defects caused by lysoso-
mal dysfunction, disturbances of mitophagy could be the cause for the mitochondrial defects 
seen in deletion mutants of the lysosomal P-type ATPase CATP-6. In line with this, it was 
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shown that blocking autophagy in yeast causes dysfunctional mitochondria to accumulate 
and leads to increased ROS levels (Zhang et al., 2007). Furthermore, mitochondrial dysfunc-
tion due to defective mitophagy has been implicated in the pathogenesis of PD as mutations 
in the PD-related genes PINK1 and Parkin which are involved in targeting damaged mito-
chondria for mitophagy (Narendra et al., 2008; Narendra et al., 2010), cause mitochondrial 
defects (Clark et al., 2006; Greene et al., 2003; Park et al., 2006; Yang et al., 2006). Due to 
the lack of specific markers for mitophagy it is to date not possible to directly assess whether 
catp-6 mutants display defects in mitophagy. Basal levels of autophagy though seem not to 
be affected in catp-6 mutant worms at postembryonic stages (preliminary results, data not 
shown) and were also not seen in cell culture models using siRNA against the human 
ortholog ATP13A2 (Gusdon et al., 2011; Ramonet et al., 2012). It is still possible that au-
tophagic flux is changed in the mutants but Gusdon et al. also demonstrated that lysosomal 
stability and pH are not affected by KD of ATP13A2 indicating that degradation in the lyso-
somes is presumably working. Recent data suggests that lysosomes, besides their degrada-
tive function are also part of the cellular signaling network with the mTOR complex 1 
(mTORC1) being translocated to the lysosomal membrane and activated in the presence of 
amino acids causing inhibition of autophagy (Zoncu et al., 2011). Interestingly, a lysosomal 
v-ATPase is required for amino acid induced activation of mTOR (Zoncu et al., 2011) indicat-
ing that lysosomes not only are required for autophagosomal clearance but are also involved 
in the regulation of autophagy. Furthermore, Korolchuk et al. have demonstrated that lyso-
somal positioning is also an important factor controlling autophagy. While lysosomes are lo-
cated in the periphery of the cell when nutrients are available, upon starvation they are 
transported to the perinuclear region, where also most of the autophagosomes are accumu-
lating. This leads to decreased mTORC1 activity and stimulates both autophagosome for-
mation and fusion of autophagosomes with lysosomes for degradation (Korolchuk et al., 
2011). As mTORC1 activity has also been implicated in the control of mitochondrial function 
(Cunningham et al., 2007; Koyanagi et al., 2011), mTORC1 might be the missing link be-
tween loss of function of the lysosomal protein CATP-6 and severe mitochondrial dysfunction 
and needs to be subjected to future investigations. 
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6. Materials and methods 
 
6.1. Molecular cloning 
 
Standard molecular biology techniques were used for cloning. A list of all constructs generat-
ed including cloning strategy and primers used for the PCR is provided in the appendix (Ta-
ble 8.2).  
 
PCR 
PCR on the genes of interest was performed using Taq Polymerase (Invitrogen; for con-
structs <1 kb) or PfuUltra II Polymerase (Stratagene; for constructs >1 kb) according to the 
manufacturer’s instructions. The primers that were used in this study are listed in Table 8.3 in 
the Appendix.  
 
Restriction digests 
Restriction enzymes were purchased from Fermentas. For preparative digests 1 µg DNA was 
either cut with 0.5 µL of the respective enzymes and incubated OVN at 37 °C (except for 
enzymes that have different optimal temperatures) or with 1-2 µL of the enzymes and incu-
bated for 3 h at the same temperature. Digestion buffers were used according to the manu-
facturer’s instructions. Depending on the amount of enzyme used, digests were performed in 
20-50 µL total volume (enzyme should not account for more than 10% of the total volume). 
Digests were then run on a 1% agarose gel in 1x TBE and gel extraction (kit from Fermen-
tas) was performed for the bands of interest. Alternatively, if the digest was performed on a 
PCR product or if it resulted in just one cut in a plasmid resulting in linearization, the digest 
was purified using a PCR purification kit (Fermentas). 
 
Ligation 
For Ligations, usually a 3:1 ratio of insert to vector was used. For 3-fragment ligations, either 
a 3:3:1 ratio (insert 1:insert 2:vector) was used or ratios were adjusted if there was a dis-
crepancy of the size of the two inserts. Ligation reactions were performed in 10-20 µL final 
volume with 1-2 µL 10x T4 Ligase buffer (Fermentas) and 1 µL T4 DNA Ligase (Fermentas). 
Ligations were incubated at RT for 1-3 h or at 16 °C OVN. For pGEM-T cloning of PCR prod-
ucts, ligations were performed using a kit purchased from Promega. 
 
Transformation 
Transformations were done using chemocompetent E. coli DH5α (Invitrogen). Competent 
cells were stored at -80 °C until use and thawed on ice for 10-15 min before adding 100 µL of 
competent cells to the ligation sample or to 1 µL of the plasmid to be retransformed. After 
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20-30 min of incubation of cells with the DNA on ice, cells were heat-shocked at 42 °C for 
2 min followed by 5 min incubation on ice. Subsequently, 400 mL LB medium were added 
and cells were incubated for 30-60 min in a 37 °C shaker. For retransformations, 80-100 µL 
of the cell suspension were plated on LB plates containing the selection antibiotics. For 
transformation of ligations, cells were centrifuged at 4000 rpm for 5 min and the supernatant 
was taken away leaving the cells in a volume of approximately 150 µL. Cells were resus-
pended by pipetting up and down and then plated on LB plates containing the appropriate 
selection antibiotic. For transformation of pGEM-T cloned PCR products, JM109 (Promega) 
competent cells were used and transformation plates (containing Amp) were treated with 
10 µL 1 M IPTG and 20 µL X-Gal (50 mg/ml) before plating the transformed bacteria. 
 
Miniprep 
OVN cultures were prepared by inoculating 5mL LB containing Ampicillin (100 µg/ml) with 
one colony each from a transformation plate and incubation OVN at 37 °C. Bacteria were 
centrifuged at 2500 rpm for 10 min. Miniprep was done using a kit from Invitrogen according 
to the manufacturer’s instructions. In the end, DNA was eluted with 75 µL ddH2O. Correct 
clones were identified by test digest and subsequent sequencing. 
 
 
6.2. C. elegans maintenance and genetics 
 
C. elegans strains 
C. elegans strains were cultured on NGM (Nematode Growth Medium) plates seeded with 
E. coli OP50 as described previously (Brenner, 1974). Strains were kept at 20 °C if not oth-
erwise mentioned. Strains used in this study are listed in Table 8.5 in the appendix. Bristol 
N2 was used as wild type strain. Strains were ordered from the C. elegans Gene Knockout 
Consortium (CGC; Vancouver, Canada and Minnesota/Oklahoma, USA) and the National 
Biosource Project for the Nematode C. elegans (Tokyo, Japan) if not stated differently.  
 
Generation of transgenic worms by microinjection 
Microinjection of plasmid mixes into wild type worms was used to generate transgenic lines 
carrying extrachromosomal arrays as described by Mello & Fire (Mello and Fire, 1995). The 
injection mixes were containing the plasmids of interest along with coinjection markers which 
allow screening for progeny of the injected worms for positives carrying an extrachromoso-
mal array. The total DNA concentration of injection mixes was adjusted to 100 ng/µL by addi-
tion of pBluescript II SK(+). For injection, L4 or young adult worms were fixed in a drop of 
injection oil (Sigma H8898) on a dried 2% agarose pad. Injection into the distal gonads was 
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performed using a micromanipulator and a pump as described earlier (Mello and Fire, 1995). 
After injection, worms were rescued by addition of M9 Buffer onto the pad and put onto fresh 
NGM plates seeded with E. coli OP50. The F1 progeny is screened for worms carrying the 
extrachromosomal array as seen by expression of the coinjection marker and positive proge-
ny is separated on individual plates. Each of these positive F1 animals that produces positive 
F2 is considered as an independent transgenic line. A list of the injection mixes used in this 
study is provided in the appendix (Table 8.4) and the transgenic strains used in this study are 
listed in Table 8.5. 
 
Crosses 
For crossings, males of a him-8; ccIs4251 strain (which carries a GFP-marker for muscle 
cells in a him-8 (high incidence of males 8) background which leads to increased occurrence 
of male progeny). The GFP-marker allows for the distinction of cross-progeny from self-
progeny. Alternatively, males of the marker strain to be crossed into the mutants were gen-
erated by subjecting L4 worms of the marker strain to a heat shock at 30 °C for 6 h which 




Worm PCR was performed for genotyping the progeny of crosses. Primers used for worm 
PCRs are listed in Table 8.3. First, worm lysates were generated by picking either one worm 
in 10 µL (for single worm PCR) or 10-20 worms into 10-20 µL lysis buffer (1x PCR buffer con-
taining 1µg/µL Proteinase K (Roth) freshly prepared from 10x Worm PCR buffer and a Pro-
teinase K stock (20 mg/ml)). Worms in lysis buffer were then frozen at -80 °C for at least 
10 min before performing worm lysis in a PCR machine. The protocol was as follows: 65 °C 
for 1 h followed by 15 min at 95 °C to inactivate proteinase K. 2 µL of the worm lysate where 
then used as template for the worm PCR. Reaction mix for worm PCR per reaction (total vol-
ume: 25 µL): 
Worm lysate    2.0 µL 
10x Worm PCR buffer   2.5 µL 
Forward Primer   0.25 µL 
Reverse Primer    0.25 µL 
dNTPs (Fermentas)      0.5 µL 
Taq A or pTC-Taq (homemade) 0.25 µL 
dH2O     19.25 µL 
 
 





High Pressure Freeze Electron Microscopy (HPF-EM) 
HPF-EM was done by Dr. Jan Hegerman as described previously (Sumakovic et al., 2009). 
Worms were subjected to HPF as young adults. For analysis of solutions containing αS, ni-
trocellulose capillary tubes were used. The protocol for generating tomograms of mitochon-
dria for catp-6 worms and wild type control was described in (Witte et al., 2011). The tomo-
grams were generated on longitudinal sections through BWMs of the worms. Analysis of 
cross-section areas of mitochondria for catp-6 mutants and wild type control was performed 
in cross-sections through BWM cells. 
 
Preparation of worms for light microscopy 
Before imaging, worms were anaesthetized in a drop of 50 mM NaN3 (sodium azide) in 
M9 buffer on a fresh 2% agarose pad and incubated several minutes until worms were im-
mobilized before covering with a glass coverslip (Bargmann and Avery, 1995). If not other-
wise stated, young adult worms (3 days after the eggs have been laid) were imaged. 
 
DIC microscopy 
DIC (Differential interference contrast) images were taken at a Zeiss Axiovert 200 Micro-
scope. DIC images of whole worms were generated by taking a series of images of different 
segments of the worms with a 20x objective and then merging them in Photoshop to get a 
picture of the full-length worm. For these images, adult worms 24 h post-L4 stage were used. 
Images of the uterus were taken form adults 48 h post-L4 with a 20x microscope and the 
vulva was imaged in young adult worms using a 63x objective. 
 
Imaging of DA neurons 
Imaging of C. elegans DA neurons expressing mRFP from a dat-1 promoter was performed 
by Dr. Stefan Eimer using a Leica Confocal Laser Scanning Microscope SP2 and the images 
were scored for defects in neurite morphology. 
 
Imaging αS-mYFP aggregation in vulva muscles  
αS-mYFP aggregation was assessed by imaging the vulva musculature of 10-day-old adults 
on a UltraviewVOX spinning disk microscope (Perkin Elmer) with a 60x/1.35 objective. Anal-
ysis was performed on z-stacks (with a z-spacing of 2 µm) which were projected into a single 
plane using the extended focus tool of the Volocity software (Perkin Elmer). At least two in-
dependent transgenic lines were analyzed for each αS variant. Vulva muscles were scored 
positive if, at least, one fibrillar aggregate was visible. 
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Imaging mitochondria and DRP-1 in muscle cells and neurons 
Mitochondria in BWM cells were visualized by using the OMM marker pmyo-3::tom70-cfp 
(kindly provided by A. van der Bliek, UCLA; (Labrousse et al., 1999)). For analysis of DRP-1 
localization, a TagRFP-DRP-1 fusion protein was expressed along with the mitochondrial 
marker in the muscle cells. Imaging was done on a UltraviewVOX spinning disk microscope 
(Perkin Elmer) with a 100x/1.40 oil immersion objective. Muscle cells were classified accord-
ing to the appearance of wild type-like, thin or fragmented mitochondria. The classification 
was done on z-stacks (with a z-spacing of 1 µm) which were projected into a single plane 
using the extended focus tool of the Volocity software (Perkin Elmer). DRP-1 localization was 
scored as normal, if distinct spots were equally distributed throughout the cell and as clus-
tered if larger aggregated of DRP-1 were present in proximity to the nucleus. 
In order to analyze changes in mitochondrial morphology occurring during aging, we com-
pared the mitochondrial morphology in muscle cells of young adult worms (3 days after 
hatching) with that of worms in the post-reproductive stage (7 days after hatching). This ex-
periment was performed with two of the transgenic lines described above – one with and one 
without ectopic expression of αS. 
For the starvation experiment, worms were transferred to special NGM plates that lack pep-
tone and contain 100 µg/ml Amp and that were not seeded with bacteria. Transfer of the 
worms from normal NGM plates with bacteria to the starvation plates was done when they 
had reached L4 or L3 stage and worms were grown on these plates for 24 and 52 h, respec-
tively, before imaging mitochondria in BWMs. 
For visualization of mitochondria and DRP-1 in neurons, the TagRFP-DRP-1 and 
TOM70-CFP markers were expressed under the control of a pan-neuronal rab-3 promoter. 
Imaging of ventral nerve cord neurons was performed in the same way as described for the 
muscle cells but z-spacing in the case of neurons was set to 0.3 µm. Mitochondrial appear-
ance in the neuronal cell bodies was classified into three categories: ring like, tubular or high-
ly fragmented structures. In the case of αS-expressing worms, the αS-mYFP signal was also 
imaged to assess aggregation in neurons. 
 
Expression pattern analysis 
For the expression pattern analysis, GFP was expressed from the catp-6 promoter. For clon-
ing of the promoter, the sequence spanning 4 kb upstream of the catp-6 start ATG was am-
plified and the pcatp-6::gfp construct was generated by Katrin Schwarze, a former technician 
in the lab. Worms carrying an extrachromosomal array expressing this construct were gener-
ated and imaged with an UltraviewVOX spinning Disk microscope (Perkin Elmer) with a 
60x/1.35 oil immersion objective was used. Images were taken as z-stacks (with a z-spacing 
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of 2 µm) and were subsequently projected into a single plane using the extended focus tool 
of the Volocity software (Perkin Elmer). 
 
Imaging of vulva muscles 
For imaging of the vulva muscle morphology and arrangement, a 40x/0.75 objective at the 
UltraviewVOX spinning disk microscope (Perkin Elmer) was used. Vulva muscles were visu-
alized by using the strain PD4595 which carries an integrated array expressing ceh-24::gfp, a 
marker that has been described to label all eight vulva muscles (Harfe et al., 1998). The vul-
va was imaged from a lateral view. Analysis was performed on z-stacks (with a z-spacing of 
2 µm) which were projected into a single plane using the extended focus tool of the Volocity 
software (Perkin Elmer). The vulva musculature was scored for three defects: muscles that 
are not properly attached to the vulva, muscle with irregular arrangement and lack of at least 
one muscle. 
 
Imaging of myo-filament arrangement in BWM cells 
Analysis of the myo-filament arrangement in BWM cells of catp-6 worms and wild type con-
trols was performed by Dr. Sabine König using an UltraviewVOX spinning Disk microscope 
(Perkin Elmer) with a 60x/1.35 oil immersion objective. For visualization of the myo-filaments, 
a translational fusion of GFP with MYO-3, a myosin heavy chain protein, was used (Meissner 
et al., 2009). 
 
Imaging germline apoptosis 
Apoptotic corpses in the C. elegans germline were visualized using the previously described  
reporter construct plim-7::ced-1-gfp (Schumacher et al., 2005). The gonads of young adult 
worms were imaged on an UltraviewVOX spinning Disk microscope (Perkin Elmer) with a 
40x/0.75 oil immersion objective. Apoptotic corpses per gonad arm were counted in z-stacks 
with z-spacing of 2 µm. 
 
Imaging autophagic foci in C. elegans embryos 
Autophagic foci were visualized by using a previously described GFP-LGG-1 reporter con-
struct driven by the lgg-1 promoter (Kang et al., 2007; Melendez et al., 2008). Eggs of the 
150-300 cell stage were imaged in M9 buffer on a fresh 2% agarose pad on an Ultra-
viewVOX spinning Disk microscope (Perkin Elmer) with a 100x/1.40 oil immersion objective. 
Analysis of the autophagic foci was done on z-stacks (with a z-spacing of 1 µm) which were 
projected into a single plane using the extended focus tool of the Volocity software (Perkin 
Elmer). Analysis of number and size of the autophagic foci was done in ImageJ. For this pur-
pose, the image was converted to 8 bit and a threshold was set to create a binary image. 
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Then, a built-in multiple particle analyzer was used with the following settings: size 
50-100 pixels and circularity 0.3-1.0. 
 
6.4. RNAi by feeding 
 
The mitochondrial dynamics genes drp-1, fis-1, fzo-1 and eat-3 were knocked down by feed-
ing RNAi as described previously (Kamath and Ahringer, 2003). For this purpose, the genes 
were cloned into the RNAi vector L4440 and transformed in HT115 cells which were then 
seeded onto RNAi plates (NGM plates containing 100 µg/ml Amp and 1 mM IPTG). The 
empty L4440 vector was used as negative control and RNAi against pos-1 was used as posi-
tive control as it had previously been shown that RNAi against this gene results in embryonic 
lethality (Kamath and Ahringer, 2003). The RNAi experiments were done in an RNAi-
hypersensitive eri-1(mg366) background. For the RNAi experiments, the F0 generation was 
transferred to RNAi plates at the L3 larval stage. The mothers were subsequently transferred 
to new RNAi plates every 12 h. As judged by lethality of pos-1 RNAi, RNAi was working effi-
ciently for eggs of mothers that had been on the RNAi plates for 24 h. Therefore, F1 progeny 
that had been laid in a time window between 24 and 36 h after transfer of the mothers to 
RNAi plates were analyzed. Mitochondrial morphology and DRP-1 localization in these 
worms was analyzed as described above. 
 
 
6.5. Phenotypic analysis/Behavioural Assays 
 
Food slowing response 
The food slowing response of worms expressing different αS constructs under the control of 
a dat-1 promoter was analyzed by Dr. Stefan Eimer. The slowing rate was determined as the 
average decrease in movement (body bends/min) for animals placed on food as compared to 
animals without food. 
 
Brood size 
Brood size analysis of catp-6 deletion mutants and wild type controls was performed by 
Dr. Sabine König. L4 worms were separated onto individual plates and each worm was 
transferred to a new plate every 12-24 h and the progeny of the previous plate was counted. 
Besides determining the brood size, worms were scored for Egl and pVul phenotypes. 
 
PED 
To determine the duration of postembryonic development (PED) of catp-6 mutants and wild 
type controls, young adult worms were allowed to lay eggs for 4 h. After 12 h, hatched L1 
larvae were separated onto individual NGM plates and it was determined how long it takes 
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until they reach adulthood and are producing eggs themselves. For this purpose, the worms 
were analyzed every six hours. 
 
Movement 
Movement of catp-6 mutants and controls was analyzed at the L3 larval stage and in young 
adult worms. For this analysis, worms were transferred on NGM plates without food. After an 
adaptation period of 30 min, movement was analyzed by counting the number of body bends 
(complete sinusoidal wave) per minute. This was done by visual inspection under a dissec-




The sensitivity to oxidative stress was assessed by treatment with paraquat, which causes 
massive generation of superoxide (Bus and Gibson, 1984), as described previously (Samann 
et al., 2009). Paraquat plates were produced by adding 200 µL of a 150 mM paraquat solu-
tion in M9 buffer onto small (3.5 cm in diameter) NGM plates seeded with E. coli OP50. 
Worms were transferred to paraquat plates at the L4 larval stage and survival of the worms 
was assessed after 2 days. 
 
Lifespan 
As catp-6 worms have a strong Egl phenotype, they often die because their progeny is 
hatching inside the mother, eventually killing it. In order to assess lifespan independent of 
this, we were performing lifespan analyses in a glp-4(bn2) background, a temperature-
sensitive allele in which germline proliferation is inhibited at the non-permissive temperature 
of 25 °C (Beanan and Strome, 1992). For the lifespan assay, 3 plates of 15 L2 worms were 
prepared per strain and the plates were kept at 25 °C until the worms reached adulthood so 
that no gonads were formed. Then, the worms were grown at 20 °C and survival was as-
sessed every day. 
 
 
6.6. Analysis of mitochondrial function 
 
Isolation of C. elegans mitochondria 
For mitochondrial isolation, worms were grown on big (12x12 cm) double peptone NGM 
plates (peptone concentration doubled when compared to normal NGM plates) which were 
seeded with a fast-growing E. coli OP50 strain generating a thick bacterial lawn. For each 
strain, 60 plates were prepared and worms were washed with M9 buffer when the plate was 
full of worms, shortly before starvation. Worms were collected in 15 mL Falcon tubes and 
centrifuged for 5 min at 800 rpm before taking off the supernatant. Subsequently, worms 
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were washed twice in M9 buffer and the pellets were brought to the lab of Prof. Peter Rehling 
where Dr. Jan Dudek was performing the isolation of the mitochondria. 
 
Membrane potential 
The membrane potential of isolated mitochondria was measured by Dr. Jan Dudek. Mito-
chondria were incubated in isoosmotic potassium buffer in the presence of 1 µM DiSC3(5). 
Fluorescence of this dye is quenched by the mitochondrial membrane potential. The specific-
ity of the measurement was assessed by KCN (potassium cyanide; 1 M in H2O) inhibition of 
complex IV of the respiratory chain. The membrane potential was calculated as the differ-
ence between mitochondrial quenching of active and KCN-intoxicated mitochondria. 
 
Analysis of respiratory chain complex IV activity 
Analysis of the activity and composition of complex IV of the respiratory chain was done by 
Dr. Jan Dudek. Shortly, mitochondrial respiratory chain complexes were solubilized by Blue 
Native polyacrylamide gel electrophoresis (BN-PAGE). For staining of complex IV, reduced 
cytochrome c (cyt c) was added in the gel. Oxidation of cyt c by complex IV is supported by 
the diaminobenzidine specifically reducing cytochrome c. Thereby generated oxidized dia-
minobenzidine falls out as a brown precipitate, thus staining for complex IV activity.  
 
Oxygen consumption 
Oxygen consumption was measured in whole worms using a Seahorse Flux Analyzer XF96. 
The experiment was performed in 96-well plates and for each well, 20 young adult worms of 
the respective strains were picked into 180 µL M9 buffer. Measurements were done at 
20-25 °C. First, the basal oxygen consumption rate (OCR) was determined. Then, the mito-
chondrial uncoupler FCCP was added to a final concentration of 10 µM followed by another 
measurement of the OCR and finally, the OCR after inhibition of complex IV with sodium az-
ide (NaN3) was assessed. 
 
 
6.7. Assessing induction of the cellular stress responses  
 
Induction of the cellular stress responses was assessed using GFP-reporter constructs and 
determining GFP expression by fluorescence microscopy using a Keyence BZ9000 micro-
scope and by Western Blot using a monoclonal anti-GFP antibody (Roche). 
 
Mitochondrial stress response 
For the mitochondrial stress response, a hsp-6::gfp reporter strain (SJ4100) was used 
(Yoneda et al., 2004) and for induction of the mitochondrial stress response, L3 worms were 
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incubated for 24 h on NGM plates containing paraquat. Paraquat plates were produced by 
adding 200 µL of a 150 mM paraquat solution in M9 buffer onto small (3.5 cm in diameter) 
NGM plates seeded with E. coli OP50. 
 
ER unfolded protein response (UPRER) 
For the ER stress response, the strain SJ4005 expressing a hsp-4::gfp reporter construct 
was used (Calfon et al., 2002) and for induction of the UPRER, worms were grown on plates 
containing 2 µg/ml Tunicamycin as described previously (Durieux et al., 2011; Yoneda et al., 
2004). 
 
Cytosolic unfolded protein response (UPRcyt) 
For the cytosolic stress response, a hsp-16.2::gfp reporter strain (CL2070) was used (Link et 
al., 1999) and for induction of the UPRcyt, worms were subjected to a heat-shock for 6 h at 
30 °C as described previously (Durieux et al., 2011). 
 
 
6.8. Western blotting  
 
α-synuclein 
αS expression levels were determined by Western Blot. Worm lysates were prepared by lysis 
of 30 young adult worms in PAGE buffer containing β-Mercaptoethanol. 15 µL of these ly-
sates were cooked at 95 °C for 10 minutes followed by vortexing and centrifugation to re-
move debris. Samples were separated on a 12% SDS-PAGE gel and transferred to a nitro-
cellulose membrane and probed against αS using either a 1:750 dilution of a polyclonal rab-
bit anti-αS antibody (Anaspec) or a 1:50 dilution of a monoclonal rat 15G7 anti-αS antibody 
((Kahle et al., 2000); kindly provided by Prof. Christian Haass). A horse radish peroxidase-
coupled secondary anti-rat antibody (Jackson) was used in 1:10000 dilution. Images were 
quantified using ImageJ and normalized to the tubulin loading control which was probed with 
the monoclonal mouse anti-tubulin antibody 12G10 (DSHB) in a 1:1000 dilution and a horse 
radish peroxidase-coupled secondary anti-mouse antibody (Jackson) in 1:10000 dilution. 
 
GFP 
Western Blot to determine the expression levels of the cellular stress response reporters (as 
described above) was done as described above for αS but in this case a mouse monoclonal 
anti-GFP antibody (Roche) was used in a 1:1000 dilution as primary antibody, again, tubulin 
was used as loading control. 
 




For determination of the levels of phosphorylated AMPK, worms were grown on three big 
NGM plates and harvested by washing off with M9 buffer shortly before starvation. The worm 
pellet was washed twice with M9 buffer to eliminate bacteria from the solution and was then 
resuspended in 1x PAGE buffer with β-Mercaptoethanol. The Western Blot was described as 
described above for αS but a 1:500 dilution of a phosphorylation specific antibody (Thr172) 
for AMPK was used as primary AB in this case (40H9, monoclonal rabbit anti p-AMPK; Cell 
Signaling). Again, tubulin served as loading control. 
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8.1. Alignment of C. elegans CATP-6 and human ATP13A2 
 
Alignment of the protein sequences of C. elegans CATP--6 and human ATP13A2 was per-




hATP13A2     1 PLLLFRWKPLWGVRLRLRPCNLAHAETLVIEIRDKEDSSWQLFTVQVQTEAIGEGSLEPSPQSQAEDGRSQAAVGAVPEGAWKDTAQLHK 
Ce CATP-6    1 FRLILHWKQKWDVKMRMVPCTFEAAEYIYI----------------IDNHNVSE--LQPVLR------KSNATIPT-------ENGEMRK 
consensus    1   *. .**  * *..*. **    ** . *                .    . *..* *         .*.* .         . . ..* 
 
hATP13A2    91 SEEAKRVLRYYLFQGQRYIWIETQQAFYQVSLLDHGRSCDD----------------VHRSRHGLSLQDQMVRKAIYGPNVISIPVKSYP 
Ce CATP-6   60 VPE----LRWFVYRKLEYVWIDDLNSDESVDEISDNDNCWKTSFEIANRIPCRSLLAVSESNFGLTLSEISRRLEFYGRNEIVVQLRPIL 
consensus   91   *    **....    *.**.  .    *  .     *                  *  *  **.* .   *   ** * * . ..    
 
hATP13A2   165 QLLVDEALNPYYGFQAFSIALWLADHYYWYALCIFLISSISICLSLYKTRKQSQTLRDMVKLSMRVCVCRPGGEEEWVDSSELVPGDCLV 
Ce CATP-6  146 YLLVMEVITPFYVFQIFSVTVWYNDEYAYYASLIVILSLGSIVMDVYQIRTQEIRLRSMVHSTESVEVIREGTEMT-IGSDQLVPGDILL 
consensus  181  *** * . *.* ** **. .*  * * .**  * ..*  ** . .*  * *   ** **. .  * * * * *  .. *  ***** *. 
 
hATP13A2   255 LPQEGGLMPCDAALVAGECMVNESSLTGESIPVLKTALPEGLGP--YCAETHRRHTLFCGTLILQARAYVGPHVLAVVTRTGFCTAKGGL 
Ce CATP-6  235 IPPHGCLMQCDSVLMNGTVIVNESVLTGESVPITKVALTDETNDSVFNIEKNSKNVLFCGTQVLQTRFYRGKKVKAIVLRTAYSTLKGQL 
consensus  271 .*  * ** **  *. *  .**** *****.*. * ** .      .  *   .  ***** .** * * * .* *.* **.. * ** * 
 
hATP13A2   343 VSSILHPRPINFKFYKHSMKFVAALSVLALLGTIYSIFILYRNRVPLNEIVIRALDLVTVVVPPALPAAMTVCTLYAQSRLRRQGIFCIH 
Ce CATP-6  325 VRSIMYPKPVDFRFTKDLFKFILFLACISGCGFIYTIIVMIMRGNTLRRIIVRSLDIITITVPPALPAAMSVGIINAQLRLKKKEIFCIS 
consensus  361 * **. *.*. *.* *   **.  *  .   * **.* ..      *  *..* **..*. *********.*  . ** **..  ****  
 
hATP13A2   433 PLRINLGGKLQLVCFDKTGTLTEDGLDVMGVVPLKGQA----------------FLPLVPE---PRRLPV-GPLLRALATCHALSRLQDT 
Ce CATP-6  415 PSTINTCGAINVVCFDKTGTLTEDGLDFHVVRPVMSAVNQEIQKVKLEKSNRTEFMGEMTELTSRNGLPFDGDLVKAIATCHSLTRINGV 
consensus  451 *  **  * ...***************   * *.                    *.  . *      **  * *..*.**** *.*..   
 
hATP13A2   503 PVGDPMDLKMVESTGWVLEEEPAADSAFGTQVLAVMRPPLWEPQLQAMEEPPVPVSVLHRFPFSSALQRMSVVVAWPGATQPEA---YVK 
Ce CATP-6  505 LHGDPLDLILFQKTGWTMEEGIEGDIEEETQRFDNVQPSIIKPT----DDKSAEYSVIRQFTFSSSLQRMSVIVFDPREDRPDNMMLYSK 
consensus  541   ***.** .   *** .**   .*    **    . * .  *     ..     **.. * *** ******.*  *    *.    * * 
 
hATP13A2   590 GSPELVAGLCNPETVPTDFAQMLQSYTAAGYRVVALASKPLPTVPSLEAAQQLTRDTVEGDLSLLGLLVMRNLLKPQTTPVIQALRRTRI 
Ce CATP-6  591 GSPEMILSLCDPNTVPEDYLLQVNSYAQHGFRLIAVARRPLDL--NFNKASKVKRDAVECDLEMLGLIVMENRVKPVTLGVINQLNRANI 
consensus  631 ****..  ** * *** *.   ..**   *.*..*.* .**        *  . ** ** ** .***.** * .** *  **. * *  * 
 
hATP13A2   680 RAVMVTGDNLQTAVTVARGCGMVAPQEHLIIVHATHPE-------------------------------------RGQPASLEFLPMES- 
Ce CATP-6  679 RTVMVTGDNLLTGLSVARECGIIRPSKRAFLVEHVPGELDEYGRTKIFVKQSVSSSDEVIEDDASVSISMCSSTWKGSSEGDGFSPTNTE 
consensus  721 * ******** *...*** **.. *  .  .*     *                                     .*      * *  .  
 
hATP13A2   732 -----PTAVNGVKVLVQGT-----------------------------VFARMAPEQKTELVCELQKLQYCVGMCGDGANDCGALKAADV 
Ce CATP-6  769 VETPNPVTADSLGHLIASSYHLAISGPTFAVIVHEYPELVDQLCSVCDVFARMAPDQKQSLVEQLQQIDYTVAMCGDGANDCAALKAAHA 
consensus  811      *     .  *.  .                             *******.**  **  ** . * *.*********.*****   
 
hATP13A2   788 GISLSQAEASVVSPFTSSMASIECVPMVIREGRCSLDTSFSVFKYMALYSLTQFISVLILYTINTNLGDLQFLAIDLVITTTVAVLMSRT 
Ce CATP-6  859 GISLSDAEASIAAPFTSKVPDIRCVPTVISEGRAALVTSFGIFKYMAGYSLTQFVTVMHLYWISNILTDGQFMYIDMFLITMFALLFGNT 
consensus  901 ***** ****.  **** .  * *** ** ***  * *** .***** ******..*. ** *   * * **. **. . *  *.*   * 
 
hATP13A2   878 GPALVLGRVRPPGALLSVPVLSSLLLQMVLVTGVQLGGYFLTLAQPWFVPLNRTVAAP-DNLPNYENTVVFSLSSFQYLILAAAVSKGAP 
Ce CATP-6  949 PAFYRLAHTPPPTRLLSIASMTSVVGQLIIIGVVQFIVFFSTSQQPWFTPYQPPVDDEVEDKRSMQGTALFCVSMFQYIILALVYSKGPP 
consensus  991      *..  **  ***.  ..*.. *....  **   .* *  **** * .  *    .       * .* .* ***.***   *** * 
 
hATP13A2   967 FRRPLYTNERARPV--------------PPRLPAPPPAQAGLQEALQAAGTRAGRAALAAAARRPPEVVQAHGHPRHWNSLPLSHQLDPS 
Ce CATP-6 1039 FRGNLWSNKPMCALTIFATLLCLFIVIWPTELVLKTLGNVELPSLTFRIFIVIVGAVNAAVSYGFETLFVDFFLLGYWERYKKKRSIEAI 
consensus 1081 **  *..*     .              *  *     ..  *             *  **       .         *      . ..   
 
hATP13A2  1043 PATPPPPPPTSLRLATVY-TPPPRPPPPWGSVDYCPLPWT--------------------IPRRGGSPQ-----LPSVLLSV-------- 
Ce CATP-6 1129 IDYVPTTNSDHIRRPSINGVTSSRTESTLLSAEGQQLHMTTSKNGKGGENPHSSALFERLISRIGGEPTWLTNPIPPHSLSEPEEPEKLE 
consensus 1171     *      .*  .. .    *      * .   *  *                    * * ** *      .*   **  
 
hATP13A2       --- 
Ce CATP-6 1219 RTY 
consensus          
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8.2. Plasmids, primers and strains 
 
Table 8.1: List of plasmids used in this study. 
Plasmid name Resistance Description Source 
pBluescript II SK(+) Amp
R 
Entry vector for cloning Stratagene 
pGEM-T Amp
R
 Entry vector for TA cloning Promega 
L4440 Amp
R






Muscle expression vector for C. elegans 
contains unc-54 3’ UTR 
Addgene, Andrew 




pPD115.62 in which gfp was replaced by 
yfp 
Kindly provided by 




Neuronal expression vector for C. elegans 
based on pPD155.62 backbone 






Muscle expression vector for C. elegans 
based on pPD115.62 backbone 
for N-terminal Tags 
Kindly provided by 
Dr. Ling Luo 
pT7_7 wt αS Amp
R
 used as template for αS PCR 
Kindly provided by 
Prof. Markus 
Zweckstetter 
pT7_7 TP αS Amp
R
 used as template for αS PCR 
Kindly provided by 
Prof Markus 
Zweckstetter 
pT7_7 A56P αS Amp
R
 used as template for αS PCR 
Kindly provided by 
Prof Markus 
Zweckstetter 
pT7_7 A30P αS Amp
R
 used as template for αS PCR 
Kindly provided by 
Prof Markus 
Zweckstetter 
pT7_7 A53T αS Amp
R
 used as template for αS PCR 









expression of mRFP in C. elegans DA 
neurons 




expression of eGFP in C. elegans DA 
neurons 




expression of wt αS in C. elegans DA 
neurons 




expression of A56P αS in C. elegans DA 
neurons 




expression of TP αS in C. elegans DA 
neurons 




expression of A30P αS in C. elegans DA 
neurons 




expression of A53T αS in C. elegans DA 
neurons 




expression of wt αS-YFP in C. elegans 
muscle cells 





expression of TP αS-YFP in C. elegans 
muscle cells 







expression of A30P αS-YFP in C. elegans 
muscle cells 







expression of A53T αS-YFP in C. elegans 
muscle cells 





marker for outer mitochondrial membrane 
(TM domain of yeast TOM70 fused to 
CFP) in C. elegans muscle cells 
Kindly provided by 
Alexander van der 
Bliek 






expression of wt αS-YFP in C. elegans 
neurons 





marker for outer mitochondrial membrane 
(TM domain of yeast TOM70 fused to 
CFP) in C. elegans neurons 





expression of TagRFP-DRP-1 in 
C. elegans muscle cells 





expression of TagRFP-DRP-1 in 
C. elegans neurons 




 For expression pattern analysis of catp-6 





Expression of CATP-6 in C. elegans mus-
cle cells 
pPD115.62 backbone 




 For feeding RNAi against drp-1 




 For feeding RNAi against fis-1 




 For feeding RNAi against fzo-1 




 For feeding RNAi against eat-3 




 For feeding RNAi against pos-1 Kamath, 2003 





TagRFP_T in Entry vector for subsequent 
cloning 




Table 8.2: Cloning strategies for constructs used in this study. 
Plasmid name PCR Cloning 
pGEM-T wt αS template: pT7_7 wt αS 
primers: oGQ1340/oGQ1341 
polymerase: Taq 
Ligate PCR product into pGEM-T 
(AT cloning) 
pGEM-T TP αS template: pT7_7 TP αS 
primers: oGQ1340/oGQ1341 
polymerase: Taq 
Ligate PCR product into pGEM-T 
(AT cloning) 
pGEM-T A30P αS template: pT7_7 A30P αS 
primers: oGQ1340/oGQ1341 
Polymerase: Taq 
Ligate PCR product into pGEM-T 
(AT cloning) 
pGEM-T A53T αS template: pT7_7 A53T αS 
primers: oGQ1340/oGQ1341 
polymerase: Taq 
Ligate PCR product into pGEM-T 
(AT cloning) 
Pmyo-3::wt αS-myfp  wt αS from pGEM-T wt αS cloned 
into pmyo-3::myfp (KpnI/NotI) 
pmyo-3::TP αS-myfp  wt αS in pmyo-3::wt αS-myfp re-
placed by TP αS from pGEM-T TP 
αS (KpnI/NotI) 
pmyo-3::A30P αS-myfp  wt αS in pmyo-3::wt αS-myfp re-
placed by A30P αS from pGEM-T 
A30P αS (KpnI/NotI) 
pmyo-3::A53T αS-myfp  wt αS in pmyo-3::wt αS-myfp re-
placed by A53T αS from pGEM-T 
A53T αS (KpnI/NotI) 
prab-3::wt αS-myfp  pmyo-3 in pmyo-3::wt αS-myfp 
replaced by prab-3 from 
prab-3::mcherry (PstI/KpnI) 
prab-3::tom70-cfp  pmyo-3 in pmyo-3::tom70-cfp re-
placed by prab-3 from 
prab-3::mcherry (PstI/KpnI) 
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pGEM-T tagrfp (w/o stop) template: pQL41 
primers: oGQ456/539 
polymerase: Taq 
TagRFP_T cloned into pGEM-T 
(AT cloning) 
pBluescript II SK(+) drp-1 template: C. elegans genomic DNA 
primers: oGQ1216/oGQ1217 
polymerase: Pfu 
PCR product cloned into 
pBluescript II SK(+) (XhoI/BamHI) 
pmyo-3::tagrfp-drp-1  tagrfp from pGEM-T tagrfp (w/o 
stop) (KpnI/NotI) and drp-1 from 
pBluescript II SK(+) drp-1  
(NotI/XhoI) cloned into 
pmyo-3::gfp-grip (KpnI/XhoI) 
prab-3::tagrfp-drp-1  tagrfp from pGEM-T tagrfp (w/o 
stop) (KpnI/NotI) and drp-1 from 
pBluescript II SK(+) drp-1  
(NotI/XhoI) cloned into 
prab-3::mcherry (KpnI/XhoI) 
L4440 drp-1  drp-1 from pBluescript II SK(+) 
cloned into L4440 (NotI/XhoI) 




PCR product ligated in L4444 cut 
with EcoRV 




PCR product ligated in L4444 cut 
with EcoRV 








Table 8.3: List of primers used in this study. 
Primer Description Sequence Tm 
oGQ456 TagRFP forward primer that matches the 
Start codon and introduces a BamHI and 




oGQ539 TagRFP reverse primer that matches the end 
of TagRFP and introduces a NotI, NheI, 





oGQ1216 fwd primer for drp-1 genomic DNA that intro-
duces a Eco47III half site and BamHI site 






oGQ1217 rev primer drp-1 genomic DNA that introduc-






oGQ1340 for Primer for human α-synuclein (w/o stop) 
that introduces Kpn I and Age I sites up-







oGQ1341 rev Primer for human α-synuclein that re-
moves the stop codon and introduces Not I 





oGQ1723 fwd primer for eat-3 cDNA for N-terminal 
fusions that introduces Eco47III, NotI and 
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oGQ1724 rev primer for eat-3 cDNA for N-terminal fu-
sions that introduces XhoI and SmaI sites 




oGQ1725 fwd Primer for fis-1 cDNA for N-terminal fu-
sions that introduces Eco47III, NotI and AgeI 






oGQ1726 rev primer for fis-1 cDNA for N-terminal fu-
sions that introduces XhoI and SmaI sites 





oGQ1727 fwd primer for fzo-1 cDNA for N-terminal 
fusions that introduces Eco47III and NotI 







oGQ1728 rev primer for fzo-1 cDNA for N-terminal fu-
sions that introduces a SmaI sites down-
stream of the stop codon (XhoI and EcoRI 






oGQ1948 forward primer to amplify the catp-6 promoter 





oGQ1949 reverse primer to amplify the catp-6 promoter 
that start just upstream of the start ATG and 




oGQ1358 Forward primer 1 for detecting the eri-1 
(mg366) insertion 
actgatgggtaaggaatcgaagacg 60 °C 
oGQ1359 Reverse primer 1 for detecting the eri-1 
(mg366) insertion 
gataaaacttcggaacatatggggc 58 °C 
oGQ1849 Deletion Primer for catp-6 (ok3473) outer left 
Sequence:  
cttaaaatttcgcggctgag 53 °C 
oGQ1852 Deletion Primer for catp-6 (ok3473) inner 
right sequence:  
tggtgagctcgatgaatacg 55 °C 
oGQ2221 Fwd Primer (external) catp-6 for screening for 
tm3190 
ccagctcttccaggtaacct 57 °C 
oGQ2222 Primer (external) catp-6 for screening for 
tm3190 deletion 
ggttgaacattatcgaatcgttgag 56 °C 
oGQ1906 Fwd primer for gfp w/o stop that introduces a 




oGQ1907 rev Primer for gfp w/o stop that introduces a 
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Table 8.4: List of injection mixes used in this study. 
Injection mix 
name 
Plasmids of interest Markers 
InNo17 40 ng/µL  pmyo-3::wt αS-mYFP  40 ng/µL  pRF4 (rol-6(su1006)) 
20 ng/µL  pttx-3::gfp 
InNo23 40 ng/µL  pmyo-3::TP αS-mYFP 40 ng/µL  pRF4 (rol-6(su1006)) 
20 ng/µL  pttx-3::gfp 
InNo29   5 ng/µL  pmyo-3::tagrfp-drp-1 
  5 ng/µL  pmyo-3::tom70-cfp 
40 ng/µL  pRF4 (rol-6(su1006)) 
20 ng/µL  pttx-3::gfp 
InNo30   5 ng/µL  pmyo-3::tom70-cfp 
55 ng/µL  pmyo-3::wt αS-mYFP 
40 ng/µL  pRF4 (rol-6(su1006)) 
 
InNo31   5 ng/µL  pmyo-3::tom70-cfp 40 ng/µL  pRF4 (rol-6(su1006)) 
InNo33   5 ng/µL  pmyo-3::tom70-cfp 
30 ng/µL  pmy-o3::wt αS-mYFP 
40 ng/µL  pRF4 (rol-6(su1006)) 
 
InNo39   5 ng/µL  pmyo-3::tom70-cfp 
30 ng/µL  pmyo-3::TP αS-mYFP 
40 ng/µL  pRF4 (rol-6(su1006)) 
 
InNo41   5 ng/µL  pmyo-3::tom70-cfp 
  5 ng/µL  pmyo-3::wt αS-mYFP 
40 ng/µL  pRF4 (rol-6(su1006)) 
 
InNo42   5 ng/µL  prab-3::tom70-cfp 40 ng/µL  pRF4 (rol-6(su1006)) 
InNo43   5 ng/µL  prab-3::tom70-cfp 
30 ng/µL  prab-3::wt αS-mYFP 
40 ng/µL  pRF4 (rol-6(su1006)) 
 
InNo47   5 ng/µL  pmyo-3::tom70-cfp 
30 ng/µL  pmyo-3::A30P αS-mYFP 
40 ng/µL  pRF4 (rol-6(su1006)) 
 
InNo50 5 ng/µL  pmyo-3::tom70-cfp 
30 ng/µL  pmyo-3::A53T αS-mYFP 
40 ng/µL  pRF4 (rol-6(su1006)) 
 
InNo61   5 ng/µL  prab-3::tom70-cfp 
  5 ng/µL  prab-3::tagrfp-drp-1 
40 ng/µL  pRF4 (rol-6(su1006)) 
 
InNo62   5 ng/µL  pmyo-3::tagrfp-drp-1 
  5 ng/µL  pmyo-3::tom70-cfp 
40 ng/µL  pRF4 (rol-6(su1006)) 
 
InNo68   5 ng/µL  pmyo-3::yfp-catp-6   5 ng/µL  pmyo-2::gfp 
InNo70 40 ng/µL  pcatp-6::gfp 30 ng/µL  pRF4 (rol-6(su1006)) 
InNo71 80 ng/µL  pcatp-6::gfp 30 ng/µL  pRF4 (rol-6(su1006)) 
 
 
Table 8.5: List of strains used in this study. 
Strain 
name 
Genotype Injection mix/Line 
GQ155 gzEx117 [pmyo-3::tom70-cfp; rol-6(su1006)] InNo31/2 
GQ156 gzEx118 [pmyo-3::tom70-cfp; rol-6(su1006)] InNo31/9 
GQ157 gzEx119 [pmyo-3::wt αS-myfp; pmyo-3::tom70-cfp; 
rol-6(su1006)] 
InNo33/3 
GQ158 gzEx120 [pmyo-3::wt αS-myfp; pmyo-3::tom70-cfp; 
rol-6(su1006)] 
InNo33/4 
GQ159 gzEx121 [pmyo-3::wt αS-myfp; pmyo-3::tom70-cfp; 
rol-6(su1006)] 
InNo30/3 
GQ160 gzEx122 [prab-3::tom70-cfp; rol-6(su1006)] InNo42/1 
GQ161 gzEx123 [prab-3::tom-70-cfp; rol-6(su1006)] InNo42/4 
GQ162 gzEx124 [prab-3:: wt αS-myfp; prab-3::tom70-CFP; 
rol-6(su1006sd)] 
InNo43/1 
GQ163 gzEx125 [prab-3:: wt αS-myfp; prab-3::tom70-CFP; 
rol-6(su1006sd)] 
InNo43/2 
GQ164 gzEx126 [prab-3:: wt αS-myfp; prab-3::tom70-CFP; 
rol-6(su1006sd)] 
InNo43/3 
GQ165 gzEx127 [pmyo-3::wt αS-myfp; pmyo-3::tom70-cfp; 
rol-6(su1006)] 
InNo30/1 
GQ166 gzEx128 [pmyo-3::wt αS-myfp; pmyo-3::tom70-cfp; 
rol-6(su1006)] 
InNo30/2 
GQ167 gzEx129 [pmyo-3::wt αS-myfp; pmyo-3::tom70-cfp; 
rol-6(su1006)] 
InNo33/1 
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CB5600 him-8; ccIs4251 [pmyo-3::Ngfp-lacZ; pmyo-3::Mtgfp]  
GQ707 catp-6(ok3473) 2*  
GQ708 catp-6(tm3190) 2*  
GQ709 N2; gzEx214[pcatp-6::gfp] InNo70/1 
GQ710 N2; gzEx215 [pcatp-6::gfp] InNo71/1 
GQ186 catp-6(ok3473) gzEx212 [pmyo-3::tom70-cfp; 
pmyo-3::tagrfp-drp-1; rol-6(su1006)] 
InNo29/3 
GQ670 gzEx212 [pmyo-3::tom70-cfp;tagrfp-drp-1; 
rol-6(su1006)] 
InNo29/3 
GQ671 eri-1(mg366); gzEx212 [pmyo-3::tom70-cfp; 
pmyo-3::tagrfp-drp-1; rol-6(su1006)] 
InNo29/3 




PD4595 ccIs4595 [ceh-24::gfp; rol-6(su1006)]  
GQ712 catp-6(ok3473); ccIs4595 [ceh-24::gfp; rol-6(su1006)]  
SJ4100 zcIs13[hsp-6::gfp]  
GQ713 catp-6(ok3473) ; zcIs13 [hsp-6::gfp]  
SJ4005 zcIs4 [hsp-4::gfp]  
GQ714 catp-6(ok3473) ; zcIs4[hsp-4::gfp]  
CL2070 dvIs70 [hsp-16.2::gfp; rol-6(su1006)]  
GQ715 catp-6(ok3473) ; dvIs70 [hsp-16.2::gfp; rol-6(su1006)]  
SS104 glp-4(bn2)  
GQ716 catp-6(ok3473); glp-4(bn2)  
QG717 catp-6(tm3190); glp-4(bn2) I  








GQ720 N2; gzEx217[prab-3::tom70-cfp; 
prab-3::tagrfp_t-drp-1] 
InNo61-8 
GQ721 catp-6(ok3473); gzEx217[prab-3::tom70-cfp; 
prab-3::tagrfp_t-drp-1] 
InNo61-8 
MD701 bcIs39[plim-7::ced-1-gfp]  
GQ722 catp-6(ok3473); bcIs39[plim-7::ced-1-gfp]  
DA2123 adIs2122[lgg-1::GFP, rol-6(su1006)]  
GQ723 catp-6(ok3473); adIs2122[lgg-1::GFP, rol-6(su1006)]  




CF1553 muIs84[psod-3::gfp]  
GQ725 catp-6(ok3473); muIs84[psod-3::gfp]  
GQ726 catp-6(tm3190); muIs84[psod-3::gfp]  
GQ727 N2; gzEx218[pmyo-3::yfp-catp-6; pmyo-2::gfp] InNo/68-1 
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8.3. Media, solutions and buffers 
 
Luria-Bertani (LB) Medium, liquid 
5 g Peptone 
2.5 g Yeast extract 
5 g NaCl 
Add ddH20 to 1 L 
→ Autoclave 
 
Luria-Bertani (LB) Medium, for plates 
5 g Peptone 
2.5 g Yeast extract 
5 g NaCl 
7.5 g Agar  
Add ddH20 to 1 L 
→ Autoclave 
If needed add Amp (1:500) after cooling down to 




Nematode Growth Medium (NGM) 
16 g Agar 
3 g Peptone 
3 g NaCl 
Add ddH20 to 1 L 
→ Autoclave 
After cooling down add the following solutions: 
25 mL 1 M KPO4 Solution 
1 mL 1 M MgSO4 Solution 
1 mL 1 M CaCl2 Solution 
1mL 10 mg/ml Nystatin in DMSO 




3 g KH2PO4 
6 g Na2HPO4 
5 g NaCl 




Worm lysis/PCR buffer (10x) 
1 M Tris pH 8.3 
5 M KCl 
200 mM MgCl2 
 
 
TBE buffer (10x) 
108 g  Tris NaOH 
55 g  Boric acid 
9.3 g  EDTA (pH 8.0) 
Add ddH20 to 1 L 
→ Autoclave 




10 mM Tris-HCl pH 8.0 
0.05% Tween 20 
150 mM NaCl 
 
2x PAGE sample buffer with  
β-Mercaptoethanol 
121.1 g/L  Tris pH 6.8 
20%  Glycerol (v/v) 
100 g/L     SDS 
0.002%     Bromophenol blue (w/v) 
200 mL     β-Mercaptoethanol (Sigma Aldrich) 
Add ddH20 to 1 L 
 
SDS PAGE Running buffer(10x) 
30.3 g  Tris 
144 g Glycine 
10 g SDS 
Add ddH20 to 1 L 
Adjust to pH 8.3 
 
Blotting buffer 
5.8 g   Tris 
2.9 g  Glycine 
0.37 g  SDS 
400 mL  MeOH 
Add ddH20 to 1 L 
Adjust to pH 8.9 
 
Stripping buffer 
100 mM  β-Mercaptoethanol 
2%  SDS 
62.5 mM TRIS-HCl 
400 mL  MeOH 
Add ddH20 to 1 L 
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